,Date,Title,Page Type,Country Code,Author,Category Details,Full Text,Gender,Hashtags,Interest,Professions,Total Monthly Visitors,Twitter Author ID,Twitter Channel Role,Twitter Followers,Twitter Following,Twitter Reply Count,Twitter Reply to,Twitter Retweet of,Twitter Retweets,Twitter Likes,Twitter Tweets,Twitter Verified,clean_tw
0,2023-10-16 02:28:53.0,@RealTalkMS_jon Yes Judging by the Science revealed at ECTRIMS we need to strat calling MS a virus instead of Autoimmune,twitter,,bam214_bam,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@realtalkms_jon yes judging by the science revealed at ectrims we need to strat calling ms a virus instead of autoimmune,unknown,,,,6000000000,1354700283494821892,,35,48,0,http://twitter.com/RealTalkMS_jon/statuses/1713648689460269565,,0,1,700,false,yes judging by the science revealed at ectrims we need to strat calling ms a virus instead of autoimmune
1,2023-10-15 23:00:29.0,"StimRouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with #MultipleSclerosis based on a recent study presented at #MSMilan2023. @ACTRIMS @ECTRIMS 

Dive into the details: https://t.co/wrJ8e34meO",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",stimrouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with #multiplesclerosis based on a recent study presented at #msmilan2023. @actrims @ectrims dive into the details: https://t.co/wrj8e34meo,,"#neuromodulation, #multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8630,518,0,,,0,0,33766,false,stimrouter #neuromodulation system shows remarkable improvements in lower urinary tract issues for patients with multiple sclerosis based on a recent study presented at ms milan. dive into the details:
2,2023-10-15 21:00:30.0,"New Research Alert! #Satralizumab continues demonstrating long-term efficacy in patients with AQP4-IgG seropositive #NMOSD, according to a recent study presented at #MSMilan2023. @ACTRIMS @ECTRIMS @UniofOxford

Explore more here: https://t.co/pLMfjjWROy",twitter,USA,neurology_live,"{id=20740632, name=Enspryng / satralizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","new research alert! #satralizumab continues demonstrating long-term efficacy in patients with aqp4-igg seropositive #nmosd, according to a recent study presented at #msmilan2023. @actrims @ectrims @uniofoxford explore more here: https://t.co/plmfjjwroy",,"#satralizumab, #nmosd, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,0,33765,false,"new research alert! #satralizumab continues demonstrating long-term efficacy in patients with aqp4-igg seropositive #nmosd, according to a recent study presented at ms milan. explore more here:"
3,2023-10-15 19:00:45.0,"Discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with #MS from this recent study presented at #MSMilan2023. Stay on the cutting edge by learning about the latest advances in #MScare. @ECTRIMS 

Read: https://t.co/I5IueX85Ps",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with #ms from this recent study presented at #msmilan2023. stay on the cutting edge by learning about the latest advances in #mscare. @ectrims read: https://t.co/i5iuex85ps,,"#stemcelltherapy, #ms, #msmilan2023, #mscare",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,2,33764,false,discover the exciting cognitive biomarker improvements in mesenchymal #stemcelltherapy for patients with ms from this recent study presented at ms milan. stay on the cutting edge by learning about the latest advances in mscare. read:
4,2023-10-15 17:00:56.0,"The optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b Ocarina I trial and was also presented at the recent #MSMilan2023. @ECTRIMS @ACTRIMS @genentech @OCREVUS_USA @HopkinsMedicine

Get the details: https://t.co/AXL0BTa9Ns",twitter,USA,neurology_live,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b ocarina i trial and was also presented at the recent #msmilan2023. @ectrims @actrims @genentech @ocrevus_usa @hopkinsmedicine get the details: https://t.co/axl0bta9ns,,"#ocrelizumab, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8629,517,0,,,0,0,33763,false,the optimal dosage for subcutaneous #ocrelizumab was uncovered in findings from the phase 1b ocarina i trial and was also presented at the recent ms milan. get the details:
5,2023-10-15 15:25:01.0,We are very proud that 4 neuropharmacists from the UK had posters @ECTRIMS this year. Highlighting the important contribution of #pharmacists to MS care. Well done to @DebzClark Roshni Dattani @joelamathews @RayDorsey7 #MSMilan2023 #neuropharmacy https://t.co/NDmZyWbFWY,twitter,GBR,UKCPANeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we are very proud that 4 neuropharmacists from the uk had posters @ectrims this year. highlighting the important contribution of #pharmacists to ms care. well done to @debzclark roshni dattani @joelamathews @raydorsey7 #msmilan2023 #neuropharmacy https://t.co/ndmzywbfwy,,"#pharmacists, #msmilan2023, #neuropharmacy",,,6000000000,3184780972,,439,79,1,,,1,5,1066,false,we are very proud that 4 neuropharmacists from the uk had posters this year. highlighting the important contribution of #pharmacists to ms care. well done to roshni dattani ms milan #neuropharmacy
6,2023-10-15 13:01:03.0,"Learn how #ofatumumab holds the line in patients with #MS previously treated with anti-CD20 therapies in a recent study presented at #MSMilan2023. Stay up-to-date with the latest research in #neurology @ECTRIMS @ACTRIMS @ClevelandClinic

Read: https://t.co/6tbt5z1qP8",twitter,USA,neurology_live,"{id=20767265, name=Kesimpta, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740624, name=Kesimpta / ofatumumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",learn how #ofatumumab holds the line in patients with #ms previously treated with anti-cd20 therapies in a recent study presented at #msmilan2023. stay up-to-date with the latest research in #neurology @ectrims @actrims @clevelandclinic read: https://t.co/6tbt5z1qp8,,"#ofatumumab, #ms, #msmilan2023, #neurology",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8628,517,0,,,0,0,33761,false,learn how #ofatumumab holds the line in patients with ms previously treated with anti-cd20 therapies in a recent study presented at ms milan. stay up-to-date with the latest research in #neurology read:
7,2023-10-15 11:25:47.0,"@RachelHorne19 Hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ECTRIMS. Next year will be the 40th congress!  MS research still seems to be a growth industry - good for Professors, PhD students and pharma profits.",twitter,GBR,charnbrook,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@rachelhorne19 hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ectrims. next year will be the 40th congress! ms research still seems to be a growth industry - good for professors, phd students and pharma profits.",unknown,,,,6000000000,202330588,,2,2,0,http://twitter.com/RachelHorne19/statuses/1713278832642241019,,0,0,91,false,"hopefully, breakthroughs in treatments (for progression, remyelination etc.) in the next few years will mean the end of ectrims. next year will be the 40th congress! ms research still seems to be a growth industry - good for professors, phd students and pharma profits."
8,2023-10-15 10:54:02.0,"The three women presidents of @ectrims !!!
üëçüëç Great !!!
#MSMilan2023 
#multiplesclerosis 
@MarTintore https://t.co/6nSrBr8ZDR",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the three women presidents of @ectrims !!! üëçüëç great !!! #msmilan2023 #multiplesclerosis @martintore https://t.co/6nsrbr8zdr,female,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4151,1106,0,,,3,35,23743,false,the three women presidents of !!! great !!! ms milan multiple sclerosis
9,2023-10-15 10:47:20.0,"Was great to share our work at @ECTRIMS¬† #MSMilan2023 (P1513, P1639)!!!! @I_GomezEstevez   @loregarcia8 #multiplesclerosis
 #msresearch #esclerosismultiple #somosclinico https://t.co/1MdzNVi2Dj",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","was great to share our work at @ectrims #msmilan2023 (p1513, p1639)!!!! @i_gomezestevez @loregarcia8 #multiplesclerosis #msresearch #esclerosismultiple #somosclinico https://t.co/1mdznvi2dj",female,"#msmilan2023, #multiplesclerosis, #msresearch, #esclerosismultiple, #somosclinico",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4151,1106,0,,,3,8,23742,false,"was great to share our work at ms milan (p1513, p1639)!!!! multiple sclerosis msresearch #esclerosismultiple #somosclinico"
10,2023-10-15 00:23:00.0,Cognitive processing speed improved in nearly 50% of people treated with #Zeposia (@bmsnews) for early relapsing #MultipleSclerosis (#RMS) according to an ad hoc interim analysis presented at #MSMilan2023 @ECTRIMS @ACTRIMS. https://t.co/CkduDUVrTf,twitter,,PracticalNeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",cognitive processing speed improved in nearly 50% of people treated with #zeposia (@bmsnews) for early relapsing #multiplesclerosis (#rms) according to an ad hoc interim analysis presented at #msmilan2023 @ectrims @actrims. https://t.co/ckduduvrtf,,"#zeposia, #multiplesclerosis, #rms, #msmilan2023",,,6000000000,386755226,,15377,154,0,,,0,4,3860,false,cognitive processing speed improved in nearly 50% of people treated with #zeposia () for early relapsing multiple sclerosis (#rms) according to an ad hoc interim analysis presented at ms milan .
12,2023-10-14 21:07:00.0,"An international panel of experts in #MultipleSclerosis developed new consensus statements on #SmolderingDisease in #MS, which were presented at #MSMilan2023 @ECTRIMS @ACTRIMS. @sanofi https://t.co/2FdUO1LfD2",twitter,,PracticalNeuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","an international panel of experts in #multiplesclerosis developed new consensus statements on #smolderingdisease in #ms, which were presented at #msmilan2023 @ectrims @actrims. @sanofi https://t.co/2fduo1lfd2",,"#multiplesclerosis, #smolderingdisease, #ms, #msmilan2023",,,6000000000,386755226,,15378,154,0,,,0,4,3859,false,"an international panel of experts in multiple sclerosis developed new consensus statements on #smolderingdisease in ms, which were presented at ms milan ."
14,2023-10-14 20:05:48.0,"Infection with the Epstein-Barr virus may prime the immune system to accidentally attack a brain protein called ANO2, research shows. https://t.co/WkTDiQpxFb",twitter,,james_jamstew,"{id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. https://t.co/wktdiqpxfb",male,,,,6000000000,2930969043,,111,243,0,,,0,0,509,false,"infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows."
15,2023-10-14 17:35:52.0,"@drBWillekens @Brandon_Beaber @MarTintore @EANeurology @ECTRIMS #CCSVI
Venous Hypertension
>microbleedings
>iron
>inflammation
>free radicals 
>neurodegeneration
#multiplesclerosis

M.S. - Mystery Solved

Mysterious Autoimmunity
= CCSVI Neurodegeneration",twitter,CAN,ms_matko,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@drbwillekens @brandon_beaber @martintore @eaneurology @ectrims #ccsvi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration #multiplesclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration,male,"#ccsvi, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,364700032,,696,2708,1,http://twitter.com/ms_matko/statuses/1713246757243769040,,0,0,37769,false,#ccsvi venous hypertension >microbleedings >iron >inflammation >free radicals >neurodegeneration multiple sclerosis m.s. - mystery solved mysterious autoimmunity = ccsvi neurodegeneration
16,2023-10-14 17:33:52.0,@drBWillekens @Brandon_Beaber @MarTintore @EANeurology @ECTRIMS So happens a protocol of treatment for MS and Neurovascular Disease CCSVI Venous Angioplasty to fix mechanical Vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky Veins! #VagusNerve,twitter,CAN,ms_matko,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@drbwillekens @brandon_beaber @martintore @eaneurology @ectrims so happens a protocol of treatment for ms and neurovascular disease ccsvi venous angioplasty to fix mechanical vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky veins! #vagusnerve,male,#vagusnerve,Beauty/Health & Fitness,,6000000000,364700032,,696,2708,1,http://twitter.com/ms_matko/statuses/1713246357706944633,,0,0,37768,false,so happens a protocol of treatment for ms and neurovascular disease ccsvi venous angioplasty to fix mechanical vascular issue and stem cell therapy to repair neurological damage caused by leaky narrow malfotmed often leaky veins! vagus nerve
17,2023-10-14 15:00:01.0,"Thanks for joining us at #MSMilan2023! Stay connected to OCREVUS and learn more about the CHIMES study below.

Please see full Prescribing Information at https://t.co/k33kg31vLt. Intended for US healthcare professionals only.",twitter,USA,OCREVUSHCP_USA,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thanks for joining us at #msmilan2023! stay connected to ocrevus and learn more about the chimes study below. please see full prescribing information at https://t.co/k33kg31vlt. intended for us healthcare professionals only.,,#msmilan2023,,,6000000000,1480658024738009092,,155,0,0,,,0,0,31,false,thanks for joining us at ms milan! stay connected to ocrevus and learn more about the chimes study below. please see full prescribing information at . intended for us healthcare professionals only.
18,2023-10-14 14:23:52.0,"Really proud to provide the most recent advances presented at #ECTRIMS2023 #MSMILAN2023 in the diagnostic work-up of #MS, #NMOSD, and #MOGAD at the second Patient‚Äôs Community day https://t.co/tfyotMYsxu",twitter,ITA,paolopreziosa,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","really proud to provide the most recent advances presented at #ectrims2023 #msmilan2023 in the diagnostic work-up of #ms, #nmosd, and #mogad at the second patient‚Äôs community day https://t.co/tfyotmysxu",male,"#ectrims2023, #msmilan2023, #ms, #nmosd, #mogad",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1058541278,,397,563,0,,,1,11,722,false,"really proud to provide the most recent advances presented at ec trims ms milan in the diagnostic work-up of ms, #nmosd, and #mogad at the second patients community day"
19,2023-10-14 13:08:21.0,"Such a privilege to be here as @MarTintore opens the @ECTRIMS Patient Community Day at #MSMilan2023. Ensuring that information about #MultipleSclerosis research is accurately communicated to the #MS community is something we are passionate about, so it‚Äôs fantastic to be involved! https://t.co/aCXjNFRNlw",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","such a privilege to be here as @martintore opens the @ectrims patient community day at #msmilan2023. ensuring that information about #multiplesclerosis research is accurately communicated to the #ms community is something we are passionate about, so it‚Äôs fantastic to be involved! https://t.co/acxjnfrnlw",,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,833579503,,4910,4079,0,,,2,17,3608,false,"such a privilege to be here as opens the patient community day at ms milan. ensuring that information about multiple sclerosis research is accurately communicated to the ms community is something we are passionate about, so its fantastic to be involved!"
20,2023-10-14 12:56:09.0,Our team was also present at the #ECTRIMS2023 and we were delighted to disclose our works based on our lines of research to the #MultipleSclerosis community. @ECTRIMS https://t.co/L08LjJOaSl,twitter,ESP,UNIEMTGirona,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our team was also present at the #ectrims2023 and we were delighted to disclose our works based on our lines of research to the #multiplesclerosis community. @ectrims https://t.co/l08ljjoasl,unknown,"#ectrims2023, #multiplesclerosis",,,6000000000,329846559,,318,274,1,,,3,7,998,false,our team was also present at the ec trims and we were delighted to disclose our works based on our lines of research to the multiple sclerosis community.
21,2023-10-14 12:33:25.0,ECTRIMS 2023: Treating SPMS with OCH shows promise in small study | #MultipleSclerosis News Today https://t.co/OijA1XwhEk,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: treating spms with och shows promise in small study | #multiplesclerosis news today https://t.co/oija1xwhek,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,2,25544,false,ectrims 2023: treating spms with och shows promise in small study | multiple sclerosis news today
22,2023-10-14 12:33:02.0,ECTRIMS 2023: Early high-efficacy DMTs may help slow MS disability | Slower disability progression found in RRMS patients on early DMTs | #MultipleSclerosis News Today https://t.co/JPH1GBswzq,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: early high-efficacy dmts may help slow ms disability | slower disability progression found in rrms patients on early dmts | #multiplesclerosis news today https://t.co/jph1gbswzq,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,1,1,25543,false,ectrims 2023: early high-efficacy dmts may help slow ms disability | slower disability progression found in rrms patients on early dmts | multiple sclerosis news today
23,2023-10-14 12:32:32.0,ECTRIMS 2023: Personalized Tysabri dosing shows good efficacy | #MultipleSclerosis News Today https://t.co/UhxLo7fcgg,twitter,GBR,AbiBuddComms,"{id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: personalized tysabri dosing shows good efficacy | #multiplesclerosis news today https://t.co/uhxlo7fcgg,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,0,25542,false,ectrims 2023: personalized tysabri dosing shows good efficacy | multiple sclerosis news today
24,2023-10-14 09:10:05.0,"Don't forget the MSMilan Patient Community Day is happening later today. 

Connect with the MS community online: share your questions, voice your needs and spark conversations.

üìÖSaturday 14 October 2023
‚û°Ô∏èRegister to the event: https://t.co/IKRU9Eg19J

#ECTRIMS4me https://t.co/9Dt6dvE3ZH",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","don't forget the msmilan patient community day is happening later today. connect with the ms community online: share your questions, voice your needs and spark conversations. üìÖsaturday 14 october 2023 ‚û°Ô∏èregister to the event: https://t.co/ikru9eg19j #ectrims4me https://t.co/9dt6dve3zh",female,#ectrims4me,,,6000000000,10869022,,55546,4342,0,,,4,16,54561,false,"don't forget the msmilan patient community day is happening later today. connect with the ms community online: share your questions, voice your needs and spark conversations. saturday 14 october 2023 register to the event: ec trims4me"
25,2023-10-14 08:56:36.0,Thank you for having us @tarunyaarun at the Women in MS evening dinner @ECTRIMS . Exciting times ahead üôè@NoreenB06207742 @MavisAyer1 https://t.co/S9x7Cbrhjb,twitter,GBR,TheUKMSSNA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thank you for having us @tarunyaarun at the women in ms evening dinner @ectrims . exciting times ahead üôè@noreenb06207742 @mavisayer1 https://t.co/s9x7cbrhjb,unknown,,Beauty/Health & Fitness,,6000000000,2569726689,,489,537,0,,,1,12,497,false,thank you for having us at the women in ms evening dinner . exciting times ahead
26,2023-10-14 08:48:46.0,"It has been an honour to present our work at #ECTRIMS2023 
@MAGNIMS @imscogs @MScentrum020 #MSMilan2023 #MS https://t.co/2TD50EJWpI",twitter,GBR,elisacolato,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",it has been an honour to present our work at #ectrims2023 @magnims @imscogs @mscentrum020 #msmilan2023 #ms https://t.co/2td50ejwpi,female,"#ectrims2023, #msmilan2023, #ms","Travel, Food & Drinks",,6000000000,2411136657,,102,112,0,,,1,16,28,false,it has been an honour to present our work at ec trims ms milan ms
27,2023-10-14 06:28:55.0,"@MsStacyEllis @mssocietyHCP @mssociety @ECTRIMS @ACTRIMS To cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. Might be longer term relief, but the disease is not cured",twitter,CAN,BurnabyAnn,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@msstacyellis @mssocietyhcp @mssociety @ectrims @actrims to cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. might be longer term relief, but the disease is not cured",unknown,,,,6000000000,36122900,,391,349,1,http://twitter.com/MsStacyEllis/statuses/1713059583311130902,,0,0,13511,false,"to cure & to perhaps vaccinate to prevent origin is required; otherwise its all symptom management. might be longer term relief, but the disease is not cured"
28,2023-10-14 05:10:06.0,"@BurnabyAnn @mssocietyHCP @mssociety @ECTRIMS @ACTRIMS #MS caused by different things in different people, usually by the Epstein-Barr virus. But there are many ways to cure diseases. You don‚Äôt even necessarily need to know the cause in order to cure disease. Detox, homeopathy, etc.",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@burnabyann @mssocietyhcp @mssociety @ectrims @actrims #ms caused by different things in different people, usually by the epstein-barr virus. but there are many ways to cure diseases. you don‚Äôt even necessarily need to know the cause in order to cure disease. detox, homeopathy, etc.",female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,985,559,1,http://twitter.com/BurnabyAnn/statuses/1712972528917041388,,0,0,31772,false,"ms caused by different things in different people, usually by the epstein-barr virus. but there are many ways to cure diseases. you dont even necessarily need to know the cause in order to cure disease. detox, homeopathy, etc."
29,2023-10-14 03:02:51.0,@GenentechMed It's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at #MSMilan2023. Bridging science and clinical practice is vital for improving health outcomes.,twitter,USA,MinneBio,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@genentechmed it's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at #msmilan2023. bridging science and clinical practice is vital for improving health outcomes.,unknown,#msmilan2023,Beauty/Health & Fitness,,6000000000,1693294855814844416,,83,958,0,http://twitter.com/GenentechMed/statuses/1712860753055904186,,0,0,761,false,it's truly remarkable to witness the dedication to advancements in multiple sclerosis research and patient care at ms milan. bridging science and clinical practice is vital for improving health outcomes.
30,2023-10-14 02:05:02.0,"Five of six people with secondary progressive MS treated with OCH in a small clinical trial experienced no disease activity over six months. https://t.co/XhmHjU8kBj 

#ectrims2023 #ms #multiplesclerosis #msresearch #msnews #ECTRIMS #MSMilan2023 https://t.co/z63KJfRy6A",twitter,USA,MSNewsToday,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",five of six people with secondary progressive ms treated with och in a small clinical trial experienced no disease activity over six months. https://t.co/xhmhju8kbj #ectrims2023 #ms #multiplesclerosis #msresearch #msnews #ectrims #msmilan2023 https://t.co/z63kjfry6a,female,"#ectrims2023, #ms, #multiplesclerosis, #msresearch, #msnews, #ectrims, #msmilan2023",,,6000000000,2473350271,,10062,1542,1,,,4,20,28190,false,five of six people with secondary progressive ms treated with och in a small clinical trial experienced no disease activity over six months. ec trims ms multiple sclerosis msresearch msnews ec trims ms milan
31,2023-10-14 01:25:10.0,"A recent analysis presented at #MSMilan2023 showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells.
https://t.co/KqBBfErvj7",twitter,USA,byMattHoffman,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",a recent analysis presented at #msmilan2023 showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells. https://t.co/kqbbfervj7,male,"#msmilan2023, #stemcells",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1068,989,0,,,0,0,10033,false,a recent analysis presented at ms milan showed significant cognitive and biomarker improvements among patients with progressive multiple sclerosis receiving repeated intrathecal injections of autologous mesenchymal #stemcells.
32,2023-10-14 00:53:00.0,"Research from #MSMilan2023 @ECTRIMS @ACTRIMS compared #Uplizna (@HorizonNews @Amgen) as treatment for #NMOSD to 2 other #mABs, showing decreased risk of attack and better results for life years.
https://t.co/byDKNcWwTL",twitter,,PracticalNeuro,"{id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","research from #msmilan2023 @ectrims @actrims compared #uplizna (@horizonnews @amgen) as treatment for #nmosd to 2 other #mabs, showing decreased risk of attack and better results for life years. https://t.co/bydkncwwtl",,"#msmilan2023, #uplizna, #nmosd, #mabs",,,6000000000,386755226,,15373,154,0,,,0,2,3857,false,"research from ms milan compared #uplizna ( ) as treatment for #nmosd to 2 other #mabs, showing decreased risk of attack and better results for life years."
33,2023-10-13 23:50:22.0,See you next year in Denmark! @ECTRIMS #MSMilan2023 #MultipleSclerosis #msguncel https://t.co/uoInmACBWT,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",see you next year in denmark! @ectrims #msmilan2023 #multiplesclerosis #msguncel https://t.co/uoinmacbwt,female,"#msmilan2023, #multiplesclerosis, #msguncel",,,6000000000,1338606356346048512,,1448,61,0,,,0,3,822,false,see you next year in denmark! ms milan multiple sclerosis msguncel
34,2023-10-13 23:13:50.0,"@RosaCortese5 @Brandon_Beaber @ECTRIMS My neurologist thinks I may have MOGAD and not PPMS because I do have an odd clinical history.  We are gathering more data etc.
I‚Äôm very stable neurologically‚Ä¶",twitter,USA,sardonicarious,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@rosacortese5 @brandon_beaber @ectrims my neurologist thinks i may have mogad and not ppms because i do have an odd clinical history. we are gathering more data etc. i‚Äôm very stable neurologically‚Ä¶,male,,"Science, Technology","{profession=Scientist & Researcher, jobTitle=Scientist}, {profession=Software developer & IT, jobTitle=Software Developer}",6000000000,1032433773059571712,,203,660,0,http://twitter.com/RosaCortese5/statuses/1712769799309136343,,0,0,12444,false,my neurologist thinks i may have mogad and not ppms because i do have an odd clinical history. we are gathering more data etc. im very stable neurologically
35,2023-10-13 23:00:31.0,"Enhancing patient well-being with innovative solutions! The StimRouter neuromodulation system shows promise in addressing lower urinary tract issues in #MS. Dive into the data and its implications for your practice. #MSMilan @ECTRIMS @ACTRIMS

Read more: https://t.co/wrJ8e34meO",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",enhancing patient well-being with innovative solutions! the stimrouter neuromodulation system shows promise in addressing lower urinary tract issues in #ms. dive into the data and its implications for your practice. #msmilan @ectrims @actrims read more: https://t.co/wrj8e34meo,,"#ms, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,0,33758,false,enhancing patient well-being with innovative solutions! the stimrouter neuromodulation system shows promise in addressing lower urinary tract issues in ms. dive into the data and its implications for your practice. msmilan read more:
37,2023-10-13 21:36:19.0,"T. Berger: great research on how EBV can cause #MS depending on virus and host genetic predispositions. 
In these cases, the control of molecular mimicry induced by EBV-infected B-cells is ineffective and increases #MS risk by 261 üò≥!
#MSMilan2023 
Will be published in Cell üëèüèªüëèüèª https://t.co/JPCxUUjlzA",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","t. berger: great research on how ebv can cause #ms depending on virus and host genetic predispositions. in these cases, the control of molecular mimicry induced by ebv-infected b-cells is ineffective and increases #ms risk by 261 üò≥! #msmilan2023 will be published in cell üëèüèªüëèüèª https://t.co/jpcxuujlza",unknown,"#ms, #ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1954,886,1,,,14,49,1893,false,"t. berger: great research on how ebv can cause ms depending on virus and host genetic predispositions. in these cases, the control of molecular mimicry induced by ebv-infected b-cells is ineffective and increases ms risk by 261 ! ms milan will be published in cell"
38,2023-10-13 21:00:56.0,"The future of #MS care just got more versatile. Learn about the noninferiority of subcutaneous #ocrelizumab compared with IV in relapsing and primary progressive MS. How might this impact your treatment decisions? #MSMilan @ECTRIMS @HopkinsMedicine

Read: https://t.co/6OHhlDIIQY",twitter,USA,neurology_live,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}",the future of #ms care just got more versatile. learn about the noninferiority of subcutaneous #ocrelizumab compared with iv in relapsing and primary progressive ms. how might this impact your treatment decisions? #msmilan @ectrims @hopkinsmedicine read: https://t.co/6ohhldiiqy,,"#ms, #ocrelizumab, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,0,33757,false,the future of ms care just got more versatile. learn about the noninferiority of subcutaneous #ocrelizumab compared with iv in relapsing and primary progressive ms. how might this impact your treatment decisions? msmilan read:
39,2023-10-13 19:58:01.0,"Interim results from the CHIMES trial presented at #MSMilan2023 (@ECTRIMS @ACTRIMS) demonstrated the safety & efficacy of #Ocrevus (@genentech) in treating Relapsing #MultipleSclerosis (#RMS) in Black and Hispanic patients.
https://t.co/P3AyyTLthN",twitter,,PracticalNeuro,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",interim results from the chimes trial presented at #msmilan2023 (@ectrims @actrims) demonstrated the safety & efficacy of #ocrevus (@genentech) in treating relapsing #multiplesclerosis (#rms) in black and hispanic patients. https://t.co/p3ayytlthn,,"#msmilan2023, #ocrevus, #multiplesclerosis, #rms",,,6000000000,386755226,,15374,154,0,,,3,4,3856,false,interim results from the chimes trial presented at ms milan ( ) demonstrated the safety & efficacy of #ocrevus () in treating relapsing multiple sclerosis (#rms) in black and hispanic patients.
40,2023-10-13 19:14:35.0,"Last day !
Should treatments in pediatric MS ¬´¬†HEET¬†¬ª? 
Very interesting results and a nice overview of new treatments in pediatric MS by Pr Chitnis ! #Ectrims https://t.co/Lf1s8eXbMu",twitter,FRA,PrDeiva,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",last day ! should treatments in pediatric ms ¬´ heet ¬ª? very interesting results and a nice overview of new treatments in pediatric ms by pr chitnis ! #ectrims https://t.co/lf1s8exbmu,unknown,#ectrims,,,6000000000,1239175635706265601,,31,49,0,,,0,2,36,false,last day ! should treatments in pediatric ms heet ? very interesting results and a nice overview of new treatments in pediatric ms by pr chitnis ! ec trims
41,2023-10-13 18:57:10.0,"P1149: Spasticity-Plus Syndrome recently coined for 7 symptoms related to #spasticity due to #MultipleSclerosis. Most frequent SSP triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). IDing SSP can help avoid polypharmacy & improve long-term MS mgmt. #MSMilan2023 @Janigoico",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","p1149: spasticity-plus syndrome recently coined for 7 symptoms related to #spasticity due to #multiplesclerosis. most frequent ssp triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). iding ssp can help avoid polypharmacy & improve long-term ms mgmt. #msmilan2023 @janigoico",,"#spasticity, #multiplesclerosis, #msmilan2023",,,6000000000,1054320667,,901,625,0,,,0,0,4231,false,"p1149: spasticity-plus syndrome recently coined for 7 symptoms related to #spasticity due to multiple sclerosis. most frequent ssp triad: spasticity (94.6%), pain (91.9%), spasms (79.7%). iding ssp can help avoid polypharmacy & improve long-term ms mgmt. ms milan"
42,2023-10-13 18:51:22.0,"Was great to share our work at @ECTRIMS  #MSMilan2023 (P1511)! We characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia @nikosevangelou3 @DrWBRO https://t.co/9F8h8zueHG",twitter,,ChrisGSG,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","was great to share our work at @ectrims #msmilan2023 (p1511)! we characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia @nikosevangelou3 @drwbro https://t.co/9f8h8zuehg",male,#msmilan2023,,,6000000000,2344932985,,108,327,0,,,3,11,69,false,"was great to share our work at ms milan (p1511)! we characterise the degree of lymphopenia with siponimod, and demonstrate that you cannot predict which patients are more likely to experience grade 4 lymphopenia"
43,2023-10-13 18:45:00.0,"O165: Clinical trials lack #diversity. Current efforts to advance health equity via MS clinical trial participation=inadequate. Lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across MS pop. @AmezcuaLilyana #MSMilan2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","o165: clinical trials lack #diversity. current efforts to advance health equity via ms clinical trial participation=inadequate. lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across ms pop. @amezcualilyana #msmilan2023",,"#diversity, #msmilan2023",,,6000000000,1054320667,,901,625,0,,,0,0,4230,false,"o165: clinical trials lack #diversity. current efforts to advance health equity via ms clinical trial participation=inadequate. lack of inclusion& representation are obstacle to effectively understand safety, benefits&treatment response across ms pop. ms milan"
44,2023-10-13 18:29:01.0,"Thrilled to make it on to the #ECTRIMS stage at #MSMilan2023 to give Dr Rhonda Voskuhl the inaugural Rachel Horne Prize for Women's Research in MS. 
With @MSDoc_Freedman,  Massimo Filippi & @MarTintore
Thank u @ECTRIMS, @ACTRIMS &, of course, @IntNatlWiMS - who made it happen.",twitter,GBR,RachelHorne19,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","thrilled to make it on to the #ectrims stage at #msmilan2023 to give dr rhonda voskuhl the inaugural rachel horne prize for women's research in ms. with @msdoc_freedman, massimo filippi & @martintore thank u @ectrims, @actrims &, of course, @intnatlwims - who made it happen.",female,"#ectrims, #msmilan2023",,"{profession=Journalist, jobTitle=Journalist}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1284849469704540160,,6207,3465,3,,,9,95,5533,false,"thrilled to make it on to the ec trims stage at ms milan to give dr rhonda voskuhl the inaugural rachel horne prize for women's research in ms. with , massimo filippi & thank u , &, of course, - who made it happen."
46,2023-10-13 17:46:25.0,"Thank you for this beautiful congress! üáÆüáπExciting news, interesting discussions, many dear colleagues from all over the world üåénow we go home motivated and well informed #MultipleSclerosis #NMOSD #MOGAD @ECTRIMS",twitter,DEU,NeuroVisionLab,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","thank you for this beautiful congress! üáÆüáπexciting news, interesting discussions, many dear colleagues from all over the world üåénow we go home motivated and well informed #multiplesclerosis #nmosd #mogad @ectrims",male,"#multiplesclerosis, #nmosd, #mogad",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1330131970068770821,,269,147,0,,,1,8,153,false,"thank you for this beautiful congress! exciting news, interesting discussions, many dear colleagues from all over the world now we go home motivated and well informed multiple sclerosis #nmosd #mogad"
47,2023-10-13 17:40:43.0,So grateful to have met some awesome researchers focused on #femalehealth in #MultipleSclerosis during #MSMilan2023 this year! It‚Äôs so important for #GlobalHealth to also focus on #FemaleBrainHealth! Looking forward to more discoveries to come üôãüèª‚Äç‚ôÄÔ∏èüß†ü©∫ Thanks @ECTRIMS for a g8 one! https://t.co/cBNP157ZZS,twitter,DEU,ClaudiaAcadem,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",so grateful to have met some awesome researchers focused on #femalehealth in #multiplesclerosis during #msmilan2023 this year! it‚Äôs so important for #globalhealth to also focus on #femalebrainhealth! looking forward to more discoveries to come üôãüèª‚Äç‚ôÄÔ∏èüß†ü©∫ thanks @ectrims for a g8 one! https://t.co/cbnp157zzs,female,"#femalehealth, #multiplesclerosis, #msmilan2023, #globalhealth, #femalebrainhealth","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Teacher & Lecturer, jobTitle=Teacher}",6000000000,393547855,,635,738,0,,,0,3,6765,false,so grateful to have met some awesome researchers focused on #femalehealth in multiple sclerosis during ms milan this year! its so important for #globalhealth to also focus on #femalebrainhealth! looking forward to more discoveries to come thanks for a g8 one!
48,2023-10-13 17:02:12.0,"Precision medicine takes center stage in #MultipleSclerosis care! @NerdyNeuroMDshares her expertise in advancing personalized treatments for patients with #MS. Stay informed about the future of #neurology. üß¨üíä #MSMilan @ECTRIMS @ACTRIMS 

View: https://t.co/oC7c9PBbn5 https://t.co/sxI1pEpElW",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",precision medicine takes center stage in #multiplesclerosis care! @nerdyneuromdshares her expertise in advancing personalized treatments for patients with #ms. stay informed about the future of #neurology. üß¨üíä #msmilan @ectrims @actrims view: https://t.co/oc7c9pbbn5 https://t.co/sxi1pepelw,,"#multiplesclerosis, #ms, #neurology, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8625,517,0,,,0,1,33755,false,precision medicine takes center stage in multiple sclerosis care! her expertise in advancing personalized treatments for patients with ms. stay informed about the future of #neurology. msmilan view:
49,2023-10-13 16:39:34.0,"It was such an amazing experience to be able to give a talk at #ECTRIMS2023 and receive amazing feedback. Thanks to all my collaborators, especially @LeredeAnnalaura @UKMSRegister

#MSMilan2023 #Research #MultipleSclerosis
@imperialcollege @ECTRIMS",twitter,,valegiunca,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","it was such an amazing experience to be able to give a talk at #ectrims2023 and receive amazing feedback. thanks to all my collaborators, especially @leredeannalaura @ukmsregister #msmilan2023 #research #multiplesclerosis @imperialcollege @ectrims",female,"#ectrims2023, #msmilan2023, #research, #multiplesclerosis",Science,"{profession=Student, jobTitle=Student}",6000000000,1389587917924864005,,110,167,2,,,1,13,84,false,"it was such an amazing experience to be able to give a talk at ec trims and receive amazing feedback. thanks to all my collaborators, especially ms milan #research multiple sclerosis"
50,2023-10-13 16:33:28.0,"@MarTintore @ECTRIMS @XMontalban @J_SastreGarriga @GeoArrambide @TheSumairaFDN @vallhebron @EuropeanCharcot @CEspejoRuiz @CarmenTur1 @cobo_calvo @Villacieros_J ‚Äú We are committed to making further progress in treatment and cure for multiple sclerosis. Every patient counts‚Äù, Prof. @MarTintore says farewell to all #MSMilan2023 participants.

This is a wrap! 

Looking forward to meeting you next year! Many thanks üëèüëè https://t.co/k6FNYIslww",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore @ectrims @xmontalban @j_sastregarriga @geoarrambide @thesumairafdn @vallhebron @europeancharcot @cespejoruiz @carmentur1 @cobo_calvo @villacieros_j ‚Äú we are committed to making further progress in treatment and cure for multiple sclerosis. every patient counts‚Äù, prof. @martintore says farewell to all #msmilan2023 participants. this is a wrap! looking forward to meeting you next year! many thanks üëèüëè https://t.co/k6fnyislww",unknown,#msmilan2023,,,6000000000,1197805298,,3157,490,1,http://twitter.com/cemcat_em/statuses/1712860823381504370,,7,18,2934,false,"we are committed to making further progress in treatment and cure for multiple sclerosis. every patient counts, prof. says farewell to all ms milan participants. this is a wrap! looking forward to meeting you next year! many thanks"
51,2023-10-13 16:00:01.0,Thank you for joining us at #MSMilan2023 as we pave the way for advancements in #multiplesclerosis research & patient care. We were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all. https://t.co/hCXze6I4eC,twitter,USA,GenentechMed,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thank you for joining us at #msmilan2023 as we pave the way for advancements in #multiplesclerosis research & patient care. we were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all. https://t.co/hcxze6i4ec,,"#msmilan2023, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,1405237666677891073,,157,0,1,,,0,5,59,false,thank you for joining us at ms milan as we pave the way for advancements in multiple sclerosis research & patient care. we were excited to share our latest findings & deliver on our commitment to bridging science and clinical practice to drive better health outcomes for all.
52,2023-10-13 15:55:06.0,"Data from #DanishMSRegistry reveal patterns and predictors of conversion from #RRMS to #SPMS #MultipleSclerosis, in study from #MSMilan2023 @ECTRIMS @ACTRIMS.https://t.co/YEYReXyrHx",twitter,,TheNeurologyHub,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","data from #danishmsregistry reveal patterns and predictors of conversion from #rrms to #spms #multiplesclerosis, in study from #msmilan2023 @ectrims @actrims.https://t.co/yeyrexyrhx",,"#danishmsregistry, #rrms, #spms, #multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,1367549821612130307,,43,18,0,,,0,0,24,false,"data from #danishmsregistry reveal patterns and predictors of conversion from #rrms to #spms multiple sclerosis, in study from ms milan ."
53,2023-10-13 15:45:00.0,"P764: We provide rationale for #CHIT1 as #biomarker for early microglial activation & future #disability progression in #MS, aiding clinicians in patient stratification & therapy selection. #MSMilan2023 @Neuro_KULeuven",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","p764: we provide rationale for #chit1 as #biomarker for early microglial activation & future #disability progression in #ms, aiding clinicians in patient stratification & therapy selection. #msmilan2023 @neuro_kuleuven",,"#chit1, #biomarker, #disability, #ms, #msmilan2023",,,6000000000,1054320667,,899,624,0,,,0,0,4214,false,"p764: we provide rationale for #chit1 as #biomarker for early microglial activation & future #disability progression in ms, aiding clinicians in patient stratification & therapy selection. ms milan"
54,2023-10-13 15:13:32.0,ECTRIMS 2023: New under-the-skin Ocrevus found effective in MS | New formulation seen to suppress MS activity in Phase 3 trial | #MultipleSclerosis News Today https://t.co/xwKlC7grA6,twitter,GBR,AbiBuddComms,"{id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: new under-the-skin ocrevus found effective in ms | new formulation seen to suppress ms activity in phase 3 trial | #multiplesclerosis news today https://t.co/xwklc7gra6,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4065,2558,0,,,0,1,25538,false,ectrims 2023: new under-the-skin ocrevus found effective in ms | new formulation seen to suppress ms activity in phase 3 trial | multiple sclerosis news today
55,2023-10-13 15:12:04.0,New long-term data from #MSMilan2023 @ECTRIMS @ACTRIMS compares time to onset of #NMOSD attack for #Uplizna (@HorizonNews @Amgen) vs azathioprine + immunosuppressives vs placebo. https://t.co/gehM5RncUA,twitter,,TheNeurologyHub,"{id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",new long-term data from #msmilan2023 @ectrims @actrims compares time to onset of #nmosd attack for #uplizna (@horizonnews @amgen) vs azathioprine + immunosuppressives vs placebo. https://t.co/gehm5rncua,,"#msmilan2023, #nmosd, #uplizna",Beauty/Health & Fitness,,6000000000,1367549821612130307,,43,18,0,,,1,0,23,false,new long-term data from ms milan compares time to onset of #nmosd attack for #uplizna ( ) vs azathioprine + immunosuppressives vs placebo.
56,2023-10-13 15:03:42.0,Roche touts brain penetration shown by BTK inhibitor fenebrutinib in MS study $RHHBY #MSMilan2023 #ECTRIMS https://t.co/6s5MWLHZjo,twitter,,fwpharma,"{id=20767269, name=Fenebrutinib, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740628, name=Fenebrutinib, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711854, name=MS Drugs - BTKi, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",roche touts brain penetration shown by btk inhibitor fenebrutinib in ms study $rhhby #msmilan2023 #ectrims https://t.co/6s5mwlhzjo,,"#msmilan2023, #ectrims",,,6000000000,35789155,,54517,638,0,,,0,0,35407,true,roche touts brain penetration shown by btk inhibitor fenebrutinib in ms study $rhhby ms milan ec trims
57,2023-10-13 15:02:17.0,"How do B-cell levels influence #ocrelizumab's effectiveness in #neurology? The latest findings shed light on this critical connection. Delve into the science and its implications for patients with #MS! #MSMilan2023 @ECTRIMS @ACTRIMS @AnToSc

Read more: https://t.co/iKLkl5DqKG",twitter,USA,neurology_live,"{id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",how do b-cell levels influence #ocrelizumab's effectiveness in #neurology? the latest findings shed light on this critical connection. delve into the science and its implications for patients with #ms! #msmilan2023 @ectrims @actrims @antosc read more: https://t.co/iklkl5dqkg,,"#ocrelizumab's, #neurology, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,1,33754,false,how do b-cell levels influence #ocrelizumab's effectiveness in #neurology? the latest findings shed light on this critical connection. delve into the science and its implications for patients with ms! ms milan read more:
58,2023-10-13 15:00:24.0,"#MSMilan2023 | LIVE NOW!

Xavier Montaban @XMontalban, Director of @cemcat_em and former ECTRIMS President, delivers the Chariot Lecture, ‚ÄúA new look at diagnosing MS‚Äù.  

‚û°Ô∏è https://t.co/9wFsejA2lp 

Every patient. Every pathway.",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#msmilan2023 | live now! xavier montaban @xmontalban, director of @cemcat_em and former ectrims president, delivers the chariot lecture, ‚Äúa new look at diagnosing ms‚Äù. ‚û°Ô∏è https://t.co/9wfseja2lp every patient. every pathway.",,#msmilan2023,,,6000000000,714464982,,8020,65,0,,,1,3,7298,false,"ms milan | live now! xavier montaban , director of and former ectrims president, delivers the chariot lecture, a new look at diagnosing ms. every patient. every pathway."
59,2023-10-13 15:00:03.0,"üôèüéóÔ∏èThank you, #MSMilan2023! The $IMUX team not only had a lot of excellent and enlightening discussions with colleagues from the #MS space, but also a lot of fun! See you next year in Copenhagen üá©üá∞! 

@ECTRIMS #ECTRIMS #ACTRIMS #Immunic #MS #MultipleSclerosis #msresearch https://t.co/jqKGzyFPXY",twitter,USA,ImmunicInc,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üôèüéóÔ∏èthank you, #msmilan2023! the $imux team not only had a lot of excellent and enlightening discussions with colleagues from the #ms space, but also a lot of fun! see you next year in copenhagen üá©üá∞! @ectrims #ectrims #actrims #immunic #ms #multiplesclerosis #msresearch https://t.co/jqkgzyfpxy",,"#msmilan2023, #ms, #ectrims, #actrims, #immunic, #ms, #multiplesclerosis, #msresearch","Beauty/Health & Fitness, Business",,6000000000,951787758242226177,,592,756,0,,,3,4,1117,false,"thank you, ms milan! the $imux team not only had a lot of excellent and enlightening discussions with colleagues from the ms space, but also a lot of fun! see you next year in copenhagen ! ec trims #actrims #immunic ms multiple sclerosis msresearch"
60,2023-10-13 14:32:52.0,"Scientific Session 22: Late Breaking Abstracts at #MSMilan2023. Varied and engaging presentations. Special congratulations to David Levitz, a med student who did a great job presenting alongside big MS specialists! #ECTRIMS #ACTRIMS https://t.co/2k4DndnWb5",twitter,ESP,GeoArrambide,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","scientific session 22: late breaking abstracts at #msmilan2023. varied and engaging presentations. special congratulations to david levitz, a med student who did a great job presenting alongside big ms specialists! #ectrims #actrims https://t.co/2k4dndnwb5",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,547,180,0,,,1,1,749,false,"scientific session 22: late breaking abstracts at ms milan. varied and engaging presentations. special congratulations to david levitz, a med student who did a great job presenting alongside big ms specialists! ec trims #actrims"
61,2023-10-13 14:25:41.0,Late breaking at #ECTRIMS fenebrutinib reduces MRI lesions by 69% & no serious adverse effects. #MSMilan2023 https://t.co/UIzFWPdoYE,twitter,GBR,RayDorsey7,"{id=20767269, name=Fenebrutinib, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740628, name=Fenebrutinib, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711854, name=MS Drugs - BTKi, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",late breaking at #ectrims fenebrutinib reduces mri lesions by 69% & no serious adverse effects. #msmilan2023 https://t.co/uizfwpdoye,male,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Family & Parenting, Business, Sports","{profession=Health practitioner, jobTitle=Pharmacist}",6000000000,1277159750,,575,382,0,,,1,6,2148,false,late breaking at ec trims fenebrutinib reduces mri lesions by 69% & no serious adverse effects. ms milan
62,2023-10-13 14:04:38.0,"A personalized dosing schedule for Tysabri (natalizumab) seems to be just as effective as standard dosing for controlling MS disease activity https://t.co/3YmlD9BnZx 

#ectrims2023 #multiplesclerosis #msresearch #msdiagnosis #mssymptoms https://t.co/p66LhNkEt8",twitter,USA,MSNewsToday,"{id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",a personalized dosing schedule for tysabri (natalizumab) seems to be just as effective as standard dosing for controlling ms disease activity https://t.co/3ymld9bnzx #ectrims2023 #multiplesclerosis #msresearch #msdiagnosis #mssymptoms https://t.co/p66lhnket8,female,"#ectrims2023, #multiplesclerosis, #msresearch, #msdiagnosis, #mssymptoms",,,6000000000,2473350271,,10058,1542,0,,,2,7,28184,false,a personalized dosing schedule for tysabri (natalizumab) seems to be just as effective as standard dosing for controlling ms disease activity ec trims multiple sclerosis msresearch msdiagnosis mssymptoms
63,2023-10-13 13:37:11.0,"""#EBV may be necessary‚Äîbut not sufficient‚Äîto #cause #MS"" https://t.co/BAM3jXoZI7 @MSIntFederation @ECTRIMS @ACTRIMS #MSMilan2023",twitter,USA,SaligramaLab,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","""#ebv may be necessary‚Äîbut not sufficient‚Äîto #cause #ms"" https://t.co/bam3jxozi7 @msintfederation @ectrims @actrims #msmilan2023",unknown,"#ebv, #cause, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1424715908212199426,,1046,618,0,,,0,2,1295,false,"""#ebv may be necessarybut not sufficientto #cause ms"" ms milan"
64,2023-10-13 13:06:06.0,"üß°A big thanks to @ECTRIMS for enabling our team & our members to participate in #MSMilan2023 and striving to make people with #MultipleSclerosis an equal partner in all #MS relates discussions. See you @ ECTRIMS '24!
üëãNothing about us without us!
@ACTRIMS https://t.co/4MYTCP69pE",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üß°a big thanks to @ectrims for enabling our team & our members to participate in #msmilan2023 and striving to make people with #multiplesclerosis an equal partner in all #ms relates discussions. see you @ ectrims '24! üëãnothing about us without us! @actrims https://t.co/4mytcp69pe,female,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,600110872,,4875,894,1,,,6,20,5948,false,a big thanks to for enabling our team & our members to participate in ms milan and striving to make people with multiple sclerosis an equal partner in all ms relates discussions. see you ectrims '24! nothing about us without us!
65,2023-10-13 12:52:03.0,"dreaMS collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for #MS #MSMilan2023 
@ECTRIMS @ThINk_Basel https://t.co/eltRg2wuWf",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",dreams collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for #ms #msmilan2023 @ectrims @think_basel https://t.co/eltrg2wuwf,,"#ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,1493181686426779654,,91,65,0,,,4,6,22,false,dreams collaborators putting their minds together in the context of an upcoming multi-center international validation study to develop digital biomarkers for ms ms milan
66,2023-10-13 12:46:30.0,"Had a great in-person turnout @ECTRIMS Optimiz(s)ing üòÉ prognosis in MS session! Thanks also for tuning in! Engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering üòÉ & a wonderful co-chair, it was such a pleasure! #ECTRIMS2023 @DrWBRO https://t.co/tn49q2FYKN",twitter,,burcuzeydanmd,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","had a great in-person turnout @ectrims optimiz(s)ing üòÉ prognosis in ms session! thanks also for tuning in! engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering üòÉ & a wonderful co-chair, it was such a pleasure! #ectrims2023 @drwbro https://t.co/tn49q2fykn",female,#ectrims2023,Beauty/Health & Fitness,,6000000000,1221551673463705602,,547,444,0,http://twitter.com/burcuzeydanmd/statuses/1712571509686845640,,2,17,92,false,"had a great in-person turnout optimiz(s)ing prognosis in ms session! thanks also for tuning in! engaged audience, interesting sometimes challenging questions such as smoldering vs smouldering & a wonderful co-chair, it was such a pleasure! ec trims"
67,2023-10-13 12:39:57.0,@DrAmyBSullivan provided more evidence for treating depression early after #multiplesclerosis diagnosis at #ECTRIMS2023. Progression independent of disease activity #PIRA was all the talk in #MSMilan2023 with @DrJNicholas breaking down the pathways and opportunities for early tx! https://t.co/qWZ23orX6t,twitter,USA,Heena_Manglani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}",@dramybsullivan provided more evidence for treating depression early after #multiplesclerosis diagnosis at #ectrims2023. progression independent of disease activity #pira was all the talk in #msmilan2023 with @drjnicholas breaking down the pathways and opportunities for early tx! https://t.co/qwz23orx6t,female,"#multiplesclerosis, #ectrims2023, #pira, #msmilan2023",Beauty/Health & Fitness,,6000000000,3000485326,,406,671,0,,,1,2,179,false,provided more evidence for treating depression early after multiple sclerosis diagnosis at ec trims. progression independent of disease activity #pira was all the talk in ms milan with breaking down the pathways and opportunities for early tx!
68,2023-10-13 12:32:57.0,"@RachelHorne19 @ECTRIMS Everyone with MS needs a little hep for his mental health, not only because you have changes in your live. It is because the inflamation in our brain makes you feel depressed. It is because of the proper MS. I believe so, an I take medicines for it",twitter,ESP,LR_lolarivera,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@rachelhorne19 @ectrims everyone with ms needs a little hep for his mental health, not only because you have changes in your live. it is because the inflamation in our brain makes you feel depressed. it is because of the proper ms. i believe so, an i take medicines for it",female,,,,6000000000,58454283,,277,603,1,http://twitter.com/RachelHorne19/statuses/1712565686482985441,,0,0,5182,false,"everyone with ms needs a little hep for his mental health, not only because you have changes in your live. it is because the inflamation in our brain makes you feel depressed. it is because of the proper ms. i believe so, an i take medicines for it"
69,2023-10-13 12:32:22.0,"As the #MS community gathers at @ECTRIMS #MSMilan2023, we're inspired by scientific exchange & breakthroughs in MS. 

Co-founder Richard Ransohoff recently sat down with John Maraganore to discuss our new understanding of MS pathology & progression.
ICYMI: https://t.co/jQ2i5DmkDe",twitter,,AbataTx,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","as the #ms community gathers at @ectrims #msmilan2023, we're inspired by scientific exchange & breakthroughs in ms. co-founder richard ransohoff recently sat down with john maraganore to discuss our new understanding of ms pathology & progression. icymi: https://t.co/jq2i5dmkde",unknown,"#ms, #msmilan2023",Science,,6000000000,1367149082700087297,,208,78,0,,,0,0,137,false,"as the ms community gathers at ms milan, we're inspired by scientific exchange & breakthroughs in ms. co-founder richard ransohoff recently sat down with john maraganore to discuss our new understanding of ms pathology & progression. icymi:"
70,2023-10-13 12:24:52.0,Breastfeeding recommendations in #ECTRIMS2023. We should encourage exclusive breastfeeding in MS patients. #iwims #MSmilan2023. https://t.co/sZfnJFXZQH,twitter,,GilPerotin,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",breastfeeding recommendations in #ectrims2023. we should encourage exclusive breastfeeding in ms patients. #iwims #msmilan2023. https://t.co/szfnjfxzqh,female,"#ectrims2023, #iwims, #msmilan2023","Books, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1490739116635561987,,92,275,0,,,2,5,42,false,breastfeeding recommendations in ec trims. we should encourage exclusive breastfeeding in ms patients. #iwims ms milan.
71,2023-10-13 11:47:58.0,Participating in the most important #MSMilan2023Congress in the world on #MultipleSclerosis with great colleagues and friends. We continue working on research #msresearch @ECTRIMS https://t.co/9yyMDhsjaa,twitter,ESP,DrRafaelArroyo,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",participating in the most important #msmilan2023congress in the world on #multiplesclerosis with great colleagues and friends. we continue working on research #msresearch @ectrims https://t.co/9yymdhsjaa,male,"#msmilan2023congress, #multiplesclerosis, #msresearch",,,6000000000,2933988141,,1851,519,0,,,0,2,1096,false,participating in the most important ms milancongress in the world on multiple sclerosis with great colleagues and friends. we continue working on research msresearch
72,2023-10-13 11:27:09.0,"Chiari Zecca: Nice talk on managing anti-B cel therapy to reduce infectious risks over time.
Most used is extended dosing intervals (or dose reductions) with fixed interval or by following B-cel reoccurrence.
Monitoring IgG levels is advised üòå
#MSMilan2023 
#MultipleSclerosis https://t.co/k6ntGlb1Yb",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}",chiari zecca: nice talk on managing anti-b cel therapy to reduce infectious risks over time. most used is extended dosing intervals (or dose reductions) with fixed interval or by following b-cel reoccurrence. monitoring igg levels is advised üòå #msmilan2023 #multiplesclerosis https://t.co/k6ntglb1yb,unknown,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1946,885,0,,,0,1,1885,false,chiari zecca: nice talk on managing anti-b cel therapy to reduce infectious risks over time. most used is extended dosing intervals (or dose reductions) with fixed interval or by following b-cel reoccurrence. monitoring igg levels is advised ms milan multiple sclerosis
73,2023-10-13 11:01:21.0,"Exploring the intersection of hormones and #MS! Dive into this discussion on hormone replacement therapy during menopause with Rhonda Voskuhl, PhD. What could this mean for patients with MS? ü§î @UCLA @UCLAHealth @ECTRIMS @ACTRIMS #MSMilan

Watch: https://t.co/57RjlHnFuq https://t.co/bb8PXbibr7",twitter,USA,neurology_live,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","exploring the intersection of hormones and #ms! dive into this discussion on hormone replacement therapy during menopause with rhonda voskuhl, phd. what could this mean for patients with ms? ü§î @ucla @uclahealth @ectrims @actrims #msmilan watch: https://t.co/57rjlhnfuq https://t.co/bb8pxbibr7",,"#ms, #msmilan",Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,0,33752,false,"exploring the intersection of hormones and ms! dive into this discussion on hormone replacement therapy during menopause with rhonda voskuhl, phd. what could this mean for patients with ms? msmilan watch:"
74,2023-10-13 11:01:00.0,"Great News Today: Tiziana Announces Positive Qualitative Six-Month PET Scan Results With Intranasal Foralumab Treating Multiple Sclerosis Patients Diagnosed With Non-Active Secondary Progressive MS #MSMilan2023 @ECTRIMS @ACTRIMS $TLSA #MultipleSclerosis
https://t.co/Bw3Vc7vCWY https://t.co/ESQyGU6jL9",twitter,,TizianaLS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}",great news today: tiziana announces positive qualitative six-month pet scan results with intranasal foralumab treating multiple sclerosis patients diagnosed with non-active secondary progressive ms #msmilan2023 @ectrims @actrims $tlsa #multiplesclerosis https://t.co/bw3vc7vcwy https://t.co/esqygu6jl9,unknown,"#msmilan2023, #multiplesclerosis",,,6000000000,847823456758575105,,1410,304,0,,,14,43,368,true,great news today: tiziana announces positive qualitative six-month pet scan results with intranasal foralumab treating multiple sclerosis patients diagnosed with non-active secondary progressive ms ms milan $tlsa multiple sclerosis
75,2023-10-13 10:58:58.0,"So proud of Marloes! She presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by MS. New insights on why the network becomes inefficient in some people with MS. Exciting times! #MSMilan2023 @MScentrum020",twitter,NLD,Mennoke,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","so proud of marloes! she presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by ms. new insights on why the network becomes inefficient in some people with ms. exciting times! #msmilan2023 @mscentrum020",male,#msmilan2023,,"{profession=Scientist & Researcher, jobTitle=Neuroscientist}, {profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,83447713,,592,617,0,,,1,6,1085,false,"so proud of marloes! she presented on advanced ways of investigating how patterns of communication in the brain alternate, and how these are affected by ms. new insights on why the network becomes inefficient in some people with ms. exciting times! ms milan"
76,2023-10-13 10:52:59.0,Grateful to have had the opportunity to present my work on functional brain dynamics yesterday at #ECTRIMS2023 in Milan. Special thanks to the co-authors and my supervisors @BroedersTommy  and @Mennoke  for their support! #MSMilan23 #MS https://t.co/zPw6mxBVPn,twitter,NLD,MarloesBet,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",grateful to have had the opportunity to present my work on functional brain dynamics yesterday at #ectrims2023 in milan. special thanks to the co-authors and my supervisors @broederstommy and @mennoke for their support! #msmilan23 #ms https://t.co/zpw6mxbvpn,female,"#ectrims2023, #msmilan23, #ms","Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1364940824895750144,,17,123,0,,,4,6,1,false,grateful to have had the opportunity to present my work on functional brain dynamics yesterday at ec trims in milan. special thanks to the co-authors and my supervisors and for their support! msmilan23 ms
77,2023-10-13 10:47:45.0,"This morning @valegiunca presented during the #ECTRIMS2023 scientific session. Great to see @UKMSRegister data being used in some more brilliant research!

#MSMilan2023 #Research #MultipleSclerosis @imperialcollege https://t.co/AGDXRPvCbX",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",this morning @valegiunca presented during the #ectrims2023 scientific session. great to see @ukmsregister data being used in some more brilliant research! #msmilan2023 #research #multiplesclerosis @imperialcollege https://t.co/agdxrpvcbx,,"#ectrims2023, #msmilan2023, #research, #multiplesclerosis",,,6000000000,325527212,,2296,1835,1,,,2,7,1840,false,this morning presented during the ec trims scientific session. great to see data being used in some more brilliant research! ms milan #research multiple sclerosis
78,2023-10-13 10:44:31.0,"There you go! A clear figure indicating higher prevalence of cerebrovascular comorbidity in MS compared to controls. Let‚Äôs shift spotlight to how we can manage and better so, prevent -  Stella Sivertseva @ECTRIMS #MSMilan2023 Photo credit @KarenZoszak https://t.co/Momx0kxGhY",twitter,,OliviaWillsAPD,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","there you go! a clear figure indicating higher prevalence of cerebrovascular comorbidity in ms compared to controls. let‚Äôs shift spotlight to how we can manage and better so, prevent - stella sivertseva @ectrims #msmilan2023 photo credit @karenzoszak https://t.co/momx0kxghy",female,#msmilan2023,"Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1324106810597408769,,179,200,0,,,0,2,302,false,"there you go! a clear figure indicating higher prevalence of cerebrovascular comorbidity in ms compared to controls. lets shift spotlight to how we can manage and better so, prevent - stella sivertseva ms milan photo credit"
79,2023-10-13 10:23:41.0,"Family planning in women of  childbearing age with #MS should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ü§∞
‚ÄºÔ∏èMS treatment should not be compromised because there are solutions.
#MSMilan2023
@ECTRIMS @ACTRIMS https://t.co/STrJpOtrvF",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","family planning in women of childbearing age with #ms should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ü§∞ ‚ÄºÔ∏èms treatment should not be compromised because there are solutions. #msmilan2023 @ectrims @actrims https://t.co/strjpotrvf",female,"#ms, #pregnancy, #msmilan2023",,,6000000000,600110872,,4874,893,0,,,1,7,5944,false,"family planning in women of childbearing age with ms should be included in standard clinical care, especially to choose the right treatment plans based on #pregnancy desire ms treatment should not be compromised because there are solutions. ms milan"
80,2023-10-13 10:19:12.0,"So far on Day 3 of #MSMilan2023, we‚Äôve had great chats on #MS with:

‚Ä¢ @GeoArrambide, on differential diagnosis
‚Ä¢ @drbarrysinger, on the latest in therapy & biomarkers
‚Ä¢ @melindamagyari, on the role of hormones

Check out https://t.co/Ya6BOYo5VP for all our interview footage! https://t.co/eVxw6lUGo0",twitter,USA,byMattHoffman,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","so far on day 3 of #msmilan2023, we‚Äôve had great chats on #ms with: ‚Ä¢ @geoarrambide, on differential diagnosis ‚Ä¢ @drbarrysinger, on the latest in therapy & biomarkers ‚Ä¢ @melindamagyari, on the role of hormones check out https://t.co/ya6boyo5vp for all our interview footage! https://t.co/evxw6lugo0",male,"#msmilan2023, #ms",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1067,989,0,,,2,5,10026,false,"so far on day 3 of ms milan, weve had great chats on ms with: , on differential diagnosis , on the latest in therapy & biomarkers , on the role of hormones check out for all our interview footage!"
81,2023-10-13 09:01:31.0,Dr Anthony Feinstein presents the results of the CogEx clinical trial to improve cognition in people living with progressive MS @ECTRIMS #MSMilan2023 https://t.co/Xr3HtfRkG3,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr anthony feinstein presents the results of the cogex clinical trial to improve cognition in people living with progressive ms @ectrims #msmilan2023 https://t.co/xr3htfrkg3,female,#msmilan2023,,,6000000000,256679634,,1175,1912,0,,,3,5,6585,false,dr anthony feinstein presents the results of the cogex clinical trial to improve cognition in people living with progressive ms ms milan
82,2023-10-13 08:57:37.0,"Dr Owain Howells discussing pathology and immunology at #ECTRIMS2023 yesterday, using data from @UKMSRegister üíª

#MSMilan2023 #MultipleSclerosis #Research https://t.co/AA94ddbWBH",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","dr owain howells discussing pathology and immunology at #ectrims2023 yesterday, using data from @ukmsregister üíª #msmilan2023 #multiplesclerosis #research https://t.co/aa94ddbwbh",,"#ectrims2023, #msmilan2023, #multiplesclerosis, #research",,,6000000000,325527212,,2296,1833,0,,,2,5,1839,false,"dr owain howells discussing pathology and immunology at ec trims yesterday, using data from ms milan multiple sclerosis #research"
83,2023-10-13 08:56:14.0,Proud and honored to contribute to this @ectrims @MAGNIMS teaching course representing @cemcat,twitter,ESP,J_SastreGarriga,,proud and honored to contribute to this @ectrims @magnims teaching course representing @cemcat,male,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,829744742,,3220,868,0,,,7,24,6885,false,proud and honored to contribute to this teaching course representing
84,2023-10-13 08:53:53.0,"MS new tratments: BTK inhibitors
#MSMilan2023 #ectrims2023 https://t.co/bTLQQwrdGZ",twitter,BRA,vcneri,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ms new tratments: btk inhibitors #msmilan2023 #ectrims2023 https://t.co/btlqqwrdgz,unknown,"#msmilan2023, #ectrims2023","Beauty/Health & Fitness, Science",,6000000000,53810006,,111,679,0,,,0,0,102,false,ms new tratments: btk inhibitors ms milan ec trims
85,2023-10-13 08:51:33.0,"Progression in MS..,
#ectrims #MSMilan2023 https://t.co/RGLoaJJdXk",twitter,BRA,vcneri,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","progression in ms.., #ectrims #msmilan2023 https://t.co/rgloajjdxk",unknown,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Science",,6000000000,53810006,,111,679,0,,,1,0,101,false,"progression in ms.., ec trims ms milan"
86,2023-10-13 08:49:26.0,Our editorial board member @Duttalab2017 presenting on microglial miRNA in remyelination in #MultipleSclerosis at #MSMilam2023 @ECTRIMS https://t.co/TgOIJVeFS9,twitter,GBR,MSJ_Research,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our editorial board member @duttalab2017 presenting on microglial mirna in remyelination in #multiplesclerosis at #msmilam2023 @ectrims https://t.co/tgoijvefs9,,"#multiplesclerosis, #msmilam2023",Beauty/Health & Fitness,,6000000000,764125362422972416,,3487,199,0,,,1,4,2607,false,our editorial board member presenting on microglial mirna in remyelination in multiple sclerosis at msmilam2023
87,2023-10-13 08:47:22.0,"Patient reported outcomes #PROMS- person with #MS capturing their own changes is a crucial topic at @ECTRIMS 
‚úîÔ∏èReflect daily life
‚úîÔ∏èPatient experience
‚úîÔ∏èPractical
‚úîÔ∏èLow cost
üôåHigh potential to track progression and efficacy of intervention
#MSMilan2023 https://t.co/XLodG00LEc",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",patient reported outcomes #proms- person with #ms capturing their own changes is a crucial topic at @ectrims ‚úîÔ∏èreflect daily life ‚úîÔ∏èpatient experience ‚úîÔ∏èpractical ‚úîÔ∏èlow cost üôåhigh potential to track progression and efficacy of intervention #msmilan2023 https://t.co/xlodg00lec,female,"#proms, #ms, #msmilan2023",,,6000000000,600110872,,4874,893,0,,,5,13,5941,false,patient reported outcomes #proms- person with ms capturing their own changes is a crucial topic at reflect daily life patient experience practical low cost high potential to track progression and efficacy of intervention ms milan
88,2023-10-13 08:46:17.0,"Great to breakfast with @danielsaloreich @ectrims @ACTRIMS #Milan2023 and discuss #MS #Biomarker research. Subdued & concerned about exposure of friends, family in #Israel to #HamasTerrorism https://t.co/TtWMFQwQ1h",twitter,ITA,KlausSchmierer,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","great to breakfast with @danielsaloreich @ectrims @actrims #milan2023 and discuss #ms #biomarker research. subdued & concerned about exposure of friends, family in #israel to #hamasterrorism https://t.co/ttwmfqwq1h",male,"#milan2023, #ms, #biomarker, #israel, #hamasterrorism",Politics,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1618555326,,4090,1329,1,,,0,16,8360,false,"great to breakfast with milan2023 and discuss ms #biomarker research. subdued & concerned about exposure of friends, family in #israel to #hamasterrorism"
89,2023-10-13 08:37:07.0,It has been an honour to present our work at #MSMilan2023 #ECTRIMS #MultipleSclerosis #MS #UCL #QSMSC https://t.co/K0GtzjVP20,twitter,GBR,saalaraji,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",it has been an honour to present our work at #msmilan2023 #ectrims #multiplesclerosis #ms #ucl #qsmsc https://t.co/k0gtzjvp20,male,"#msmilan2023, #ectrims, #multiplesclerosis, #ms, #ucl, #qsmsc","Beauty/Health & Fitness, Science","{profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1059537299535511552,,182,220,1,,,3,22,261,false,it has been an honour to present our work at ms milan ec trims multiple sclerosis ms #ucl #qsmsc
90,2023-10-13 08:25:50.0,"Starting Pediatric MS session this AM at #MSMilan2023 #ECTRIMS with Tanuja Chitnis discussing disability accrual, potential predictive value of sNFL, and treatment pathways https://t.co/Cng65PVEpV",twitter,USA,KSFisher,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","starting pediatric ms session this am at #msmilan2023 #ectrims with tanuja chitnis discussing disability accrual, potential predictive value of snfl, and treatment pathways https://t.co/cng65pvepv",female,"#msmilan2023, #ectrims",Family & Parenting,,6000000000,790055143433576448,,426,446,1,,,1,6,208,false,"starting pediatric ms session this am at ms milan ec trims with tanuja chitnis discussing disability accrual, potential predictive value of snfl, and treatment pathways"
91,2023-10-13 08:17:07.0,The 2nd of two @MAGNIMS educational activities at #MSMilan2023 @ECTRIMS was held this morning on ‚ÄúClinical relevance of spinal cord and optic nerve imaging in multiple sclerosis‚Äù with @rocca_mara @DrWBRO & @J_SastreGarriga - We hope you found them informative! Thanks for coming! https://t.co/ehpt8C6qXr,twitter,,MAGNIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the 2nd of two @magnims educational activities at #msmilan2023 @ectrims was held this morning on ‚Äúclinical relevance of spinal cord and optic nerve imaging in multiple sclerosis‚Äù with @rocca_mara @drwbro & @j_sastregarriga - we hope you found them informative! thanks for coming! https://t.co/ehpt8c6qxr,unknown,#msmilan2023,,,6000000000,2194426992,,1611,43,0,,,5,30,376,false,the 2nd of two educational activities at ms milan was held this morning on clinical relevance of spinal cord and optic nerve imaging in multiple sclerosis with & - we hope you found them informative! thanks for coming!
92,2023-10-13 08:08:44.0,"Great to have the opportunity to present on the development of #biosimilar medications. With decrease costs, biosimilar DMTs will allow more #MS patients üåé have access to early high efficacy treatment.  üëç #MSMilan2023 https://t.co/MIXQdVW2Mz",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}","great to have the opportunity to present on the development of #biosimilar medications. with decrease costs, biosimilar dmts will allow more #ms patients üåé have access to early high efficacy treatment. üëç #msmilan2023 https://t.co/mixqdvw2mz",male,"#biosimilar, #ms, #msmilan2023",Science,,6000000000,1430793013,,7231,393,0,,,1,4,3167,false,"great to have the opportunity to present on the development of #biosimilar medications. with decrease costs, biosimilar dmts will allow more ms patients have access to early high efficacy treatment. ms milan"
93,2023-10-13 07:47:38.0,"Check out Poster 1183 
@ECTRIMS
 #MSMilan2023 by @YasmineProbst

Tools use in the lifestyle management studies for #MS and researcher checklist for best practice https://t.co/ejUtfiUZ8o",twitter,SAU,Aloufi_loqmani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",check out poster 1183 @ectrims #msmilan2023 by @yasmineprobst tools use in the lifestyle management studies for #ms and researcher checklist for best practice https://t.co/ejutfiuz8o,unknown,"#msmilan2023, #ms","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Clinical Dietitian}, {profession=Student, jobTitle=PhD Candidate}",6000000000,1943651450,,244,1379,0,,,1,3,13440,false,check out poster 1183 ms milan by tools use in the lifestyle management studies for ms and researcher checklist for best practice
94,2023-10-13 04:37:46.0,"Our Day 2 #MSMilan2023 insights are live. Our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, AHSCT & EBV, & more! #MultipleSclerosis #MS @ECTRIMS @ACTRIMS  https://t.co/3oXgh6WTb2",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","our day 2 #msmilan2023 insights are live. our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, ahsct & ebv, & more! #multiplesclerosis #ms @ectrims @actrims https://t.co/3oxgh6wtb2",,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,833579503,,4906,4077,0,,,0,4,3601,false,"our day 2 ms milan insights are live. our team explores topics incl. the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic & epigenetic risk factors, ahsct & ebv, & more! multiple sclerosis ms"
95,2023-10-13 03:47:51.0,"@ECTRIMS @mssocietyuk @MStranslate THERE ARE SEVERAL CURES FOR #MS
https://t.co/xjl0NKz8rA",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@ectrims @mssocietyuk @mstranslate there are several cures for #ms https://t.co/xjl0nkz8ra,female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,984,560,0,http://twitter.com/ECTRIMS/statuses/1712525613184004099,,0,0,31765,false,there are several cures for ms
96,2023-10-13 03:47:21.0,"@mssocietyHCP @mssociety @ECTRIMS @ACTRIMS THERE ARE SO MANY CURES FOR #MS‚Ä¶
https://t.co/xjl0NKz8rA",twitter,USA,MsStacyEllis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@mssocietyhcp @mssociety @ectrims @actrims there are so many cures for #ms‚Ä¶ https://t.co/xjl0nkz8ra,female,#ms,Beauty/Health & Fitness,"{profession=Health practitioner, jobTitle=Psychotherapist}",6000000000,1179505063150182400,,984,560,1,http://twitter.com/mssocietyHCP/statuses/1712426407232680248,,0,0,31764,false,there are so many cures for ms
97,2023-10-13 03:16:08.0,"My @ECTRIMS Poster 1675- Redefining brain health in MS to recognise the influence of biological, psychological, social, interpersonal and contextual factors. Consistency in behaviour change messaging to maximise lifelong brain health for people with MS is also needed #MSMilan2023 https://t.co/Hzi34EgOTy",twitter,,OliviaWillsAPD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","my @ectrims poster 1675- redefining brain health in ms to recognise the influence of biological, psychological, social, interpersonal and contextual factors. consistency in behaviour change messaging to maximise lifelong brain health for people with ms is also needed #msmilan2023 https://t.co/hzi34egoty",female,#msmilan2023,"Beauty/Health & Fitness, Science","{profession=Student, jobTitle=PhD Candidate}",6000000000,1324106810597408769,,179,200,0,,,0,11,300,false,"my poster 1675- redefining brain health in ms to recognise the influence of biological, psychological, social, interpersonal and contextual factors. consistency in behaviour change messaging to maximise lifelong brain health for people with ms is also needed ms milan"
98,2023-10-13 00:58:48.0,"Great to see Comorbidities in MS receiving much more attention in #ECTRIMS #MSMilan2023 this year

Known that most comorbidities are modifiable diseases, this highlights the importance of Dietary Management to delay the onset + manage already present comorbidities",twitter,SAU,Aloufi_loqmani,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","great to see comorbidities in ms receiving much more attention in #ectrims #msmilan2023 this year known that most comorbidities are modifiable diseases, this highlights the importance of dietary management to delay the onset + manage already present comorbidities",unknown,"#ectrims, #msmilan2023","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Clinical Dietitian}, {profession=Student, jobTitle=PhD Candidate}",6000000000,1943651450,,244,1379,0,,,0,3,13438,false,"great to see comorbidities in ms receiving much more attention in ec trims ms milan this year known that most comorbidities are modifiable diseases, this highlights the importance of dietary management to delay the onset + manage already present comorbidities"
99,2023-10-13 00:29:59.0,"ECTRIMS 2023: Medical Gaslighting in People with Multiple Sclerosis, by @GavinGiovannoni https://t.co/Ir0he34LFI",twitter,,ButterflyCr8ion,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ectrims 2023: medical gaslighting in people with multiple sclerosis, by @gavingiovannoni https://t.co/ir0he34lfi",unknown,,Fashion,,6000000000,1565808354366218242,,4,51,0,,,0,0,60,false,"ectrims 2023: medical gaslighting in people with multiple sclerosis, by"
100,2023-10-13 00:18:27.0,In line with the priority topics of @MSIntFederation and @mssociety we set out to investigate the access to health services in the LGBTQ+ population with #multiplesclerosis in Argentina.  A collaborative with @EMA_Argentina presented at #MSMilan2023 congress @ECTRIMS,twitter,ITA,bereniceanabel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",in line with the priority topics of @msintfederation and @mssociety we set out to investigate the access to health services in the lgbtq+ population with #multiplesclerosis in argentina. a collaborative with @ema_argentina presented at #msmilan2023 congress @ectrims,female,"#multiplesclerosis, #msmilan2023",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,946033424296501249,,198,339,2,,,0,5,587,false,in line with the priority topics of and we set out to investigate the access to health services in the lgbtq+ population with multiple sclerosis in argentina. a collaborative with presented at ms milan congress
101,2023-10-13 00:18:08.0,"Thanks for your work, what is your poster number? #globalislocal in #MS @ECTRIMS #milan2023 https://t.co/Z8T7iMKekk",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","thanks for your work, what is your poster number? #globalislocal in #ms @ectrims #milan2023 https://t.co/z8t7imkekk",male,"#globalislocal, #ms, #milan2023",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1777,622,0,,,0,0,7996,false,"thanks for your work, what is your poster number? #globalislocal in ms milan2023"
102,2023-10-13 00:01:01.0,"Infection with the Epstein-Barr virus may prime the immune system to accidentally attack a brain protein called ANO2, research shows.¬† https://t.co/s7R8TQz248 #ectrims2023 #news https://t.co/c00HYYGT6Q",twitter,USA,MSNewsToday,"{id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. https://t.co/s7r8tqz248 #ectrims2023 #news https://t.co/c00hyygt6q",female,"#ectrims2023, #news",,,6000000000,2473350271,,10058,1542,0,,,4,9,28180,false,"infection with the epstein-barr virus may prime the immune system to accidentally attack a brain protein called ano2, research shows. ec trims #news"
104,2023-10-12 21:20:41.0,Learn about the MS research funding landscape in this poster  #msmilan2023 ‚Å¶@ECTRIMS‚Å© https://t.co/PrIrue4Hdb,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",learn about the ms research funding landscape in this poster #msmilan2023 ‚Å¶@ectrims‚Å© https://t.co/prirue4hdb,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,4,6584,false,learn about the ms research funding landscape in this poster ms milan
105,2023-10-12 21:11:02.0,@MyelinIcm @BenedettaBodin1 Wonderful talk! And thank you for the shout-out üòÄ! Please check out the poster by @ericklawiter on [18F]3F4AP in people with MS @ECTRIMS,twitter,USA,P_Brugarolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@myelinicm @benedettabodin1 wonderful talk! and thank you for the shout-out üòÄ! please check out the poster by @ericklawiter on [18f]3f4ap in people with ms @ectrims,male,,"Technology, Animals & Pets, Family & Parenting","{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Software developer & IT, jobTitle=Developer}",6000000000,952251187952316417,,628,744,0,http://twitter.com/MyelinIcm/statuses/1712089991784935779,,0,2,554,false,wonderful talk! and thank you for the shout-out ! please check out the poster by on [18f]3f4ap in people with ms
106,2023-10-12 21:04:05.0,Honoured to be invited to talk on optic nerve imaging (MS Pathophysiology and Disease Evolution) today @ECTRIMS #MSMilan2023 https://t.co/ZSd5fOAi8Q,twitter,,ahmedtoosy,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",honoured to be invited to talk on optic nerve imaging (ms pathophysiology and disease evolution) today @ectrims #msmilan2023 https://t.co/zsd5foai8q,unknown,#msmilan2023,,,6000000000,18452647,,122,246,0,,,2,16,229,false,honoured to be invited to talk on optic nerve imaging (ms pathophysiology and disease evolution) today ms milan
107,2023-10-12 20:50:40.0,Another session is coming up tomorrow on the third and last day of #ECTRIMS2023 We‚Äôll be talking about optimizing (or optimising üòÉ) prognosis in MS. Come join us and let‚Äôs discuss together @ECTRIMS @DrWBRO https://t.co/I1WIob6vXr,twitter,,burcuzeydanmd,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20279310, name=Ofev, displayName=null, parentId=20279181, parentName=ERS 2023 categories}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=15147375, name=Ofev, displayName=null, parentId=15147295, parentName=ESR 2022 Conference categories}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",another session is coming up tomorrow on the third and last day of #ectrims2023 we‚Äôll be talking about optimizing (or optimising üòÉ) prognosis in ms. come join us and let‚Äôs discuss together @ectrims @drwbro https://t.co/i1wiob6vxr,female,#ectrims2023,Beauty/Health & Fitness,,6000000000,1221551673463705602,,544,444,2,,,3,19,89,false,another session is coming up tomorrow on the third and last day of ec trims well be talking about optimizing (or optimising ) prognosis in ms. come join us and lets discuss together
108,2023-10-12 19:45:16.0,@J_SastreGarriga @clmguio @Neus_Mongay @CEMCAT @MAGNIMS @ECTRIMS @XMontalban @alexrovirarayos @MarTintore @rocca_mara @AVidalJordana @FBarkhof @CiccarelliOlga @segroppa Great! @Neus_Mongay,twitter,ITA,Vogrig_Alberto,,@j_sastregarriga @clmguio @neus_mongay @cemcat @magnims @ectrims @xmontalban @alexrovirarayos @martintore @rocca_mara @avidaljordana @fbarkhof @ciccarelliolga @segroppa great! @neus_mongay,male,,,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1188448559886229507,,1021,650,0,http://twitter.com/J_SastreGarriga/statuses/1712472004786585621,,0,1,653,false,great!
110,2023-10-12 18:02:00.0,O064 Ana Beatriz Ayrosa Galvao Ribeiro Gomes: Isolated MOG-IgA in indivs w/distinct spectrum of clinical features: suggests MOG-IgA as potential diagnostic #biomarker in indivs w/ AQP4-/MOG-IgG double-seronegative CNS demyelination. @DepBiomedicine #MSMilan2023 #MS #MOGAD #NMOSD,twitter,,IJMSCtweets,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",o064 ana beatriz ayrosa galvao ribeiro gomes: isolated mog-iga in indivs w/distinct spectrum of clinical features: suggests mog-iga as potential diagnostic #biomarker in indivs w/ aqp4-/mog-igg double-seronegative cns demyelination. @depbiomedicine #msmilan2023 #ms #mogad #nmosd,,"#biomarker, #msmilan2023, #ms, #mogad, #nmosd",,,6000000000,1054320667,,896,623,0,,,0,0,4199,false,o064 ana beatriz ayrosa galvao ribeiro gomes: isolated mog-iga in indivs w/distinct spectrum of clinical features: suggests mog-iga as potential diagnostic #biomarker in indivs w/ aqp4-/mog-igg double-seronegative cns demyelination. ms milan ms #mogad #nmosd
111,2023-10-12 18:01:07.0,"@MerckHealthcare @ECTRIMS @TawakkolKarman Why promote islam ideology, Merck?",twitter,,gtratwar,"{id=16441708, name=Merck, displayName=null, parentId=16441705, parentName=CI Updates'22}","@merckhealthcare @ectrims @tawakkolkarman why promote islam ideology, merck?",unknown,,,,6000000000,49117120,,495,165,0,http://twitter.com/MerckHealthcare/statuses/1712037892141322651,,0,1,101649,false,"why promote islam ideology, merck?"
112,2023-10-12 18:00:43.0,Great to see this topic being addressed in the collab between @UniMelb Neuroepidemiliogy Unit @UKMSRegister @SwanseaUni on diet and #MS at#ECTRIMS2023,twitter,GBR,drrachhunter,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great to see this topic being addressed in the collab between @unimelb neuroepidemiliogy unit @ukmsregister @swanseauni on diet and #ms at#ectrims2023,female,"#ms, #ectrims2023","Beauty/Health & Fitness, Science, Family & Parenting","{profession=Teacher & Lecturer, jobTitle=Senior Lecturer}, {profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Health practitioner, jobTitle=Clinical Psychologist}",6000000000,775366410,,877,1057,0,,,0,3,3029,false,great to see this topic being addressed in the collab between neuroepidemiliogy unit on diet and ms atec trims
113,2023-10-12 17:45:00.0,"O130 @HCL_research: Immune checkpoint inhibitors & CAR-T cell therapy have dramatically improved #malignancy prognosis. Due to mechanism, both can trigger immune-related AEs. Neurological irAE are relatively rare but potentially serious. #MSMilan2023 #cancer #MultipleSclerosis",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","o130 @hcl_research: immune checkpoint inhibitors & car-t cell therapy have dramatically improved #malignancy prognosis. due to mechanism, both can trigger immune-related aes. neurological irae are relatively rare but potentially serious. #msmilan2023 #cancer #multiplesclerosis",,"#malignancy, #msmilan2023, #cancer, #multiplesclerosis",,,6000000000,1054320667,,896,623,0,,,0,0,4198,false,"o130 : immune checkpoint inhibitors & car-t cell therapy have dramatically improved #malignancy prognosis. due to mechanism, both can trigger immune-related aes. neurological irae are relatively rare but potentially serious. ms milan #cancer multiple sclerosis"
114,2023-10-12 17:40:09.0,A stolen selfie from today #MultipleSclerosis Journal Editorial Board Meeting at #MSMilan2023 @ECTRIMS https://t.co/TlkY5RHGN1,twitter,GBR,MSJ_Research,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",a stolen selfie from today #multiplesclerosis journal editorial board meeting at #msmilan2023 @ectrims https://t.co/tlky5rhgn1,,"#multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,764125362422972416,,3484,199,0,,,3,12,2604,false,a stolen selfie from today multiple sclerosis journal editorial board meeting at ms milan
115,2023-10-12 17:26:45.0,@RealTalkMS_jon our @DigiVidBio team had the honor to work with Jon to capture the latest MS research coming out of #ectrims #MSMilan2023 #ACTRIMS to help the MS community https://t.co/no6Qwlmi1F,twitter,USA,jfairdigital,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@realtalkms_jon our @digividbio team had the honor to work with jon to capture the latest ms research coming out of #ectrims #msmilan2023 #actrims to help the ms community https://t.co/no6qwlmi1f,male,"#ectrims, #msmilan2023, #actrims","Food & Drinks, Family & Parenting",,6000000000,66810011,,1022,2474,0,,,2,1,9389,false,our team had the honor to work with jon to capture the latest ms research coming out of ec trims ms milan #actrims to help the ms community
116,2023-10-12 17:04:55.0,"Long-lasting friendship and many hours together dedicated to clinical care, research and teaching in #multiplesclerosis. Congratulations to  @MarTintore ,  President of @ECTRIMS, for the 2023 meeting in #Milano that is already an absolute success. @cemcat_em @vallhebron @VHIR_ https://t.co/OFDIAnAL4Y",twitter,ESP,XMontalban,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","long-lasting friendship and many hours together dedicated to clinical care, research and teaching in #multiplesclerosis. congratulations to @martintore , president of @ectrims, for the 2023 meeting in #milano that is already an absolute success. @cemcat_em @vallhebron @vhir_ https://t.co/ofdianal4y",male,"#multiplesclerosis, #milano",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,757774178,,5565,1117,2,,,15,153,2627,false,"long-lasting friendship and many hours together dedicated to clinical care, research and teaching in multiple sclerosis. congratulations to , president of , for the 2023 meeting in milano that is already an absolute success."
117,2023-10-12 16:31:14.0,ViewMind Inc.¬†will be exhibiting at¬†#msmilan2023 and presenting posters based on studies supported by Biogen and Hospital Ramos Mej√≠a. (Booth D30)#MS ¬†#healthcare¬†#MSresearch ECTRIMS Congress ACTRIMS ¬Æ Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) https://t.co/XafKDY2l41,twitter,USA,ViewMind_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}",viewmind inc. will be exhibiting at #msmilan2023 and presenting posters based on studies supported by biogen and hospital ramos mej√≠a. (booth d30)#ms #healthcare #msresearch ectrims congress actrims ¬Æ americas committee for treatment & research in multiple sclerosis (actrims) https://t.co/xafkdy2l41,unknown,"#msmilan2023, #ms, #healthcare, #msresearch",Beauty/Health & Fitness,,6000000000,986583802154799104,,215,776,0,,,0,0,393,false,viewmind inc. will be exhibiting at ms milan and presenting posters based on studies supported by biogen and hospital ramos meja. (booth d30)ms #healthcare msresearch ectrims congress actrims americas committee for treatment & research in multiple sclerosis (actrims)
118,2023-10-12 16:22:02.0,"Exciting insights from @drbarrysinger into biosimilar natalizumab! Thanks a lot! üß¨üí°

#MS #MultipleSclerosis #natalizumab #MSMilan2023 #ECTRIMS #sandoz https://t.co/3flJ7WiGJ7",twitter,,MSguncel,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441706, name=Novartis, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",exciting insights from @drbarrysinger into biosimilar natalizumab! thanks a lot! üß¨üí° #ms #multiplesclerosis #natalizumab #msmilan2023 #ectrims #sandoz https://t.co/3flj7wigj7,female,"#ms, #multiplesclerosis, #natalizumab, #msmilan2023, #ectrims, #sandoz",,,6000000000,1338606356346048512,,1448,61,2,,,1,14,821,false,exciting insights from into biosimilar natalizumab! thanks a lot! ms multiple sclerosis #natalizumab ms milan ec trims #sandoz
119,2023-10-12 15:37:44.0,"Slightly biased but this might possibly be the most iconic photo of #MSMilan2023 ü©∑üíïüíó 

#NMOSD #MOGAD #ECTRIMS #NeuroTwitter #girlpower https://t.co/AWdbnbP1Et",twitter,ITA,SumairaFlower,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",slightly biased but this might possibly be the most iconic photo of #msmilan2023 ü©∑üíïüíó #nmosd #mogad #ectrims #neurotwitter #girlpower https://t.co/awdbnbp1et,unknown,"#msmilan2023, #nmosd, #mogad, #ectrims, #neurotwitter, #girlpower",,"{profession=Executive, jobTitle=Founder}",6000000000,118800058,,1194,246,4,,,7,49,2985,false,slightly biased but this might possibly be the most iconic photo of ms milan #nmosd #mogad ec trims #neurotwitter #girlpower
120,2023-10-12 15:31:22.0,"Treatment with immediate release tablets of a non-covalent Bruton‚Äôs #tyrosine kinase inhibitor for relapsing forms of #MS met pharmacokinetic and pharmacodynamic goals, data from @ECTRIMS show #ECTRIMS2023. https://t.co/LuBWlJhS3E",twitter,,healioneurology,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","treatment with immediate release tablets of a non-covalent bruton‚Äôs #tyrosine kinase inhibitor for relapsing forms of #ms met pharmacokinetic and pharmacodynamic goals, data from @ectrims show #ectrims2023. https://t.co/lubwljhs3e",unknown,"#tyrosine, #ms, #ectrims2023",,,6000000000,1288887610371452928,,56,211,0,,,0,0,1601,false,"treatment with immediate release tablets of a non-covalent brutons #tyrosine kinase inhibitor for relapsing forms of ms met pharmacokinetic and pharmacodynamic goals, data from show ec trims."
121,2023-10-12 15:05:00.0,"Findings showed that the use of anti-CD20 therapies after natalizumab (Tysabri; @biogenms) were effective in treating MS, with most disease progression related being PIRA. #MSMilan2023 

https://t.co/hD8zrpBk3b",twitter,USA,neurology_live,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","findings showed that the use of anti-cd20 therapies after natalizumab (tysabri; @biogenms) were effective in treating ms, with most disease progression related being pira. #msmilan2023 https://t.co/hd8zrpbk3b",,#msmilan2023,Beauty/Health & Fitness,,6000000000,1016356467073585152,,8626,517,0,,,0,0,33750,false,"findings showed that the use of anti-cd20 therapies after natalizumab (tysabri; ) were effective in treating ms, with most disease progression related being pira. ms milan"
122,2023-10-12 15:04:31.0,#ECTRIMS2023 $TGTX presents data from the Ph3 ULTIMATE I & II trials of #ublituximab in #MS this week at #MSMILAN2023. Check out our 3 presentations at https://t.co/SvwvfB54pZ - Visit our Booth - C15. Details: https://t.co/q0aDGKS7fY #FearlessForPatients https://t.co/U9prJ7JgDu,twitter,USA,TGTherapeutics,"{id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",#ectrims2023 $tgtx presents data from the ph3 ultimate i & ii trials of #ublituximab in #ms this week at #msmilan2023. check out our 3 presentations at https://t.co/svwvfb54pz - visit our booth - c15. details: https://t.co/q0adgks7fy #fearlessforpatients https://t.co/u9prj7jgdu,,"#ectrims2023, #ublituximab, #ms, #msmilan2023, #fearlessforpatients","Beauty/Health & Fitness, Business",,6000000000,439362597,,2813,60,0,,,0,7,581,false,ec trims $tgtx presents data from the ph3 ultimate i & ii trials of #ublituximab in ms this week at ms milan. check out our 3 presentations at - visit our booth - c15. details: #fearlessforpatients
123,2023-10-12 14:33:53.0,"Ready (and happy) to Poster Session 2 where we will present our data about the relationship between MDSCs and relapse recovery (P642; @leticalahorra et al) and disease severity in PPMS (@MCrisOrtega14 et al) at #ECTRIMS2023.
@HNParaplejicos
@CIBER_ISCIII @ciberned @SanidadCLM https://t.co/uQYnIPkki0",twitter,ESP,DrDiegoClemente,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",ready (and happy) to poster session 2 where we will present our data about the relationship between mdscs and relapse recovery (p642; @leticalahorra et al) and disease severity in ppms (@mcrisortega14 et al) at #ectrims2023. @hnparaplejicos @ciber_isciii @ciberned @sanidadclm https://t.co/uqynipkki0,male,#ectrims2023,Beauty/Health & Fitness,,6000000000,761582912223514624,,1941,1217,0,,,3,16,8744,false,ready (and happy) to poster session 2 where we will present our data about the relationship between mdscs and relapse recovery (p642; et al) and disease severity in ppms ( et al) at ec trims.
124,2023-10-12 14:09:30.0,"Imaging the optic nerve and the spinal cord to understand MS pathophysiology and monitor disease evolution, #MSMilan2023. Great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. With @alexrovirarayos, @Neus_Mongay. @J_SastreGarriga #ECTRIMS #ACTRIMS https://t.co/sEw8GhLtfP",twitter,ESP,GeoArrambide,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}","imaging the optic nerve and the spinal cord to understand ms pathophysiology and monitor disease evolution, #msmilan2023. great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. with @alexrovirarayos, @neus_mongay. @j_sastregarriga #ectrims #actrims https://t.co/sew8ghltfp",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,537,175,0,,,5,27,734,false,"imaging the optic nerve and the spinal cord to understand ms pathophysiology and monitor disease evolution, ms milan. great talks mostly focused on spinal cord lesions, volume and the spinal cord reserve. with , . ec trims #actrims"
125,2023-10-12 14:06:45.0,"Greetings from the second day of #MSMilan2023!

If you haven't had the chance yet, make sure to visit our booth (E23) to get to know our team and learn more about the RIMS Initiatives.

We're looking forward to meeting you!

#RIMS #MS #MSMilan2023 #Booth #Networking https://t.co/1mc732yjfP",twitter,BEL,eurims,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","greetings from the second day of #msmilan2023! if you haven't had the chance yet, make sure to visit our booth (e23) to get to know our team and learn more about the rims initiatives. we're looking forward to meeting you! #rims #ms #msmilan2023 #booth #networking https://t.co/1mc732yjfp",,"#msmilan2023, #rims, #ms, #msmilan2023, #booth, #networking",,,6000000000,421874295,,843,88,1,,,1,15,457,false,"greetings from the second day of ms milan! if you haven't had the chance yet, make sure to visit our booth (e23) to get to know our team and learn more about the rims initiatives. we're looking forward to meeting you! #rims ms ms milan #booth #networking"
126,2023-10-12 14:05:00.0,"P003: #Neurogenetic diseases may be #misdiagnosed as MS or overlap with #MS. Careful interpretation of clinical, CSF & MRI features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to MS therapies. #MSMilan2023",twitter,,IJMSCtweets,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}","p003: #neurogenetic diseases may be #misdiagnosed as ms or overlap with #ms. careful interpretation of clinical, csf & mri features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to ms therapies. #msmilan2023",,"#neurogenetic, #misdiagnosed, #ms, #msmilan2023",,,6000000000,1054320667,,896,623,0,,,1,2,4180,false,"p003: #neurogenetic diseases may be #misdiagnosed as ms or overlap with ms. careful interpretation of clinical, csf & mri features can facilitate timely & accurate diagnosis & prevent unnecessary exposure to ms therapies. ms milan"
127,2023-10-12 14:04:25.0,"Most MS patients treated with a new under-the-skin formulation of Ocrevus had no relapses or new MRI activity over six months, data show. https://t.co/ghHLF6n5Gz #ectrims2023 #news https://t.co/dHZpJ7Uc3r",twitter,USA,MSNewsToday,"{id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","most ms patients treated with a new under-the-skin formulation of ocrevus had no relapses or new mri activity over six months, data show. https://t.co/ghhlf6n5gz #ectrims2023 #news https://t.co/dhzpj7uc3r",female,"#ectrims2023, #news",,,6000000000,2473350271,,10056,1542,0,,,4,19,28175,false,"most ms patients treated with a new under-the-skin formulation of ocrevus had no relapses or new mri activity over six months, data show. ec trims #news"
128,2023-10-12 13:59:35.0,"My favorite slide from Dr. Ilana Katz Sand's excellent presentation on diet and MS at #MSMilan2023 showing chemical compositions of foods. Just as we may pay attention to medications we take, the same care can be taken with what we eat ü•ëüçáü•¨ 

@ECTRIMS #ECTRIMS https://t.co/xv0XBqzuhR",twitter,USA,SarahLevyPhD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","my favorite slide from dr. ilana katz sand's excellent presentation on diet and ms at #msmilan2023 showing chemical compositions of foods. just as we may pay attention to medications we take, the same care can be taken with what we eat ü•ëüçáü•¨ @ectrims #ectrims https://t.co/xv0xbqzuhr",female,"#msmilan2023, #ectrims",Beauty/Health & Fitness,,6000000000,1266888615394770944,,110,169,0,,,1,4,39,false,"my favorite slide from dr. ilana katz sand's excellent presentation on diet and ms at ms milan showing chemical compositions of foods. just as we may pay attention to medications we take, the same care can be taken with what we eat ec trims"
129,2023-10-12 13:55:56.0,Very thrilled to have had the opportunity to present my PhD work in the @PratLab about the use of single-cell immune profiling for prediction of MS activity today at @ECTRIMS #MSMilan2023 üß† https://t.co/g9m6Aggfpf,twitter,,KarineThai_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",very thrilled to have had the opportunity to present my phd work in the @pratlab about the use of single-cell immune profiling for prediction of ms activity today at @ectrims #msmilan2023 üß† https://t.co/g9m6aggfpf,female,#msmilan2023,,,6000000000,1338821204195602436,,43,87,1,,,3,21,13,false,very thrilled to have had the opportunity to present my phd work in the about the use of single-cell immune profiling for prediction of ms activity today at ms milan
130,2023-10-12 13:50:47.0,"Salter: Interesting look at comorbidities in 17 clinical trials with ~18,000 #MS patients. The trial with the most comorbidities was FREEDOMS II, predominantly in the USA (101 of 117 centers). We need to work on overall health of our MS patients, especially in üá∫üá∏! #MSMilan2023 https://t.co/TL4jNd5OHg",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","salter: interesting look at comorbidities in 17 clinical trials with ~18,000 #ms patients. the trial with the most comorbidities was freedoms ii, predominantly in the usa (101 of 117 centers). we need to work on overall health of our ms patients, especially in üá∫üá∏! #msmilan2023 https://t.co/tl4jnd5ohg",male,"#ms, #msmilan2023",Science,,6000000000,1430793013,,7222,393,0,,,1,8,3164,false,"salter: interesting look at comorbidities in 17 clinical trials with ~18,000 ms patients. the trial with the most comorbidities was freedoms ii, predominantly in the usa (101 of 117 centers). we need to work on overall health of our ms patients, especially in ! ms milan"
131,2023-10-12 13:40:39.0,Almost half of participants in MS clinical trials have a comorbidity and this may be underrepresented compared to general MS population @ECTRIMS #MSMilan2023 https://t.co/wIgIKRxFoZ,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",almost half of participants in ms clinical trials have a comorbidity and this may be underrepresented compared to general ms population @ectrims #msmilan2023 https://t.co/wigikrxfoz,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,1,6582,false,almost half of participants in ms clinical trials have a comorbidity and this may be underrepresented compared to general ms population ms milan
132,2023-10-12 13:37:03.0,ECTRIMS 2023: RRMS nerve damage reduced with vidofludimus calcium | #MultipleSclerosis News Today https://t.co/aEGT48e0Oe,twitter,GBR,AbiBuddComms,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ectrims 2023: rrms nerve damage reduced with vidofludimus calcium | #multiplesclerosis news today https://t.co/aegt48e0oe,unknown,#multiplesclerosis,Books,,6000000000,1066255464,,4066,2558,0,,,0,0,25528,false,ectrims 2023: rrms nerve damage reduced with vidofludimus calcium | multiple sclerosis news today
133,2023-10-12 13:34:15.0,"Encouraging news from @ECTRIMS: ICI inhibitors appear safe in MS. Among 18 patients, only 3 relapsed‚Äîthey had stoped DMT (2 with Natalizumab), and were younger. 
If an MS patient faces cancer, a comprehensive approach to both conditions is crucial. #MSMilan2023 #MultipleSclerosis https://t.co/o5O0sTkaoA",twitter,ESP,andreuvilaseca7,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","encouraging news from @ectrims: ici inhibitors appear safe in ms. among 18 patients, only 3 relapsed‚Äîthey had stoped dmt (2 with natalizumab), and were younger. if an ms patient faces cancer, a comprehensive approach to both conditions is crucial. #msmilan2023 #multiplesclerosis https://t.co/o5o0stkaoa",male,"#msmilan2023, #multiplesclerosis",,,6000000000,226254369,,515,794,0,,,2,8,2199,false,"encouraging news from : ici inhibitors appear safe in ms. among 18 patients, only 3 relapsedthey had stoped dmt (2 with natalizumab), and were younger. if an ms patient faces cancer, a comprehensive approach to both conditions is crucial. ms milan multiple sclerosis"
134,2023-10-12 13:27:32.0,"Learning a lot in ""#MultipleSclerosis and comorbidities"".
#MSMilan2023
@ECTRIMS
@ACTRIMS https://t.co/igzFGovIkA",twitter,ESP,Laz1988L,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learning a lot in ""#multiplesclerosis and comorbidities"". #msmilan2023 @ectrims @actrims https://t.co/igzfgovika",unknown,"#multiplesclerosis, #msmilan2023",,,6000000000,1363063831,,1584,4995,0,,,0,1,10274,false,"learning a lot in ""multiple sclerosis and comorbidities"". ms milan"
135,2023-10-12 13:21:00.0,"P064: 78.8% discussed pregnancy in advance w/ at least 1 member of their MS team. 68.6% pregs were exposed to DMT or had recd previous induction therps; 41.6% still on DMT at 2nd trimester start. Most common DMT during preg: natalizumab, glatiramer acetate. #MSMilan2023",twitter,,IJMSCtweets,"{id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","p064: 78.8% discussed pregnancy in advance w/ at least 1 member of their ms team. 68.6% pregs were exposed to dmt or had recd previous induction therps; 41.6% still on dmt at 2nd trimester start. most common dmt during preg: natalizumab, glatiramer acetate. #msmilan2023",,#msmilan2023,,,6000000000,1054320667,,895,622,0,,,1,3,4176,false,"p064: 78.8% discussed pregnancy in advance w/ at least 1 member of their ms team. 68.6% pregs were exposed to dmt or had recd previous induction therps; 41.6% still on dmt at 2nd trimester start. most common dmt during preg: natalizumab, glatiramer acetate. ms milan"
136,2023-10-12 13:16:06.0,Dr. Ruth Ann Marrie shares comorbidity is common in ppl with MS and attention is needed for treatment and prevention @ECTRIMS #MSMilan2023 https://t.co/KPA7mckQaJ,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. ruth ann marrie shares comorbidity is common in ppl with ms and attention is needed for treatment and prevention @ectrims #msmilan2023 https://t.co/kpa7mckqaj,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,4,6,6581,false,dr. ruth ann marrie shares comorbidity is common in ppl with ms and attention is needed for treatment and prevention ms milan
137,2023-10-12 13:15:22.0,All influential MS conference in the world such include a session about #global perspectives  and pressing issues in #MS. Eradicating global disparities are critical for a world without MS @mssociety @MarTintore @Pluchinolab @Boaz_Spermon @XMontalban @AANmember  @ACTRIMS https://t.co/EkefKL8PMv,twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",all influential ms conference in the world such include a session about #global perspectives and pressing issues in #ms. eradicating global disparities are critical for a world without ms @mssociety @martintore @pluchinolab @boaz_spermon @xmontalban @aanmember @actrims https://t.co/ekefkl8pmv,male,"#global, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1771,621,1,http://twitter.com/DrJim4MS/statuses/1712456927005815056,,1,7,7983,false,all influential ms conference in the world such include a session about #global perspectives and pressing issues in ms. eradicating global disparities are critical for a world without ms
138,2023-10-12 13:15:21.0,"Suggestion for @ECTRIMS #Global #disparities in MS missing at #Milan2023:  According to the MS atlas, 1.1 million, 38% of MS pts live in the developing world, so ""pressing issues"" of almost half of the MS pts are not  represented in the most influential MS conference in the world",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","suggestion for @ectrims #global #disparities in ms missing at #milan2023: according to the ms atlas, 1.1 million, 38% of ms pts live in the developing world, so ""pressing issues"" of almost half of the ms pts are not represented in the most influential ms conference in the world",male,"#global, #disparities, #milan2023",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1771,621,2,,,2,9,7981,false,"suggestion for #global #disparities in ms missing at milan2023: according to the ms atlas, 1.1 million, 38% of ms pts live in the developing world, so ""pressing issues"" of almost half of the ms pts are not represented in the most influential ms conference in the world"
139,2023-10-12 13:05:40.0,De Ruth Ann Marrie discusses the latest on comorbidities in MS @ECTRIMS #MSMilan2023 https://t.co/m1ZynldMQa,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",de ruth ann marrie discusses the latest on comorbidities in ms @ectrims #msmilan2023 https://t.co/m1zynldmqa,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,0,6580,false,de ruth ann marrie discusses the latest on comorbidities in ms ms milan
140,2023-10-12 13:00:17.0,"We‚Äôre at MSMilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (NMOSD), a rare and debilitating autoimmune disease that affects the central nervous system. Learn more about the science behind NMOSD below. https://t.co/vhspaq8RXe",twitter,USA,AlexionPharma,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","we‚Äôre at msmilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (nmosd), a rare and debilitating autoimmune disease that affects the central nervous system. learn more about the science behind nmosd below. https://t.co/vhspaq8rxe",unknown,,Beauty/Health & Fitness,,6000000000,246664765,,12811,332,1,,,0,0,1497,false,"were at msmilan2023 with global experts who are committed to advancing care for neuromyelitis optica spectrum disorder (nmosd), a rare and debilitating autoimmune disease that affects the central nervous system. learn more about the science behind nmosd below."
141,2023-10-12 12:55:15.0,Future Progressive MS trials #ectrims2023 https://t.co/AWGx14j4E5,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",future progressive ms trials #ectrims2023 https://t.co/awgx14j4e5,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,471,2044,0,,,0,0,1828,false,future progressive ms trials ec trims
142,2023-10-12 12:35:04.0,"Looking for a way to educate and empower your #MS patients?  üòé Global experts & patient advocates enlighten listeners with the latest advances and tips on living well with MS üéß
Check out MS Living Well #podcast! #MSMilan2023 https://t.co/V1KclLKTTp 5 years of episodes!",twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",looking for a way to educate and empower your #ms patients? üòé global experts & patient advocates enlighten listeners with the latest advances and tips on living well with ms üéß check out ms living well #podcast! #msmilan2023 https://t.co/v1kcllkttp 5 years of episodes!,male,"#ms, #podcast, #msmilan2023",Science,,6000000000,1430793013,,7220,393,0,,,0,6,3162,false,looking for a way to educate and empower your ms patients? global experts & patient advocates enlighten listeners with the latest advances and tips on living well with ms check out ms living well #podcast! ms milan 5 years of episodes!
143,2023-10-12 12:27:11.0,"What are your hopes for the future of #MS? Add your thread to the screen at our #ECTRIMS2023 booth. 
#AsOneForPatients #Neurology @ECTRIMS https://t.co/3Tz0DZO5dP",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",what are your hopes for the future of #ms? add your thread to the screen at our #ectrims2023 booth. #asoneforpatients #neurology @ectrims https://t.co/3tz0dzo5dp,unknown,"#ms, #ectrims2023, #asoneforpatients, #neurology",,,6000000000,857893749959086080,,7571,623,0,,,2,3,4083,false,what are your hopes for the future of ms? add your thread to the screen at our ec trims booth. #asoneforpatients #neurology
144,2023-10-12 12:04:56.0,"üåì#MSMilan2023 is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. 
üó£Ô∏èWhat are they talking about, what we are the learnings so far?
üîçWatch our @PatriciaMghms highlighting  main themesüëá 
@ECTRIMS @ACTRIMS #MultipleSclerosis https://t.co/R9uHD9tCBz",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","üåì#msmilan2023 is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. üó£Ô∏èwhat are they talking about, what we are the learnings so far? üîçwatch our @patriciamghms highlighting main themesüëá @ectrims @actrims #multiplesclerosis https://t.co/r9uhd9tcbz",female,"#msmilan2023, #multiplesclerosis",,,6000000000,600110872,,4870,893,1,,,4,12,5938,false,"ms milan is half-way through. 9,000 researchers, clinicians, experts from more than 108 countries are here. what are they talking about, what we are the learnings so far? watch our highlighting main themes multiple sclerosis"
145,2023-10-12 11:57:01.0,"Another important abstract using @PregnancyMs @UKMSRegister data. Looking at medication exposure in MS pregnancies.

@ECTRIMS #ECTRIMS2023 #MSMilan2023 https://t.co/VSItUbWAVq",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",another important abstract using @pregnancyms @ukmsregister data. looking at medication exposure in ms pregnancies. @ectrims #ectrims2023 #msmilan2023 https://t.co/vsitubwavq,,"#ectrims2023, #msmilan2023",,,6000000000,325527212,,2295,1830,0,,,6,14,1833,false,another important abstract using data. looking at medication exposure in ms pregnancies. ec trims ms milan
146,2023-10-12 11:56:43.0,Thanks #ECTRIMS for giving  @VinzFleischer the opportunity to share this exciting work with the #MSMilan2023 community! #msresearch @MAGNIMS https://t.co/BzgIrdrjK9,twitter,DEU,NeurologyMainz,,thanks #ectrims for giving @vinzfleischer the opportunity to share this exciting work with the #msmilan2023 community! #msresearch @magnims https://t.co/bzgirdrjk9,,"#ectrims, #msmilan2023, #msresearch",,,6000000000,1369995180108087298,,131,138,0,,,3,8,135,false,thanks ec trims for giving the opportunity to share this exciting work with the ms milan community! msresearch
147,2023-10-12 10:54:18.0,@MarkusMatilain1 Markus Matilainen from #airasgroup at #ECTRIMS : #microglia activation in #MS brain increases with longer disease duration. #MSMilan2023 Well done Markus üëèüèª#PET #SmolderingMS https://t.co/mYaWnwE3fG,twitter,,LauraAiras1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@markusmatilain1 markus matilainen from #airasgroup at #ectrims : #microglia activation in #ms brain increases with longer disease duration. #msmilan2023 well done markus üëèüèª#pet #smolderingms https://t.co/myawnwe3fg,female,"#airasgroup, #ectrims, #microglia, #ms, #msmilan2023, #pet, #smolderingms",,,6000000000,2539611216,,359,108,0,,,0,0,202,false,markus matilainen from #airasgroup at ec trims : #microglia activation in ms brain increases with longer disease duration. ms milan well done markus #pet #smolderingms
148,2023-10-12 10:50:09.0,Very happy to listen to Dr Calvi @EmImagin presenting our work ‚ÄúEvolution of diffusivity measures within slowly expanding lesions (SELs) in multiple sclerosis‚Äù at @ECTRIMS https://t.co/KwMR2wuh3t,twitter,ESP,SaraLlufriu,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",very happy to listen to dr calvi @emimagin presenting our work ‚Äúevolution of diffusivity measures within slowly expanding lesions (sels) in multiple sclerosis‚Äù at @ectrims https://t.co/kwmr2wuh3t,female,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,923878828111532032,,548,180,0,,,7,29,221,false,very happy to listen to dr calvi presenting our work evolution of diffusivity measures within slowly expanding lesions (sels) in multiple sclerosis at
149,2023-10-12 10:45:47.0,The poster numero uno from #airasgroup was presented yesterday at #ECTRIMS #MSMilan2023 Looking at impact of #MS susceptibility risk genes and astrocyte activation on lesion expansion.  P 193. Saraste et al. #smolderingMS https://t.co/IrZnv73JqE,twitter,ITA,LauraAiras1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the poster numero uno from #airasgroup was presented yesterday at #ectrims #msmilan2023 looking at impact of #ms susceptibility risk genes and astrocyte activation on lesion expansion. p 193. saraste et al. #smolderingms https://t.co/irznv73jqe,female,"#airasgroup, #ectrims, #msmilan2023, #ms, #smolderingms",,,6000000000,2539611216,,359,108,0,,,1,5,201,false,the poster numero uno from #airasgroup was presented yesterday at ec trims ms milan looking at impact of ms susceptibility risk genes and astrocyte activation on lesion expansion. p 193. saraste et al. #smolderingms
150,2023-10-12 10:34:23.0,"I'm not sure if it was a point of emphasis for the @ECTRIMS or @ACTRIMS organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. 
#YoungInvestigators #MSMilan",twitter,USA,titostiles,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","i'm not sure if it was a point of emphasis for the @ectrims or @actrims organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. #younginvestigators #msmilan",male,"#younginvestigators, #msmilan","Business, Science, Politics","{profession=Executive, jobTitle=CEO}, {profession=Executive, jobTitle=Entrepreneur}, {profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Neuroscientist}",6000000000,213397655,,1051,1708,0,http://twitter.com/titostiles/statuses/1712405505333948668,,1,4,28177,false,"i'm not sure if it was a point of emphasis for the or organizing teams, but so far the spotlight on young investigators has been obvious and an overwhelming success. #younginvestigators msmilan"
151,2023-10-12 10:26:31.0,"The quality of life for people with #MS is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems!
‚û°Ô∏è‚û°Ô∏è This only highlights how important #symptomatic management ‚ÄºÔ∏è of #MultipleSclerosis #symptoms to improve the quality of life!

@ECTRIMS @ACTRIMS https://t.co/8wWPjRxj3k",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","the quality of life for people with #ms is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems! ‚û°Ô∏è‚û°Ô∏è this only highlights how important #symptomatic management ‚ÄºÔ∏è of #multiplesclerosis #symptoms to improve the quality of life! @ectrims @actrims https://t.co/8wwpjrxj3k",female,"#ms, #symptomatic, #multiplesclerosis, #symptoms",,,6000000000,600110872,,4869,893,0,,,5,9,5938,false,"the quality of life for people with ms is strongly affected by depression, fatigue, pain, muscle weakness, and memory problems! this only highlights how important #symptomatic management of multiple sclerosis #symptoms to improve the quality of life!"
152,2023-10-12 10:19:35.0,"Bennett (Swi):  sGFAP (corrected for age, BMI and sex) is a promising biomarker for disease progression independently from relapse or sNFL in #MS patients on highly active treatment!
#MSMilan2023 https://t.co/xGHbiNtZVI",twitter,BEL,bart_professor,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}","bennett (swi): sgfap (corrected for age, bmi and sex) is a promising biomarker for disease progression independently from relapse or snfl in #ms patients on highly active treatment! #msmilan2023 https://t.co/xghbintzvi",unknown,"#ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Immunologist}, {profession=Teacher & Lecturer, jobTitle=Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1109554254979743744,,1943,884,1,,,0,1,1868,false,"bennett (swi): sgfap (corrected for age, bmi and sex) is a promising biomarker for disease progression independently from relapse or snfl in ms patients on highly active treatment! ms milan"
153,2023-10-12 10:16:03.0,"Prof Olga Ciccarelli @olgacicc (@UCLIoN) presenting at @ECTRIMS - the world's largest organisation dedicated to treatment and research in #MultipleSclerosis. 

#MS #MSMilan2023 https://t.co/FEExImC7Xe",twitter,GBR,UCLBrainScience,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",prof olga ciccarelli @olgacicc (@uclion) presenting at @ectrims - the world's largest organisation dedicated to treatment and research in #multiplesclerosis. #ms #msmilan2023 https://t.co/feeximc7xe,,"#multiplesclerosis, #ms, #msmilan2023",,,6000000000,440719416,,22346,1266,0,,,1,5,9275,false,prof olga ciccarelli () presenting at - the world's largest organisation dedicated to treatment and research in multiple sclerosis. ms ms milan
154,2023-10-12 10:14:45.0,"Dr. Jens Kuhle presenting in the Auditorium @ECTRIMS exciting data on promising biomarkers in #MultipleSclerosis 
@JensKuhle @UniSpitalBasel @DKFBasel https://t.co/XrFOFLd26H",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. jens kuhle presenting in the auditorium @ectrims exciting data on promising biomarkers in #multiplesclerosis @jenskuhle @unispitalbasel @dkfbasel https://t.co/xrfofld26h,,#multiplesclerosis,Beauty/Health & Fitness,,6000000000,1493181686426779654,,90,65,0,,,3,12,20,false,dr. jens kuhle presenting in the auditorium exciting data on promising biomarkers in multiple sclerosis
155,2023-10-12 10:12:09.0,Dr. Bardia Nourbakhsh (United States) identifies key future directions for addressing fatigue in #MS @ECTRIMS #MSMilan2023 https://t.co/noiuGXZSu1,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}",dr. bardia nourbakhsh (united states) identifies key future directions for addressing fatigue in #ms @ectrims #msmilan2023 https://t.co/noiugxzsu1,female,"#ms, #msmilan2023",,,6000000000,256679634,,1174,1912,0,,,0,0,6576,false,dr. bardia nourbakhsh (united states) identifies key future directions for addressing fatigue in ms ms milan
156,2023-10-12 10:08:42.0,"üåüüåüüåü14 abstracts from our Nottingham MS Research Group at #MSMilan2023! Well done us!!! 

@researchneuro1 @nikosevangelou3 @researchNuh @RaduTanasescu1 @MegiClarke @BlancaDios @LaurenATaylor26 @NEuRoMSproject",twitter,GBR,GogemTopcu,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üåüüåüüåü14 abstracts from our nottingham ms research group at #msmilan2023! well done us!!! @researchneuro1 @nikosevangelou3 @researchnuh @radutanasescu1 @megiclarke @blancadios @laurenataylor26 @neuromsproject,unknown,#msmilan2023,"Beauty/Health & Fitness, Science, Animals & Pets, Travel","{profession=Scientist & Researcher, jobTitle=Researcher}",6000000000,942062432,,226,502,1,,,3,11,449,false,14 abstracts from our nottingham ms research group at ms milan! well done us!!!
157,2023-10-12 10:04:28.0,"#Fatigue in #MS is a crucial topic!
‚ùìÔ∏èHow to measure it?
üë§ It's subjective: ""the goldest standard is what the person with MS tells you""
üëÇlisten to the patient - There is no better measure than patient reported
#PROMS #MultipleSclerosis
@ECTRIMS @ACTRIMS 
#MSMilan2023 https://t.co/P2BsZX7SmG",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#fatigue in #ms is a crucial topic! ‚ùìÔ∏èhow to measure it? üë§ it's subjective: ""the goldest standard is what the person with ms tells you"" üëÇlisten to the patient - there is no better measure than patient reported #proms #multiplesclerosis @ectrims @actrims #msmilan2023 https://t.co/p2bszx7smg",female,"#fatigue, #ms, #proms, #multiplesclerosis, #msmilan2023",,,6000000000,600110872,,4869,893,0,,,8,18,5935,false,"#fatigue in ms is a crucial topic! how to measure it? it's subjective: ""the goldest standard is what the person with ms tells you"" listen to the patient - there is no better measure than patient reported #proms multiple sclerosis ms milan"
158,2023-10-12 10:04:15.0,We finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with #MultipleSclerosis at @ECTRIMS #MSMilan2023 - paper coming up soon @ClevelandClinic @HopPitieSalpe @ChumNeuro @TheNeuro_MNI https://t.co/8y6R7OeE9C,twitter,CAN,GMacaronMD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with #multiplesclerosis at @ectrims #msmilan2023 - paper coming up soon @clevelandclinic @hoppitiesalpe @chumneuro @theneuro_mni https://t.co/8y6r7oee9c,female,"#multiplesclerosis, #msmilan2023",,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}",6000000000,1177957381566808069,,982,445,1,,,2,32,393,false,we finally present the results of or multinational (7 centers) study on adult-onset leukodystrophies misdiagnosed or occurring with multiple sclerosis at ms milan - paper coming up soon
159,2023-10-12 10:02:32.0,"üü†Our members came to #MSMilan2023 from all around Europe to bring #MS community voice & perspective to ultimately make life better for people with #MultipleSclerosis. 
üìπWatch the President of @SPEMportugal, our member organisation in Portugal üáµüáπ.
 @ECTRIMS @ACTRIMS #ECTRIMS4me https://t.co/W8ZgQh7Gms",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","üü†our members came to #msmilan2023 from all around europe to bring #ms community voice & perspective to ultimately make life better for people with #multiplesclerosis. üìπwatch the president of @spemportugal, our member organisation in portugal üáµüáπ. @ectrims @actrims #ectrims4me https://t.co/w8zgqh7gms",female,"#msmilan2023, #ms, #multiplesclerosis, #ectrims4me",,,6000000000,600110872,,4869,893,0,,,2,9,5934,false,"our members came to ms milan from all around europe to bring ms community voice & perspective to ultimately make life better for people with multiple sclerosis. watch the president of , our member organisation in portugal . ec trims4me"
160,2023-10-12 10:01:13.0,More posters from Nottingham MS Research Group! Come check out! #MSMilan2023 https://t.co/5eQvgAsrbE,twitter,GBR,NEuRoMSproject,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",more posters from nottingham ms research group! come check out! #msmilan2023 https://t.co/5eqvgasrbe,unknown,#msmilan2023,Beauty/Health & Fitness,,6000000000,1134060973789237249,,506,234,0,,,3,11,561,false,more posters from nottingham ms research group! come check out! ms milan
161,2023-10-12 09:59:16.0,"Brilliant opportunity for @ECTRIMS  attendees to ask the experts - @GeoArrambide and Andrew Solomon discuss complex #MultipleSclerosis differential diagnoses.

#MSMilan2023 https://t.co/lZ1Imtmugo",twitter,GBR,AnneHelme,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",brilliant opportunity for @ectrims attendees to ask the experts - @geoarrambide and andrew solomon discuss complex #multiplesclerosis differential diagnoses. #msmilan2023 https://t.co/lz1imtmugo,female,"#multiplesclerosis, #msmilan2023",Beauty/Health & Fitness,,6000000000,46126120,,1055,1041,1,,,2,7,3296,false,brilliant opportunity for attendees to ask the experts - and andrew solomon discuss complex multiple sclerosis differential diagnoses. ms milan
162,2023-10-12 09:57:12.0,Dr. Bardia Nourbakhsh shares the impact and importance of fatigue in MS #MSMilan2023 @ECTRIMS https://t.co/F8glvHTXoY,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}",dr. bardia nourbakhsh shares the impact and importance of fatigue in ms #msmilan2023 @ectrims https://t.co/f8glvhtxoy,female,#msmilan2023,,,6000000000,256679634,,1174,1912,0,,,0,0,6575,false,dr. bardia nourbakhsh shares the impact and importance of fatigue in ms ms milan
163,2023-10-12 09:40:48.0,Alexion to Present Data Reinforcing Effectiveness of Ultomiris and Soliris in Treating Rare Neurological Disorder at ECTRIMS-ACTRIMS Meeting https://t.co/YE2ZPrSBwL https://t.co/mKwioo6Po8,twitter,,europawire,"{id=20740635, name=Ultomiris / ravulizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740634, name=Soliris / eculizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=16441711, name=AstraZeneca, displayName=null, parentId=16441705, parentName=CI Updates'22}",alexion to present data reinforcing effectiveness of ultomiris and soliris in treating rare neurological disorder at ectrims-actrims meeting https://t.co/ye2zprsbwl https://t.co/mkwioo6po8,,,Business,,6000000000,712663225,,1553,1987,0,,,0,0,56542,true,alexion to present data reinforcing effectiveness of ultomiris and soliris in treating rare neurological disorder at ectrims-actrims meeting
164,2023-10-12 09:00:26.0,‚ÄúImproving MRI implementation in the clinical setting‚Äù Are we ready to implement the central vein sign in the clinic? I think the two prospective studies of the CVS (CAVS-MS and DECISIVE) presented this year at #ECTRIMS will help us answer this important question! #MSMilan2023 https://t.co/9gZqMTvs5R,twitter,GBR,MegiClarke,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",‚Äúimproving mri implementation in the clinical setting‚Äù are we ready to implement the central vein sign in the clinic? i think the two prospective studies of the cvs (cavs-ms and decisive) presented this year at #ectrims will help us answer this important question! #msmilan2023 https://t.co/9gzqmtvs5r,female,"#ectrims, #msmilan2023",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Neuroscientist}",6000000000,855537687662604288,,236,178,2,,,1,14,146,false,improving mri implementation in the clinical setting are we ready to implement the central vein sign in the clinic? i think the two prospective studies of the cvs (cavs-ms and decisive) presented this year at ec trims will help us answer this important question! ms milan
165,2023-10-12 08:38:27.0,"Three speakers, including me, at our session @ECTRIMS session today condemned Hamas terrorists clear and loud.",twitter,,jonykipnis,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","three speakers, including me, at our session @ectrims session today condemned hamas terrorists clear and loud.",male,,,,6000000000,60739511,,23661,608,4,,,2,47,12656,false,"three speakers, including me, at our session session today condemned hamas terrorists clear and loud."
166,2023-10-12 08:34:01.0,"Are you at #MSMilan2023 and would like to meet us? Pass by the @EuropeanCharcot booth E.02 & let‚Äôs have a chat! 

You can also grab one of our brochures to learn more about our work towards meaningful PROs‚Äô use in MS research & care

Stay tuned for more PROMS news from @ECTRIMS! https://t.co/Ud3JHHbaaC",twitter,,PromsInitiative,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",are you at #msmilan2023 and would like to meet us? pass by the @europeancharcot booth e.02 & let‚Äôs have a chat! you can also grab one of our brochures to learn more about our work towards meaningful pros‚Äô use in ms research & care stay tuned for more proms news from @ectrims! https://t.co/ud3jhhbaac,unknown,#msmilan2023,,,6000000000,1579794712323624962,,86,96,0,,,2,14,59,false,are you at ms milan and would like to meet us? pass by the booth e.02 & lets have a chat! you can also grab one of our brochures to learn more about our work towards meaningful pros use in ms research & care stay tuned for more proms news from !
167,2023-10-12 08:30:46.0,"50% of women with #ms have sleep disorders. I am one of them, it‚Äôs a ‚Äûtypical problem‚Äú of women in my age, doctor said. My question: And why don‚Äôt we do something? Nothing happened. Not acceptable. Because sleeping disorders have a lot of impact on other ms symptoms. #MSMilan2023 https://t.co/l0UY3dddSq",twitter,DEU,Birgitpower,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","50% of women with #ms have sleep disorders. i am one of them, it‚Äôs a ‚Äûtypical problem‚Äú of women in my age, doctor said. my question: and why don‚Äôt we do something? nothing happened. not acceptable. because sleeping disorders have a lot of impact on other ms symptoms. #msmilan2023 https://t.co/l0uy3dddsq",female,"#ms, #msmilan2023",,,6000000000,22899395,,3334,1989,2,,,2,21,31846,false,"50% of women with ms have sleep disorders. i am one of them, its a typical problem of women in my age, doctor said. my question: and why dont we do something? nothing happened. not acceptable. because sleeping disorders have a lot of impact on other ms symptoms. ms milan"
168,2023-10-12 08:28:46.0,"Day 2 is underway at #MSMilan2023! Many exciting sessions planned for today on #MultipleSclerosis research topics such as EBV, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. What are you most looking forward to? @ECTRIMS https://t.co/Jm5pVD9k15",twitter,AUS,MStranslate,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","day 2 is underway at #msmilan2023! many exciting sessions planned for today on #multiplesclerosis research topics such as ebv, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. what are you most looking forward to? @ectrims https://t.co/jm5pvd9k15",,"#msmilan2023, #multiplesclerosis",,,6000000000,833579503,,4899,4075,0,,,2,13,3595,false,"day 2 is underway at ms milan! many exciting sessions planned for today on multiple sclerosis research topics such as ebv, environmental & genetic risk factors, biomarkers, lifestyle modifications, the gut microbiome & much more. what are you most looking forward to?"
169,2023-10-12 08:22:48.0,"#PIRA stands for progression independent of relapse activity .

‚ÄúIt is the main mechanism of accumulation of disability and can predict multiple sclerosis progression‚Äù insightful talk by @CarmenTur1 at #MSMilan2023 Hot Topic 6 Session. https://t.co/mF6T8bt9Ky",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",#pira stands for progression independent of relapse activity . ‚Äúit is the main mechanism of accumulation of disability and can predict multiple sclerosis progression‚Äù insightful talk by @carmentur1 at #msmilan2023 hot topic 6 session. https://t.co/mf6t8bt9ky,unknown,"#pira, #msmilan2023",,,6000000000,1197805298,,3146,487,1,http://twitter.com/cemcat_em/statuses/1712354426172719132,,5,14,2908,false,#pira stands for progression independent of relapse activity . it is the main mechanism of accumulation of disability and can predict multiple sclerosis progression insightful talk by at ms milan hot topic 6 session.
170,2023-10-12 08:21:58.0,"#MSMilan2023: analysis of the PREVENT and CHAMPION-NMOSD found no significant differences in safety outcomes for patients with AQP4+ #NMOSD who were treated with rituximab prior to starting C5 complement inhibitors in specific timeframes.
https://t.co/auQ5IPLBDM",twitter,USA,byMattHoffman,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#msmilan2023: analysis of the prevent and champion-nmosd found no significant differences in safety outcomes for patients with aqp4+ #nmosd who were treated with rituximab prior to starting c5 complement inhibitors in specific timeframes. https://t.co/auq5iplbdm,male,"#msmilan2023, #nmosd",,"{profession=Journalist, jobTitle=Associate Editorial Director}, {profession=Artist, jobTitle=Producer}",6000000000,895689692271828992,,1067,989,0,,,0,0,10021,false,ms milan: analysis of the prevent and champion-nmosd found no significant differences in safety outcomes for patients with aqp4+ #nmosd who were treated with rituximab prior to starting c5 complement inhibitors in specific timeframes.
171,2023-10-12 08:00:13.0,"Don‚Äôt forget to book your Braindate at #MSMilan2023. Topic meetings are filling up. Connect & network with your colleagues via this customised service, available onsite and online. 
‚û°Ô∏è https://t.co/gr5X58BSBi https://t.co/aU1BE7mwMO",twitter,CHE,ECTRIMS,,"don‚Äôt forget to book your braindate at #msmilan2023. topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online. ‚û°Ô∏è https://t.co/gr5x58bsbi https://t.co/au1be7mwmo",,#msmilan2023,,,6000000000,714464982,,7978,65,0,,,0,1,7206,false,"dont forget to book your braindate at ms milan. topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online."
172,2023-10-12 07:56:43.0,"After an inspiring first day, I am proud to present our latest work on immune response to SARS-CoV-2 in people with Multiple Sclerosis at today‚Äòs poster session at #MSMilan2023  #ECTRIMS @NeurologyMainz https://t.co/EZ37HvHGHl",twitter,,Muriel85354596,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","after an inspiring first day, i am proud to present our latest work on immune response to sars-cov-2 in people with multiple sclerosis at today‚Äòs poster session at #msmilan2023 #ectrims @neurologymainz https://t.co/ez37hvhghl",female,"#msmilan2023, #ectrims","Beauty/Health & Fitness, Science","{profession=Health practitioner, jobTitle=Medical Doctor}",6000000000,1407283003257151490,,22,72,0,,,0,4,16,false,"after an inspiring first day, i am proud to present our latest work on immune response to sars-cov-2 in people with multiple sclerosis at todays poster session at ms milan ec trims"
173,2023-10-12 07:42:15.0,"Not sure if Ocrevus side effects were discussed at #MSMilan2023 #NS #MultipleSclerosis meeting. 

Neurologist now starting her on #briumvi

$TGTX @TGTherapeutics https://t.co/ekLg0pNEq7",twitter,,Biotech2050,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",not sure if ocrevus side effects were discussed at #msmilan2023 #ns #multiplesclerosis meeting. neurologist now starting her on #briumvi $tgtx @tgtherapeutics https://t.co/eklg0pneq7,male,"#msmilan2023, #ns, #multiplesclerosis, #briumvi",Business,,6000000000,2494896473,,6157,1535,0,,,2,8,66138,false,not sure if ocrevus side effects were discussed at ms milan #ns multiple sclerosis meeting. neurologist now starting her on #briumvi $tgtx
174,2023-10-12 07:27:48.0,"Day 2 of #ECTRIMS2023 starts soon! We are looking forward to meeting many of you at our booth today. 
#HCPsOnly #MultipleSclerosis #Neurology @ECTRIMS https://t.co/jMvQRwnC1B",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",day 2 of #ectrims2023 starts soon! we are looking forward to meeting many of you at our booth today. #hcpsonly #multiplesclerosis #neurology @ectrims https://t.co/jmvqrwnc1b,unknown,"#ectrims2023, #hcpsonly, #multiplesclerosis, #neurology",,,6000000000,857893749959086080,,7569,623,0,,,0,9,4081,false,day 2 of ec trims starts soon! we are looking forward to meeting many of you at our booth today. #hcpsonly multiple sclerosis #neurology
175,2023-10-12 07:05:40.0,Thrilled to learn that AI can aid in early identification of disease progression[PIRA] in MS. Early interventions in MS are now more possible than ever! üôå Kudos to Llucia Coll for presenting her groundbreaking work. #MultipleSclerosis #AIinHealthcare #AI #MSawarness #ectrims2023 https://t.co/Fsoxvpmed1,twitter,GBR,AgneStraukiene,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",thrilled to learn that ai can aid in early identification of disease progression[pira] in ms. early interventions in ms are now more possible than ever! üôå kudos to llucia coll for presenting her groundbreaking work. #multiplesclerosis #aiinhealthcare #ai #msawarness #ectrims2023 https://t.co/fsoxvpmed1,unknown,"#multiplesclerosis, #aiinhealthcare, #ai, #msawarness, #ectrims2023",Beauty/Health & Fitness,"{profession=Executive, jobTitle=Founder}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1246352834897076224,,1074,920,1,,,5,40,620,true,thrilled to learn that ai can aid in early identification of disease progression[pira] in ms. early interventions in ms are now more possible than ever! kudos to llucia coll for presenting her groundbreaking work. multiple sclerosis #aiinhealthcare #ai msawarness ec trims
176,2023-10-12 06:47:31.0,@GavinGiovannoni on the stage üòç #ms #MSMilan2023 #ectrims https://t.co/c9Qb0muRhE,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}",@gavingiovannoni on the stage üòç #ms #msmilan2023 #ectrims https://t.co/c9qb0murhe,female,"#ms, #msmilan2023, #ectrims",,,6000000000,1338606356346048512,,1448,61,0,,,0,0,820,false,on the stage ms ms milan ec trims
177,2023-10-12 06:39:30.0,@MSIRELAND for anyone living with MS this information day is being run by @ECTRIMS and is free to attend. Registration here: https://t.co/F7vmKfg3R5,twitter,IRL,hugh_kearney,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@msireland for anyone living with ms this information day is being run by @ectrims and is free to attend. registration here: https://t.co/f7vmkfg3r5,male,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,619101398,,513,815,0,,,5,4,563,false,for anyone living with ms this information day is being run by and is free to attend. registration here:
178,2023-10-12 06:17:14.0,"Don't miss Scientific Session 6: Imaging MS progression, today at #MSMilan2023. @VinzFleischer will be discussing the prognostic value of single-subject grey matter networks in early #MultipleSclerosis üß†",twitter,DEU,NeurologyMainz,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","don't miss scientific session 6: imaging ms progression, today at #msmilan2023. @vinzfleischer will be discussing the prognostic value of single-subject grey matter networks in early #multiplesclerosis üß†",,"#msmilan2023, #multiplesclerosis",,,6000000000,1369995180108087298,,129,137,0,,,0,2,131,false,"don't miss scientific session 6: imaging ms progression, today at ms milan. will be discussing the prognostic value of single-subject grey matter networks in early multiple sclerosis"
179,2023-10-12 05:03:11.0,"Our presence at ECTRIMS demonstrates our commitment to staying at the forefront of MS research and ensuring that our community benefits from the latest development.

#MSMilan2023 #MultipleStoriesUnitedAsOne #MSSocietyUAE #MultipleSclerosis #MSawareness #LivingwithMS",twitter,,nmssocietyuae,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",our presence at ectrims demonstrates our commitment to staying at the forefront of ms research and ensuring that our community benefits from the latest development. #msmilan2023 #multiplestoriesunitedasone #mssocietyuae #multiplesclerosis #msawareness #livingwithms,female,"#msmilan2023, #multiplestoriesunitedasone, #mssocietyuae, #multiplesclerosis, #msawareness, #livingwithms",,,6000000000,1514928447931494403,,178,28,0,http://twitter.com/nmssocietyuae/statuses/1712333063814865045,,0,0,392,true,our presence at ectrims demonstrates our commitment to staying at the forefront of ms research and ensuring that our community benefits from the latest development. ms milan #multiplestoriesunitedasone mssocietyuae multiple sclerosis msawareness #livingwithms
180,2023-10-12 05:01:24.0,#Breaking: New 10-year data at #MSMilan2023 show the effect of our aCD20 antibody on slowing disease progression in a number of endpoints for people with #MultipleSclerosis. Learn more: https://t.co/3Rag3gUFAO,twitter,USA,genentech,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",#breaking: new 10-year data at #msmilan2023 show the effect of our acd20 antibody on slowing disease progression in a number of endpoints for people with #multiplesclerosis. learn more: https://t.co/3rag3gufao,,"#breaking, #msmilan2023, #multiplesclerosis",,,6000000000,16150688,,128312,236,0,,,0,0,7668,false,#breaking: new 10-year data at ms milan show the effect of our acd20 antibody on slowing disease progression in a number of endpoints for people with multiple sclerosis. learn more:
181,2023-10-12 05:01:02.0,"Learn more about the evolving mindset in detection and treatment of MS, involving biomarkers & anti-CD20 therapies during this year‚Äôs #ECTRIMS #MSMilan2023

https://t.co/VZoH0mSn4V https://t.co/xMcPa5lXNN",twitter,,NovartisMedical,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learn more about the evolving mindset in detection and treatment of ms, involving biomarkers & anti-cd20 therapies during this year‚Äôs #ectrims #msmilan2023 https://t.co/vzoh0msn4v https://t.co/xmcpa5lxnn",,"#ectrims, #msmilan2023",Beauty/Health & Fitness,,6000000000,1529472917397970946,,7798,4,0,,,0,0,111,true,"learn more about the evolving mindset in detection and treatment of ms, involving biomarkers & anti-cd20 therapies during this years ec trims ms milan"
182,2023-10-11 23:30:45.0,Are we ready for biosimilar natalizumab? #MSMilan2023 #ectrims,twitter,GBR,UKCPANeuro,"{id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740626, name=Tysabri / natalizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767267, name=Tysabri, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",are we ready for biosimilar natalizumab? #msmilan2023 #ectrims,,"#msmilan2023, #ectrims",,,6000000000,3184780972,,438,79,0,,,0,0,1065,false,are we ready for biosimilar natalizumab? ms milan ec trims
183,2023-10-11 20:44:29.0,"Hello #ECTRIMS! Interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in #MS? 

Check out ePoster P1059 ""Systematic review of cognitive reserve in multiple sclerosis: Accounting for methods used and disease-related aspects"" #MSMilan2023",twitter,,ClaraMStein,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944092, name=Symptoms, displayName=null, parentId=15944091, parentName=AML emotional journey}","hello #ectrims! interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in #ms? check out eposter p1059 ""systematic review of cognitive reserve in multiple sclerosis: accounting for methods used and disease-related aspects"" #msmilan2023",female,"#ectrims, #ms, #msmilan2023",,"{profession=Scientist & Researcher, jobTitle=Scholar}",6000000000,1405202918916169728,,807,836,0,,,3,20,390,false,"hello ec trims! interested in cognitive reserve/ outcomes & 'invisible' symptoms (fatigue, depression, anxiety) in ms? check out eposter p1059 ""systematic review of cognitive reserve in multiple sclerosis: accounting for methods used and disease-related aspects"" ms milan"
184,2023-10-11 20:00:01.0,"P344: Switching Btwn #DMT for #RRMS, Retrospective Review of Practice: There was mean of 1 #switch every 3 ys & mean time on any particular DMT was 1-2 ys. Post2015 1st-line: dimethyl #fumarate 51%. Post2019 2nd-line: #ocrelizumab 52%. @DebzClark @jonessa1980 #MSMilan2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}","p344: switching btwn #dmt for #rrms, retrospective review of practice: there was mean of 1 #switch every 3 ys & mean time on any particular dmt was 1-2 ys. post2015 1st-line: dimethyl #fumarate 51%. post2019 2nd-line: #ocrelizumab 52%. @debzclark @jonessa1980 #msmilan2023",,"#dmt, #rrms, #switch, #fumarate, #ocrelizumab, #msmilan2023",,,6000000000,1054320667,,894,622,0,,,0,3,4168,false,"p344: switching btwn #dmt for #rrms, retrospective review of practice: there was mean of 1 #switch every 3 ys & mean time on any particular dmt was 1-2 ys. post2015 1st-line: dimethyl #fumarate 51%. post2019 2nd-line: #ocrelizumab 52%. ms milan"
185,2023-10-11 19:11:39.0,üß† Delighted to have shared today our research on MS lesions from white matter at #ECTRIMS2023 in Milan! I've talked about how our single-nuc and spatial atlas sheds light on disease progression. Grateful for the opportunity to present and happy to see that the room was packed üòä https://t.co/BPyX8mjvVj,twitter,DEU,Cels121,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üß† delighted to have shared today our research on ms lesions from white matter at #ectrims2023 in milan! i've talked about how our single-nuc and spatial atlas sheds light on disease progression. grateful for the opportunity to present and happy to see that the room was packed üòä https://t.co/bpyx8mjvvj,unknown,#ectrims2023,Science,"{profession=Student, jobTitle=Student}",6000000000,819895202353737729,,68,85,1,,,5,21,14,false,delighted to have shared today our research on ms lesions from white matter at ec trims in milan! i've talked about how our single-nuc and spatial atlas sheds light on disease progression. grateful for the opportunity to present and happy to see that the room was packed
186,2023-10-11 19:10:15.0,"Day 1 of ECTRIMS 2023 with MS and neuroimmune diseases team of University of Antwerp and Antwerp University Hospital. üáßüá™
Ready üí™for  #MSMilan2023 #girlpower https://t.co/vRYQvRjocr",twitter,BEL,drBWillekens,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",day 1 of ectrims 2023 with ms and neuroimmune diseases team of university of antwerp and antwerp university hospital. üáßüá™ ready üí™for #msmilan2023 #girlpower https://t.co/vryqvrjocr,female,"#msmilan2023, #girlpower",Beauty/Health & Fitness,"{profession=Scientist & Researcher, jobTitle=Researcher}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1172127267222360064,,364,313,2,,,2,14,181,false,day 1 of ectrims 2023 with ms and neuroimmune diseases team of university of antwerp and antwerp university hospital. ready for ms milan #girlpower
187,2023-10-11 18:41:28.0,"@PamelaKanellis @ECTRIMS Are you talking about people with progressive MS, who live for 20 years and have breath problems, dependence and low quality of life? Why patients with severe dependency and disability due to the progression of MS are  abandoned by the neurologist?",twitter,,mptg1971,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=17199544, name=Unmet need, displayName=null, parentId=17199542, parentName=KRAS NSCLC unmet need}, {id=15389479, name=Unmet needs, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580997, name=Unmet needs, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@pamelakanellis @ectrims are you talking about people with progressive ms, who live for 20 years and have breath problems, dependence and low quality of life? why patients with severe dependency and disability due to the progression of ms are abandoned by the neurologist?",unknown,,,,6000000000,193848740,,926,1240,0,http://twitter.com/PamelaKanellis/statuses/1712048324730089585,,0,1,7992,false,"are you talking about people with progressive ms, who live for 20 years and have breath problems, dependence and low quality of life? why patients with severe dependency and disability due to the progression of ms are abandoned by the neurologist?"
189,2023-10-11 17:45:09.0,"This year, #MSMilan2023 is bringing Braindate by @e180 back to the congress. Connect, learn, and share your insights with fellow MS researchers and experts. Don't miss this fantastic networking opportunity! 
Book now: https://t.co/gr5X58BSBi https://t.co/sYYNu0BE0x",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this year, #msmilan2023 is bringing braindate by @e180 back to the congress. connect, learn, and share your insights with fellow ms researchers and experts. don't miss this fantastic networking opportunity! book now: https://t.co/gr5x58bsbi https://t.co/syynu0be0x",,#msmilan2023,,,6000000000,714464982,,7970,65,0,,,0,0,7195,false,"this year, ms milan is bringing braindate by back to the congress. connect, learn, and share your insights with fellow ms researchers and experts. don't miss this fantastic networking opportunity! book now:"
190,2023-10-11 17:44:53.0,We are at #ECTRIMS2023 and we are ready for the patient community day on 14th October. üôè        #advocacy #ms #NMOSD #MOGAD #neurotwitter  #MSMilan2023 https://t.co/HYCzXAZb3l,twitter,,FranceNmo,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",we are at #ectrims2023 and we are ready for the patient community day on 14th october. üôè #advocacy #ms #nmosd #mogad #neurotwitter #msmilan2023 https://t.co/hyczxazb3l,unknown,"#ectrims2023, #advocacy, #ms, #nmosd, #mogad, #neurotwitter, #msmilan2023",,,6000000000,1344962861882355712,,299,670,0,,,1,5,448,false,we are at ec trims and we are ready for the patient community day on 14th october. #advocacy ms #nmosd #mogad #neurotwitter ms milan
191,2023-10-11 17:44:29.0,"On #ECTRIMS day 1, Matthias, #NMOSD patient & TSF Ambassador of Germany üá©üá™, presented his perspective on the #raredisease journey after symptoms begin & how to reinvent one‚Äôs life without letting disease define, limit or consume you. 

Thank you Roche for this platform https://t.co/SsUdRNYRdg",twitter,USA,TheSumairaFDN,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","on #ectrims day 1, matthias, #nmosd patient & tsf ambassador of germany üá©üá™, presented his perspective on the #raredisease journey after symptoms begin & how to reinvent one‚Äôs life without letting disease define, limit or consume you. thank you roche for this platform https://t.co/ssudrnyrdg",,"#ectrims, #nmosd, #raredisease",Beauty/Health & Fitness,,6000000000,2871642269,,945,404,0,,,1,6,2164,false,"on ec trims day 1, matthias, #nmosd patient & tsf ambassador of germany , presented his perspective on the #raredisease journey after symptoms begin & how to reinvent ones life without letting disease define, limit or consume you. thank you roche for this platform"
192,2023-10-11 17:40:09.0,"@TizianaLS will present SPMS safety data @ the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS) in Milan, October 11-13.
$TLSA PR: https://t.co/jBeWLGvF8Q",twitter,USA,vanjohn10,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@tizianals will present spms safety data @ the european committee for treatment and research of multiple sclerosis (ectrims) in milan, october 11-13. $tlsa pr: https://t.co/jbewlgvf8q",male,,Beauty/Health & Fitness,,6000000000,28637628,,1393,719,1,,,0,2,6561,false,"will present spms safety data the european committee for treatment and research of multiple sclerosis (ectrims) in milan, october 11-13. $tlsa pr:"
193,2023-10-11 17:24:47.0,"This week members of the MSIF team are in Milan for the #MSMilan2023. Today's presentations included reference to the @WHO decision to add MS treatments to their Essential Medicines List, which was made possible through global collaboration. 

@ECTRIMS  @ACTRIMS",twitter,,MSIntFederation,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","this week members of the msif team are in milan for the #msmilan2023. today's presentations included reference to the @who decision to add ms treatments to their essential medicines list, which was made possible through global collaboration. @ectrims @actrims",female,#msmilan2023,,,6000000000,390672087,,6657,380,0,,,2,12,3461,false,"this week members of the msif team are in milan for the ms milan. today's presentations included reference to the decision to add ms treatments to their essential medicines list, which was made possible through global collaboration."
194,2023-10-11 17:03:29.0,Six months of vidofludimus calcium led to reductions in a marker of nerve damage among people with¬†RRMS in a Phase 2 clinical trial.¬† https://t.co/7FhKRf9k5x #ectrims2023 #news https://t.co/MR0bpkNGcT,twitter,USA,MSNewsToday,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",six months of vidofludimus calcium led to reductions in a marker of nerve damage among people with rrms in a phase 2 clinical trial. https://t.co/7fhkrf9k5x #ectrims2023 #news https://t.co/mr0bpkngct,female,"#ectrims2023, #news",,,6000000000,2473350271,,10052,1541,0,,,0,4,28170,false,six months of vidofludimus calcium led to reductions in a marker of nerve damage among people with rrms in a phase 2 clinical trial. ec trims #news
195,2023-10-11 16:00:33.0,"#ECTRIMS is he world's largest meeting on #MultipleSclerosis. This year's meeting is in Milan. 

The first day at #MSMilan2023 was packed with some great talks.  The morning ""Hot Topic"" session on #EBV and #MultipleSclerosis was was particularly interesting. https://t.co/I36TtSDhK9",twitter,,Dr_Gulfaraz,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#ectrims is he world's largest meeting on #multiplesclerosis. this year's meeting is in milan. the first day at #msmilan2023 was packed with some great talks. the morning ""hot topic"" session on #ebv and #multiplesclerosis was was particularly interesting. https://t.co/i36ttsdhk9",unknown,"#ectrims, #multiplesclerosis, #msmilan2023, #ebv, #multiplesclerosis",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1227269111966785536,,602,615,2,,,4,14,1324,false,"ec trims is he world's largest meeting on multiple sclerosis. this year's meeting is in milan. the first day at ms milan was packed with some great talks. the morning ""hot topic"" session on #ebv and multiple sclerosis was was particularly interesting."
196,2023-10-11 15:58:05.0,"Very happy to present the most recent advances of #MRI application in multiple sclerosis research and clinical setting at #ECTRIMS meeting in Milan.
@ECTRIMS 
#MS #ECTRIMS2023 #MSMilan2023 https://t.co/6ENEfNhObq",twitter,ITA,paolopreziosa,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",very happy to present the most recent advances of #mri application in multiple sclerosis research and clinical setting at #ectrims meeting in milan. @ectrims #ms #ectrims2023 #msmilan2023 https://t.co/6enefnhobq,male,"#mri, #ectrims, #ms, #ectrims2023, #msmilan2023",Science,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1058541278,,398,563,0,,,0,4,720,false,very happy to present the most recent advances of #mri application in multiple sclerosis research and clinical setting at ec trims meeting in milan. ms ec trims ms milan
197,2023-10-11 15:26:17.0,Check out my poster P287. #MSMilan2023 Lymphopenia vs. normal lymphocyte counts on diroximel fumarate #DRF did not impact overall efficacy.  But quartile with lowest ALC over 96 weeks had best Gd+ & NEDA results. https://t.co/WTMkANNMRk https://t.co/Nm90qJYKCt,twitter,USA,drbarrysinger,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",check out my poster p287. #msmilan2023 lymphopenia vs. normal lymphocyte counts on diroximel fumarate #drf did not impact overall efficacy. but quartile with lowest alc over 96 weeks had best gd+ & neda results. https://t.co/wtmkannmrk https://t.co/nm90qjykct,male,"#msmilan2023, #drf",Science,,6000000000,1430793013,,7201,393,3,,,6,28,3156,false,check out my poster p287. ms milan lymphopenia vs. normal lymphocyte counts on diroximel fumarate #drf did not impact overall efficacy. but quartile with lowest alc over 96 weeks had best gd+ & neda results.
198,2023-10-11 15:25:05.0,"@ECTRIMS the buzzwords are PIRA, smoldering MS and pre-disease markers. Neurodegeneration begins early but in MS we seem to specialize in treating it late.üò±",twitter,ITA,Jagan1234,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@ectrims the buzzwords are pira, smoldering ms and pre-disease markers. neurodegeneration begins early but in ms we seem to specialize in treating it late.üò±",unknown,,,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,106094125,,138,95,0,,,1,3,1373,false,"the buzzwords are pira, smoldering ms and pre-disease markers. neurodegeneration begins early but in ms we seem to specialize in treating it late."
199,2023-10-11 15:20:55.0,"Kicking off our coverage of #ECTRIMS2023...
For those with #RRMS, treatment with #vidofludimuscalcium led to reductions in #NfL biomarkers as early as week 6 compared with placebo, according to a presentation at @ECTRIMS. https://t.co/FLSZTFf5hF",twitter,,healioneurology,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","kicking off our coverage of #ectrims2023... for those with #rrms, treatment with #vidofludimuscalcium led to reductions in #nfl biomarkers as early as week 6 compared with placebo, according to a presentation at @ectrims. https://t.co/flsztff5hf",unknown,"#ectrims2023, #rrms, #vidofludimuscalcium, #nfl",,,6000000000,1288887610371452928,,56,211,0,,,0,0,1600,false,"kicking off our coverage of ec trims... for those with #rrms, treatment with #vidofludimuscalcium led to reductions in #nfl biomarkers as early as week 6 compared with placebo, according to a presentation at ."
200,2023-10-11 15:11:29.0,Strong patient advocate Ellen @ECTRIMS : Discussion with the neurologist means not just talking. It‚Äôs about listening and understanding. Thank you! Couldn‚Äôt! #MSMilan2023 #ms,twitter,DEU,Birgitpower,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",strong patient advocate ellen @ectrims : discussion with the neurologist means not just talking. it‚Äôs about listening and understanding. thank you! couldn‚Äôt! #msmilan2023 #ms,female,"#msmilan2023, #ms",,,6000000000,22899395,,3334,1989,0,,,1,3,31842,false,strong patient advocate ellen : discussion with the neurologist means not just talking. its about listening and understanding. thank you! couldnt! ms milan ms
201,2023-10-11 15:08:59.0,"Tiziana (Nasdaq:¬†TLSA) Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress

#TizianaLifeSciences #TLSA #ALS 

https://t.co/0f6vFSFThO",twitter,USA,Tradigital__IR,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana (nasdaq: tlsa) announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress #tizianalifesciences #tlsa #als https://t.co/0f6vfsftho,,"#tizianalifesciences, #tlsa, #als",Business,,6000000000,1095001232450691072,,29,177,0,,,0,0,1142,false,tiziana (nasdaq: tlsa) announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress #tizianalifesciences tls a #als
202,2023-10-11 15:08:10.0,"Happy to share in #MSMilan2023 congress our collaborative work on COVID-19 vaccines in #MultipleSclerosis: 9 MS centres from Argentina, 3 Labs of @fundacionleloir and @gabyrabi groups working together !! @ECTRIMS https://t.co/rnitbmRKeS",twitter,ITA,bereniceanabel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","happy to share in #msmilan2023 congress our collaborative work on covid-19 vaccines in #multiplesclerosis: 9 ms centres from argentina, 3 labs of @fundacionleloir and @gabyrabi groups working together !! @ectrims https://t.co/rnitbmrkes",female,"#msmilan2023, #multiplesclerosis",Science,"{profession=Scientist & Researcher, jobTitle=Research Fellow}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,946033424296501249,,196,337,5,,,3,26,581,false,"happy to share in ms milan congress our collaborative work on covid-19 vaccines in multiple sclerosis: 9 ms centres from argentina, 3 labs of and groups working together !!"
203,2023-10-11 14:52:47.0,"More from #ECTRIMS2023 üëá

Good Q&A from @HeajerKaroui at the end of the 'Effects of MS on Cognition and Beyond' session #MSMilan2023 https://t.co/FZIBqcZPmI",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",more from #ectrims2023 üëá good q&a from @heajerkaroui at the end of the 'effects of ms on cognition and beyond' session #msmilan2023 https://t.co/fzibqczpmi,,"#ectrims2023, #msmilan2023",,,6000000000,325527212,,2292,1830,0,,,3,11,1830,false,more from ec trims good q&a from at the end of the 'effects of ms on cognition and beyond' session ms milan
204,2023-10-11 14:49:50.0,"$TLSA
Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress https://t.co/e7QPOm4Z1c",twitter,,MarcJacksonLA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$tlsa tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress https://t.co/e7qpom4z1c,unknown,,Technology,,6000000000,4058194633,,3660,385,0,,,0,1,92166,false,$tlsa tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress
205,2023-10-11 14:38:53.0,#Kickoff #ECTRIMS2023 $TGTX will be presenting data from the Ph3 ULTIMATE I & II trials of #ublituximab in #MS this Wed&Thurs at #MSMILAN2023. Check out our first 2 of 3 presentations: https://t.co/SvwvfB4wAr - Visit Booth C15 Details: https://t.co/1xbZfvcv9J #FearlessForPatients https://t.co/zGYAiPWXKV,twitter,USA,TGTherapeutics,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740625, name=Briumvi / ublituximab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767266, name=Briumvi, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",#kickoff #ectrims2023 $tgtx will be presenting data from the ph3 ultimate i & ii trials of #ublituximab in #ms this wed&thurs at #msmilan2023. check out our first 2 of 3 presentations: https://t.co/svwvfb4war - visit booth c15 details: https://t.co/1xbzfvcv9j #fearlessforpatients https://t.co/zgyaipwxkv,,"#kickoff, #ectrims2023, #ublituximab, #ms, #msmilan2023, #fearlessforpatients","Beauty/Health & Fitness, Business",,6000000000,439362597,,2814,60,0,,,1,8,580,false,#kickoff ec trims $tgtx will be presenting data from the ph3 ultimate i & ii trials of #ublituximab in ms this wed&thurs at ms milan. check out our first 2 of 3 presentations: - visit booth c15 details: #fearlessforpatients
206,2023-10-11 14:21:25.0,"Very glad I got the opportunity to present some cool work I've been working on looking into cognitive impairment in #MultipleSclerosis, and get some feedback and interest from the scientific community #ectrims2023 @ECTRIMS",twitter,GBR,HeajerKaroui,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","very glad i got the opportunity to present some cool work i've been working on looking into cognitive impairment in #multiplesclerosis, and get some feedback and interest from the scientific community #ectrims2023 @ectrims",unknown,"#multiplesclerosis, #ectrims2023",Fine arts,"{profession=Scientist & Researcher, jobTitle=Researcher}",6000000000,1403270777688965121,,130,311,1,,,4,18,101,false,"very glad i got the opportunity to present some cool work i've been working on looking into cognitive impairment in multiple sclerosis, and get some feedback and interest from the scientific community ec trims"
207,2023-10-11 14:13:32.0,"It is extremely inspiring to virtually participate in the first day of #MSMilan2023, despite of waking up early,  two monitors cannot keep up!, will review @ECTRIMS on demand #MS @ACTRIMS @mssociety https://t.co/nkmaaIQKAd",twitter,USA,DrJim4MS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","it is extremely inspiring to virtually participate in the first day of #msmilan2023, despite of waking up early, two monitors cannot keep up!, will review @ectrims on demand #ms @actrims @mssociety https://t.co/nkmaaiqkad",male,"#msmilan2023, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1770,621,1,,,1,9,7972,false,"it is extremely inspiring to virtually participate in the first day of ms milan, despite of waking up early, two monitors cannot keep up!, will review on demand ms"
208,2023-10-11 14:06:58.0,"""Cognitive dysfunction in indivs w/RRMS may respond to cognitive rehab or exercise; similar data are lacking in progressive MS: Processing speed can improve in substantial number of individuals with #progressive #MS but #interventions may need rethinking."" #MSMilan2023 @ECTRIMS",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","""cognitive dysfunction in indivs w/rrms may respond to cognitive rehab or exercise; similar data are lacking in progressive ms: processing speed can improve in substantial number of individuals with #progressive #ms but #interventions may need rethinking."" #msmilan2023 @ectrims",,"#progressive, #ms, #interventions, #msmilan2023",,,6000000000,1054320667,,893,620,0,,,0,0,4148,false,"""cognitive dysfunction in indivs w/rrms may respond to cognitive rehab or exercise; similar data are lacking in progressive ms: processing speed can improve in substantial number of individuals with #progressive ms but #interventions may need rethinking."" ms milan"
209,2023-10-11 14:01:29.0,"Learn more about FSD Pharma's therapeutic pipeline ""Lucid-MS"" candidate for targeting Multiple Sclerosis, in the link below.

https://t.co/et3kWlIbWf

#Multiplesclerosis #MSMilan2023 #Biotech #Nasdaq #Neurodegenerative #Remyelination #Healthcare https://t.co/M8Y1V0S91U",twitter,,FsdPharma,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","learn more about fsd pharma's therapeutic pipeline ""lucid-ms"" candidate for targeting multiple sclerosis, in the link below. https://t.co/et3kwlibwf #multiplesclerosis #msmilan2023 #biotech #nasdaq #neurodegenerative #remyelination #healthcare https://t.co/m8y1v0s91u",unknown,"#multiplesclerosis, #msmilan2023, #biotech, #nasdaq, #neurodegenerative, #remyelination, #healthcare","Beauty/Health & Fitness, Books",,6000000000,1012892543925850113,,5260,272,0,,,2,6,591,true,"learn more about fsd pharma's therapeutic pipeline ""lucid-ms"" candidate for targeting multiple sclerosis, in the link below. multiple sclerosis ms milan #biotech #nasdaq #neurodegenerative #remyelination #healthcare"
211,2023-10-11 13:50:06.0,$TLSA Tiziana Life Sciences to present MS treatment at ECTRIMS Annual Congress  https://t.co/izjG7pnhU2 @tizianals #TLSA,twitter,USA,proactive_NA,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$tlsa tiziana life sciences to present ms treatment at ectrims annual congress https://t.co/izjg7pnhu2 @tizianals #tlsa,,#tlsa,,,6000000000,198835982,,9691,4446,1,,,1,9,71228,false,$tlsa tiziana life sciences to present ms treatment at ectrims annual congress tls a
212,2023-10-11 13:48:07.0,That‚Äôs my PI!!!! So proud of our lab for developing a potential treatment for progressive multiple sclerosis #ECTRIMS2023 #ECTRIMS @francesca_gilli @NeuronswithNora https://t.co/YofOK4xkBI,twitter,USA,SeqWithSteve,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",that‚Äôs my pi!!!! so proud of our lab for developing a potential treatment for progressive multiple sclerosis #ectrims2023 #ectrims @francesca_gilli @neuronswithnora https://t.co/yofok4xkbi,male,"#ectrims2023, #ectrims",Science,"{profession=Student, jobTitle=Student}",6000000000,1384961019999571968,,79,135,1,,,0,15,17,false,thats my pi!!!! so proud of our lab for developing a potential treatment for progressive multiple sclerosis ec trims ec trims
213,2023-10-11 13:25:39.0,"""Many women will not have completed their family by the time of diagnosis"" 
‚û°Ô∏è MS nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in #MS

@ECTRIMS @ACTRIMS 
#MSMilan2023 https://t.co/pA5xRPdBFf",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","""many women will not have completed their family by the time of diagnosis"" ‚û°Ô∏è ms nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in #ms @ectrims @actrims #msmilan2023 https://t.co/pa5xrpdbff",female,"#pregnancy, #breastfeeding, #ms, #msmilan2023",,,6000000000,600110872,,4867,891,0,,,3,6,5926,false,"""many women will not have completed their family by the time of diagnosis"" ms nurses share their experience on how important it is to have an in-depth understanding of the concerns that women have about #pregnancy and #breastfeeding in ms ms milan"
214,2023-10-11 13:24:34.0,"üì¢Fantastic talk from @Cels121 
üéØdemonstrating tools for examining spatial transcriptomics ‚úÖdelineate which cells, what are they doing and where are they in #MS
#ECTRIMS2023 #MSMilan2023 @ECTRIMS https://t.co/LHtn7vGINM",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","üì¢fantastic talk from @cels121 üéØdemonstrating tools for examining spatial transcriptomics ‚úÖdelineate which cells, what are they doing and where are they in #ms #ectrims2023 #msmilan2023 @ectrims https://t.co/lhtn7vginm",female,"#ms, #ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1798,1037,0,,,4,5,2224,false,"fantastic talk from demonstrating tools for examining spatial transcriptomics delineate which cells, what are they doing and where are they in ms ec trims ms milan"
215,2023-10-11 13:22:54.0,"Stephen Hauser's ECTRIMS lecture: #MultipleSclerosis: a path to a #cure
This work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with #MS. 
https://t.co/M2WNq4rYCi
#ECTRIMS2023",twitter,,IJMSCtweets,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","stephen hauser's ectrims lecture: #multiplesclerosis: a path to a #cure this work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with #ms. https://t.co/m2wnq4ryci #ectrims2023",,"#multiplesclerosis, #cure, #autoantibody, #ms, #ectrims2023",,,6000000000,1054320667,,893,620,0,,,1,7,4145,false,"stephen hauser's ectrims lecture: multiple sclerosis: a path to a #cure this work identifies longitudinally stable #autoantibody profile that is present before, during & after first symptom onset for a subset of individuals with ms. ec trims"
216,2023-10-11 13:09:15.0,"$IMUX Data from Immunic's Phase 2 EMPhASIS trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis presented at MSMilan2023. 

More Info: https://t.co/1qfECJzD4j $XBI $IBB $XPH $PPH https://t.co/4k87IiQOKk",twitter,USA,OzmosiHealth,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$imux data from immunic's phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis presented at msmilan2023. more info: https://t.co/1qfecjzd4j $xbi $ibb $xph $pph https://t.co/4k87iiqokk,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1373,790,0,,,0,0,7250,true,$imux data from immunic's phase 2 emphasis trial of vidofludimus calcium in relapsing-remitting multiple sclerosis presented at msmilan2023. more info: $xbi $ibb $xph $pph
217,2023-10-11 13:09:08.0,"Tiziana to share 6-month safety and biomarker info for Intranasal Foralumab in na-SPMS patients at ECTRIMS Annual Congress.  

More Info: https://t.co/BGegqDYQ0o $XBI $IBB $XPH $PPH https://t.co/4Pr2Ct0nrA",twitter,USA,OzmosiHealth,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana to share 6-month safety and biomarker info for intranasal foralumab in na-spms patients at ectrims annual congress. more info: https://t.co/bgegqdyq0o $xbi $ibb $xph $pph https://t.co/4pr2ct0nra,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1373,790,0,,,0,0,7246,true,tiziana to share 6-month safety and biomarker info for intranasal foralumab in na-spms patients at ectrims annual congress. more info: $xbi $ibb $xph $pph
218,2023-10-11 13:04:57.0,"üì¢Dr V. wee Yong @UCalgary
‚úÖmicroglia and monocyte-derived MŒ∏ in lesions of #MS - how can we target these?
üéØBTK highly expressed on these cells in MS lesions
ü§îhydroxychloroquine for PPMS
#ECTRIMS2023 #MSMILAN2023 https://t.co/wrucXuTJFz",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üì¢dr v. wee yong @ucalgary ‚úÖmicroglia and monocyte-derived mŒ∏ in lesions of #ms - how can we target these? üéØbtk highly expressed on these cells in ms lesions ü§îhydroxychloroquine for ppms #ectrims2023 #msmilan2023 https://t.co/wrucxutjfz,female,"#ms, #ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1797,1036,2,,,0,0,2223,false,dr v. wee yong microglia and monocyte-derived m in lesions of ms - how can we target these? btk highly expressed on these cells in ms lesions hydroxychloroquine for ppms ec trims ms milan
219,2023-10-11 13:02:45.0,Depression and MS conclusions .. CBT helps depression and anxiety #ectrims2023 https://t.co/xnTL64bMwo,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",depression and ms conclusions .. cbt helps depression and anxiety #ectrims2023 https://t.co/xntl64bmwo,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1815,false,depression and ms conclusions .. cbt helps depression and anxiety ec trims
220,2023-10-11 13:01:31.0,@gianmarcoabba reveals a key issue: Epstein Barr Virus-specific CD8+ T cells decrease post-Ocrelizumab treatment. How close are we to fully grasping MS's origin and its relationship with EBV? @ECTRIMS #MSMilan2023,twitter,ESP,andreuvilaseca7,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711853, name=MS Drugs - HE, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20740623, name=Ocrevus / ocrelizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20767264, name=Ocrevus, displayName=null, parentId=20767263, parentName=ECTRIMS [MS]}",@gianmarcoabba reveals a key issue: epstein barr virus-specific cd8+ t cells decrease post-ocrelizumab treatment. how close are we to fully grasping ms's origin and its relationship with ebv? @ectrims #msmilan2023,male,#msmilan2023,,,6000000000,226254369,,504,793,0,,,1,4,2193,false,reveals a key issue: epstein barr virus-specific cd8+ t cells decrease post-ocrelizumab treatment. how close are we to fully grasping ms's origin and its relationship with ebv? ms milan
221,2023-10-11 13:00:27.0,"Have you heard of MSMilan Patient Community Day? Connect with the MS community online: share your questions, voice your needs and spark conversations.

üìÖSaturday 14 October 2023
‚û°Ô∏èRegister to the event: https://t.co/IKRU9Eg19J

#ECTRIMS4me https://t.co/iaFwrdmuxk",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","have you heard of msmilan patient community day? connect with the ms community online: share your questions, voice your needs and spark conversations. üìÖsaturday 14 october 2023 ‚û°Ô∏èregister to the event: https://t.co/ikru9eg19j #ectrims4me https://t.co/iafwrdmuxk",female,#ectrims4me,,,6000000000,10869022,,55540,4343,0,,,3,9,54548,false,"have you heard of msmilan patient community day? connect with the ms community online: share your questions, voice your needs and spark conversations. saturday 14 october 2023 register to the event: ec trims4me"
222,2023-10-11 13:00:01.0,"üì¢ #News: We‚Äôre presenting data at #ECTRIMS2023 on our investigational BTK inhibitor for people with relapsing multiple sclerosis. Find out more here: https://t.co/bD6oPKqssW 

#MS #Neurology #HCPsOnly https://t.co/oagzdgNrBi",twitter,USA,EMDSerono,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üì¢ #news: we‚Äôre presenting data at #ectrims2023 on our investigational btk inhibitor for people with relapsing multiple sclerosis. find out more here: https://t.co/bd6opkqssw #ms #neurology #hcpsonly https://t.co/oagzdgnrbi,unknown,"#news, #ectrims2023, #ms, #neurology, #hcpsonly",Business,,6000000000,574524931,,9119,781,0,,,0,0,4469,false,#news: were presenting data at ec trims on our investigational btk inhibitor for people with relapsing multiple sclerosis. find out more here: ms #neurology #hcpsonly
223,2023-10-11 12:57:17.0,GREAT speech by @BenedettaBodin1 at #MSMilan2023 about PET imaging and advances in MS! https://t.co/k7SENOJQcp,twitter,FRA,MyelinIcm,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great speech by @benedettabodin1 at #msmilan2023 about pet imaging and advances in ms! https://t.co/k7senojqcp,female,#msmilan2023,"Beauty/Health & Fitness, Science, Animals & Pets",,6000000000,1451160878309679104,,247,190,1,,,7,28,66,false,great speech by at ms milan about pet imaging and advances in ms!
224,2023-10-11 12:56:37.0,Dr Feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with MS @ECTRIMS #MSMilan2023 https://t.co/QqlpvcwN7R,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with ms @ectrims #msmilan2023 https://t.co/qqlpvcwn7r,female,#msmilan2023,,,6000000000,256679634,,1172,1912,0,,,0,2,6570,false,dr feinstein shares 16-weeks of cognitive behavioural therapy show benefits for depression in people with ms ms milan
225,2023-10-11 12:50:22.0,Atrophy in hippocampus and elevated cortisol can increase depression in MS #ectrims2023 https://t.co/xu1uQip6HW,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",atrophy in hippocampus and elevated cortisol can increase depression in ms #ectrims2023 https://t.co/xu1uqip6hw,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1812,false,atrophy in hippocampus and elevated cortisol can increase depression in ms ec trims
226,2023-10-11 12:48:56.0,Dr Anthony Feinstein discusses psychiatric comorbidity in MS @ECTRIMS #MSMilan2023 https://t.co/0TQk5NDTWB,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr anthony feinstein discusses psychiatric comorbidity in ms @ectrims #msmilan2023 https://t.co/0tqk5ndtwb,female,#msmilan2023,,,6000000000,256679634,,1172,1912,0,,,0,1,6569,false,dr anthony feinstein discusses psychiatric comorbidity in ms ms milan
227,2023-10-11 12:47:20.0,Cognition and MS Summary .. John Deluca . #ectrims2023 https://t.co/e3DMYXNfr5,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",cognition and ms summary .. john deluca . #ectrims2023 https://t.co/e3dmyxnfr5,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,469,2043,0,,,0,0,1810,false,cognition and ms summary .. john deluca . ec trims
228,2023-10-11 12:35:17.0,"@ThINk_Basel wholistic intro to AI and its application to MS detection by Prof. Cristina Granziera @ECTRIMS 
#MSMilan2023 https://t.co/1l0NGfeOHv",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",@think_basel wholistic intro to ai and its application to ms detection by prof. cristina granziera @ectrims #msmilan2023 https://t.co/1l0ngfeohv,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,2,3,16,false,wholistic intro to ai and its application to ms detection by prof. cristina granziera ms milan
229,2023-10-11 12:15:00.0,Stay up to date on findings from the Phase III OCARINA II trial at #MSMilan2023. View late-breaking Poster P370 to see the data comparing an investigational subcutaneous injection formulation of an anti-CD20 monoclonal antibody vs an IV infusion in patients with MS. #NeuroTwitter,twitter,USA,GenentechMed,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=19587268, name=SC, displayName=null, parentId=19587266, parentName=Crova generative AI_SML}",stay up to date on findings from the phase iii ocarina ii trial at #msmilan2023. view late-breaking poster p370 to see the data comparing an investigational subcutaneous injection formulation of an anti-cd20 monoclonal antibody vs an iv infusion in patients with ms. #neurotwitter,,"#msmilan2023, #neurotwitter",Beauty/Health & Fitness,,6000000000,1405237666677891073,,153,0,0,,,1,0,56,false,stay up to date on findings from the phase iii ocarina ii trial at ms milan. view late-breaking poster p370 to see the data comparing an investigational subcutaneous injection formulation of an anti-cd20 monoclonal antibody vs an iv infusion in patients with ms. #neurotwitter
230,2023-10-11 11:45:28.0,Ozanimod Data in preservation of brain volume in early MS #ectrims2023 https://t.co/9nokNryLcq,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",ozanimod data in preservation of brain volume in early ms #ectrims2023 https://t.co/9noknrylcq,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,468,2043,0,,,0,1,1802,false,ozanimod data in preservation of brain volume in early ms ec trims
231,2023-10-11 11:44:08.0,"Wonderful to see our members at #MSMilan2023! Many friends within #MultipleSclerosis community already visited our booth to say helloü§ó
If you have not done that yet, we are eagerly awaiting to see you at our booth Nr. 1‚É£4‚É£ üôå
@ECTRIMS @ACTRIMS #ECTRIMS2023 https://t.co/9lsry19Gpa",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","wonderful to see our members at #msmilan2023! many friends within #multiplesclerosis community already visited our booth to say helloü§ó if you have not done that yet, we are eagerly awaiting to see you at our booth nr. 1‚É£4‚É£ üôå @ectrims @actrims #ectrims2023 https://t.co/9lsry19gpa",female,"#msmilan2023, #multiplesclerosis, #ectrims2023",,,6000000000,600110872,,4865,891,0,,,2,14,5924,false,"wonderful to see our members at ms milan! many friends within multiple sclerosis community already visited our booth to say hello if you have not done that yet, we are eagerly awaiting to see you at our booth nr. 14 ec trims"
232,2023-10-11 11:33:37.0,Thalamus as relay station and thalamic atrophy in MS #ectrims2023 https://t.co/p0YyQ7oqsR,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",thalamus as relay station and thalamic atrophy in ms #ectrims2023 https://t.co/p0yyq7oqsr,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,468,2043,0,,,0,0,1799,false,thalamus as relay station and thalamic atrophy in ms ec trims
233,2023-10-11 11:33:32.0,"@ThINk_Basel Prof. Granziera now discussing smoldering MS @ECTRIMS 
#MSMilan2023 https://t.co/WLVhHFfVMb",twitter,ITA,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@think_basel prof. granziera now discussing smoldering ms @ectrims #msmilan2023 https://t.co/wlvhhffvmb,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,0,5,13,false,prof. granziera now discussing smoldering ms ms milan
234,2023-10-11 11:30:00.0,We're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-CD20 monoclonal antibody for #multiplesclerosis. See Poster P061 at #MSMilan2023 to learn more. #NeuroTwitter,twitter,USA,GenentechMed,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",we're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-cd20 monoclonal antibody for #multiplesclerosis. see poster p061 at #msmilan2023 to learn more. #neurotwitter,,"#multiplesclerosis, #msmilan2023, #neurotwitter",Beauty/Health & Fitness,,6000000000,1405237666677891073,,152,0,0,,,0,0,53,false,we're pleased to share the latest results from a real-world analysis of the largest available database for pregnancy and infant outcomes in women receiving an anti-cd20 monoclonal antibody for multiple sclerosis. see poster p061 at ms milan to learn more. #neurotwitter
235,2023-10-11 11:24:28.0,We're ready for day 1 of #ECTRIMS2023 in #Milan and can't wait to get started! #MS #AsOneForPatients @ECTRIMS https://t.co/qEtjoaR4jP,twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",we're ready for day 1 of #ectrims2023 in #milan and can't wait to get started! #ms #asoneforpatients @ectrims https://t.co/qetjoar4jp,unknown,"#ectrims2023, #milan, #ms, #asoneforpatients",,,6000000000,857893749959086080,,7565,623,0,,,1,15,4080,false,we're ready for day 1 of ec trims in milan and can't wait to get started! ms #asoneforpatients
236,2023-10-11 11:22:04.0,Today we announced Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress. $TLSA #multiplesclerosis #SPMS #MS #MSMilan2023 #ECTRIMS #ACTRIMS‚Ä¶,twitter,,TizianaLS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",today we announced presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress. $tlsa #multiplesclerosis #spms #ms #msmilan2023 #ectrims #actrims‚Ä¶,unknown,"#multiplesclerosis, #spms, #ms, #msmilan2023, #ectrims, #actrims",,,6000000000,847823456758575105,,1410,304,0,,,1,28,366,true,today we announced presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress. $tlsa multiple sclerosis #spms ms ms milan ec trims #actrims
237,2023-10-11 11:21:42.0,Brilliant opening lecture at #MSMilan2023 by Prof Steven Hauser on the Path to Cure for MS. So much progress and incredible opportunities to create a world free of #MS. https://t.co/kLUs6kcnCK,twitter,USA,tim_coetzee,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",brilliant opening lecture at #msmilan2023 by prof steven hauser on the path to cure for ms. so much progress and incredible opportunities to create a world free of #ms. https://t.co/klus6kcnck,male,"#msmilan2023, #ms",Science,,6000000000,29843656,,556,229,0,,,4,19,611,true,brilliant opening lecture at ms milan by prof steven hauser on the path to cure for ms. so much progress and incredible opportunities to create a world free of ms.
238,2023-10-11 11:12:04.0,Tiziana Announces Presentation of Six-Month Safety and Biomarker Data for Intranasal Foralumab in Patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) at the ECTRIMS Annual Congress $TLSA https://t.co/NeZK4H0M34,twitter,USA,health_stocks,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress $tlsa https://t.co/nezk4h0m34,unknown,,"Business, Science",,6000000000,1090012514820280324,,690,157,0,,,0,0,14832,true,tiziana announces presentation of six-month safety and biomarker data for intranasal foralumab in patients with non-active secondary progressive multiple sclerosis (na-spms) at the ectrims annual congress $tlsa
239,2023-10-11 10:57:23.0,"Incredible plenary session by Dr Hauser (UCSF) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in MS #msmilan2023 https://t.co/9IJN8kPlHi",twitter,ITA,samjcohn,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","incredible plenary session by dr hauser (ucsf) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in ms #msmilan2023 https://t.co/9ijn8kplhi",male,#msmilan2023,Games,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,8294442,,13261,3177,0,,,0,3,13007,false,"incredible plenary session by dr hauser (ucsf) about multiple phases of autoimmunity, and multiple mechanisms of inflammation in ms ms milan"
240,2023-10-11 10:40:34.0,"Thought-provoking, superb talk by Stephen Hauser: the path to prevent and cure MS. #MSMilan2023. #ECTRIMS #ACTRIMS https://t.co/JVyADCyeUh",twitter,ESP,GeoArrambide,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","thought-provoking, superb talk by stephen hauser: the path to prevent and cure ms. #msmilan2023. #ectrims #actrims https://t.co/jvyadcyeuh",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,532,171,0,,,5,22,719,false,"thought-provoking, superb talk by stephen hauser: the path to prevent and cure ms. ms milan. ec trims #actrims"
241,2023-10-11 10:37:29.0,"Day 1 of #MSMilan2023, surrounded by thousands of colleagues in the pursuit of progress for every person with MS. Every Person. Every Pathway. The energy here is brilliant! #ECTRIMS #ACTRIMS #multiplesclerosis https://t.co/UOeF7EwEmy",twitter,,mssocietyHCP,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","day 1 of #msmilan2023, surrounded by thousands of colleagues in the pursuit of progress for every person with ms. every person. every pathway. the energy here is brilliant! #ectrims #actrims #multiplesclerosis https://t.co/uoef7ewemy",female,"#msmilan2023, #ectrims, #actrims, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,1321452751818207232,,394,146,0,,,2,10,396,false,"day 1 of ms milan, surrounded by thousands of colleagues in the pursuit of progress for every person with ms. every person. every pathway. the energy here is brilliant! ec trims #actrims multiple sclerosis"
242,2023-10-11 10:28:20.0,"Prof Stephen Hauser giving opening @ECTRIMS lecture, discussing patterns of autoimmunity in different conditions. As someone living with #RheumatoidArthritis I had no idea autoantibodies could be present 20 years before clinical signs! What could it mean for #MS?
 
#MSMilan2023 https://t.co/YkT0ajqIFs",twitter,GBR,AnneHelme,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","prof stephen hauser giving opening @ectrims lecture, discussing patterns of autoimmunity in different conditions. as someone living with #rheumatoidarthritis i had no idea autoantibodies could be present 20 years before clinical signs! what could it mean for #ms? #msmilan2023 https://t.co/ykt0ajqifs",female,"#rheumatoidarthritis, #ms, #msmilan2023",Beauty/Health & Fitness,,6000000000,46126120,,1054,1040,0,,,1,5,3293,false,"prof stephen hauser giving opening lecture, discussing patterns of autoimmunity in different conditions. as someone living with #rheumatoidarthritis i had no idea autoantibodies could be present 20 years before clinical signs! what could it mean for ms? ms milan"
243,2023-10-11 10:22:26.0,"#MSMilan2023 Patient Community Day is üîú this Saturday! Prof @MarTintore highlighted during the opening:
üëç @ECTRIMS @ACTRIMS are focusing more on patient engagement and this patient day is bringing in people with #MS together with researchers
#ECTRIMS4me
Link for registration üëá",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#msmilan2023 patient community day is üîú this saturday! prof @martintore highlighted during the opening: üëç @ectrims @actrims are focusing more on patient engagement and this patient day is bringing in people with #ms together with researchers #ectrims4me link for registration üëá,female,"#msmilan2023, #ms, #ectrims4me",,,6000000000,600110872,,4863,891,0,,,4,9,5921,false,ms milan patient community day is this saturday! prof highlighted during the opening: are focusing more on patient engagement and this patient day is bringing in people with ms together with researchers ec trims4me link for registration
244,2023-10-11 10:19:45.0,"We're at @ECTRIMS the world‚Äôs largest research conference for MS. We're here to find out the latest advancements and discoveries in MS research and treatment.

We‚Äôll be sharing some of the hot topics over the coming days, on things like EBV and the gut brain axis.

#MSMilan2023 https://t.co/VBx3QzeDSm",twitter,GBR,mssocietyuk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","we're at @ectrims the world‚Äôs largest research conference for ms. we're here to find out the latest advancements and discoveries in ms research and treatment. we‚Äôll be sharing some of the hot topics over the coming days, on things like ebv and the gut brain axis. #msmilan2023 https://t.co/vbx3qzedsm",female,#msmilan2023,,,6000000000,10869022,,55539,4343,0,,,3,44,54547,false,"we're at the worlds largest research conference for ms. we're here to find out the latest advancements and discoveries in ms research and treatment. well be sharing some of the hot topics over the coming days, on things like ebv and the gut brain axis. ms milan"
245,2023-10-11 10:19:01.0,"RC2NB @ECTRIMS and excited to learn about the newest developments in MS therapy towards a cure

#MSMilan2023 https://t.co/0QcBltJ4wH",twitter,CHE,RC2NB,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",rc2nb @ectrims and excited to learn about the newest developments in ms therapy towards a cure #msmilan2023 https://t.co/0qcbltj4wh,,#msmilan2023,Beauty/Health & Fitness,,6000000000,1493181686426779654,,88,64,0,,,0,4,12,false,rc2nb and excited to learn about the newest developments in ms therapy towards a cure ms milan
246,2023-10-11 10:14:15.0,Dr. Stephen Hauser shares there are more than 230 genetic loci for MS susceptibility and more recent loci in severity @ECTRIMS #msmilan2023 https://t.co/El2WZBP5zL,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser shares there are more than 230 genetic loci for ms susceptibility and more recent loci in severity @ectrims #msmilan2023 https://t.co/el2wzbp5zl,female,#msmilan2023,,,6000000000,256679634,,1171,1912,1,,,0,0,6566,false,dr. stephen hauser shares there are more than 230 genetic loci for ms susceptibility and more recent loci in severity ms milan
247,2023-10-11 10:08:45.0,Dr. Stephen Hauser describes #MS as one of the greatest advances in molecular medicine @ECTRIMS #msmilan2023,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser describes #ms as one of the greatest advances in molecular medicine @ectrims #msmilan2023,female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,1,1,6564,false,dr. stephen hauser describes ms as one of the greatest advances in molecular medicine ms milan
248,2023-10-11 10:07:30.0,"@MarTintore, Massimo Filippi and Mark Freedman welcome us to #MSMilan2023. The most important MS highlight this year was mentioned: inclusion of certain DMTs in the WHO's essential medicines list. NMOSD and MOGAD also earning their place. #ECTRIMS #ACTRIMS @cemcat_em https://t.co/WURiFL39UO",twitter,ESP,GeoArrambide,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore, massimo filippi and mark freedman welcome us to #msmilan2023. the most important ms highlight this year was mentioned: inclusion of certain dmts in the who's essential medicines list. nmosd and mogad also earning their place. #ectrims #actrims @cemcat_em https://t.co/wurifl39uo",female,"#msmilan2023, #ectrims, #actrims",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1448356440108830725,,532,171,0,,,3,22,717,false,", massimo filippi and mark freedman welcome us to ms milan. the most important ms highlight this year was mentioned: inclusion of certain dmts in the who's essential medicines list. nmosd and mogad also earning their place. ec trims #actrims"
249,2023-10-11 10:07:03.0,Dr. Stephen Hauser : MS Path to a Cure  #ectrims2023 https://t.co/hfpXGdpLuB,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",dr. stephen hauser : ms path to a cure #ectrims2023 https://t.co/hfpxgdplub,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,1,6,1794,false,dr. stephen hauser : ms path to a cure ec trims
250,2023-10-11 09:54:22.0,"‚ú® So excited to attend #MSMilan2023! Check out our poster on healthcare utilization in MS teleneurology today üìûüì∫@MarisaMcginley 

See you all there! #MS #msresearch https://t.co/4vuSdOuQk9",twitter,,kaitlyn_palmer1,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",‚ú® so excited to attend #msmilan2023! check out our poster on healthcare utilization in ms teleneurology today üìûüì∫@marisamcginley see you all there! #ms #msresearch https://t.co/4vusdouqk9,female,"#msmilan2023, #ms, #msresearch",,,6000000000,1288660763104743429,,89,87,1,,,0,9,12,false,so excited to attend ms milan! check out our poster on healthcare utilization in ms teleneurology today see you all there! ms msresearch
251,2023-10-11 09:53:49.0,"üì£ We are ready to greet all of you at the RIMS booth during #MSMilan2023!

Make sure to swing by booth E23 in the Exhibition Area to meet our team and discover more about RIMS, its initiatives, projects, and more. Join us for an enriching conversation.

#RIMS #MS #MSMilan202 https://t.co/ERc41FQNm5",twitter,BEL,eurims,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","üì£ we are ready to greet all of you at the rims booth during #msmilan2023! make sure to swing by booth e23 in the exhibition area to meet our team and discover more about rims, its initiatives, projects, and more. join us for an enriching conversation. #rims #ms #msmilan202 https://t.co/erc41fqnm5",,"#msmilan2023, #rims, #ms, #msmilan202",,,6000000000,421874295,,843,88,0,,,1,7,456,false,"we are ready to greet all of you at the rims booth during ms milan! make sure to swing by booth e23 in the exhibition area to meet our team and discover more about rims, its initiatives, projects, and more. join us for an enriching conversation. #rims ms msmilan202"
252,2023-10-11 09:53:09.0,"The new era of MS treatment, WHO @ECTRIMS : ‚Äúthe WHO emphasises the critical need to make MS treatments available in all health systems at all times.‚Äù https://t.co/sE728BiD0s",twitter,MEX,irenetrefrenk,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","the new era of ms treatment, who @ectrims : ‚Äúthe who emphasises the critical need to make ms treatments available in all health systems at all times.‚Äù https://t.co/se728bid0s",female,,,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,196023048,,6427,1061,0,,,2,8,7019,false,"the new era of ms treatment, who : the who emphasises the critical need to make ms treatments available in all health systems at all times."
253,2023-10-11 09:52:57.0,"The team are here in Milan at #ECTRIMS2023 come and say hello üëã at Stand E.21

Looking forward to a day of talks and networking ü§ù

#MSMILAN2023 #MultipleSclerosis https://t.co/A7pX6xYGfH",twitter,GBR,UKMSRegister,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the team are here in milan at #ectrims2023 come and say hello üëã at stand e.21 looking forward to a day of talks and networking ü§ù #msmilan2023 #multiplesclerosis https://t.co/a7px6xygfh,,"#ectrims2023, #msmilan2023, #multiplesclerosis",,,6000000000,325527212,,2289,1817,0,,,4,22,1820,false,the team are here in milan at ec trims come and say hello at stand e.21 looking forward to a day of talks and networking ms milan multiple sclerosis
254,2023-10-11 09:50:41.0,"@MarTintore, President @ECTRIMS launching #MSMilan2023 
üí°""How we think of #MultipleSclerosis is changing! Every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement"" https://t.co/BiNf02JQXZ",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@martintore, president @ectrims launching #msmilan2023 üí°""how we think of #multiplesclerosis is changing! every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement"" https://t.co/binf02jqxz",female,"#msmilan2023, #multiplesclerosis, #inclusive",,,6000000000,600110872,,4863,891,0,,,8,20,5919,false,", president launching ms milan ""how we think of multiple sclerosis is changing! every person and every pathway is our theme - we aim to be #inclusive not only in research and trials, but importantly with our community engagement"""
255,2023-10-11 09:45:26.0,"Live in 15 minutes! Stephen Hauser, Prof of Neurology at @UCSF is giving this year‚Äôs ECTRIMS Lecture, ‚ÄúMultiple sclerosis: Path to a cure‚Äù
 
üìÖ Wednesday 12.00‚Äì12.30 CEST 
‚û°Ô∏è https://t.co/Mv3Q85yPdP
 
#MSMilan2023 @ACTRIMS https://t.co/CAu5wlOa9V",twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","live in 15 minutes! stephen hauser, prof of neurology at @ucsf is giving this year‚Äôs ectrims lecture, ‚Äúmultiple sclerosis: path to a cure‚Äù üìÖ wednesday 12.00‚Äì12.30 cest ‚û°Ô∏è https://t.co/mv3q85ypdp #msmilan2023 @actrims https://t.co/cau5wloa9v",,#msmilan2023,,,6000000000,714464982,,7948,65,0,,,4,15,7119,false,"live in 15 minutes! stephen hauser, prof of neurology at is giving this years ectrims lecture, multiple sclerosis: path to a cure wednesday 12.0012.30 cest ms milan"
256,2023-10-11 09:43:25.0,The first of two @MAGNIMS educational activities at #MSMilan23 @ECTRIMS was held this morning on ‚ÄúImaging features of MOGAD and differential diagnosis with MS‚Äù with @alexrovirarayos @FBarkhof M. Filippi & J. Palace - Do not miss our second course on Friday! https://t.co/L5fMN0ar9Z,twitter,,MAGNIMS,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",the first of two @magnims educational activities at #msmilan23 @ectrims was held this morning on ‚Äúimaging features of mogad and differential diagnosis with ms‚Äù with @alexrovirarayos @fbarkhof m. filippi & j. palace - do not miss our second course on friday! https://t.co/l5fmn0ar9z,unknown,#msmilan23,,,6000000000,2194426992,,1603,43,0,,,7,37,374,false,the first of two educational activities at msmilan23 was held this morning on imaging features of mogad and differential diagnosis with ms with m. filippi & j. palace - do not miss our second course on friday!
257,2023-10-11 09:43:20.0,"Prof. @mtintore has opened the #MSMilan2023 , the biggest international congress about #multiplesclerosis  
@ECTRIMS @cemcat_em https://t.co/2VQeGanM0w",twitter,ESP,C_OrejaGuevara,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","prof. @mtintore has opened the #msmilan2023 , the biggest international congress about #multiplesclerosis @ectrims @cemcat_em https://t.co/2vqeganm0w",female,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1221603110,,4142,1105,1,,,11,53,23709,false,"prof. has opened the ms milan , the biggest international congress about multiple sclerosis"
258,2023-10-11 09:41:49.0,2023 also brought consensus for a need for a new classification system for #MS #msmilan2023 @ECTRIMS https://t.co/wRxuKO1CxX,twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",2023 also brought consensus for a need for a new classification system for #ms #msmilan2023 @ectrims https://t.co/wrxuko1cxx,female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,0,2,6560,false,2023 also brought consensus for a need for a new classification system for ms ms milan
259,2023-10-11 09:40:13.0,"In 2023, WHO essential medicines list included disease-modifying therapies for #MS @ECTRIMS #MSMilan2023 https://t.co/FMUQVWIkpX",twitter,CAN,PamelaKanellis,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","in 2023, who essential medicines list included disease-modifying therapies for #ms @ectrims #msmilan2023 https://t.co/fmuqvwikpx",female,"#ms, #msmilan2023",,,6000000000,256679634,,1171,1912,0,,,1,7,6559,false,"in 2023, who essential medicines list included disease-modifying therapies for ms ms milan"
260,2023-10-11 09:30:16.0,"üìÖ Join us today at our ‚ÄúI‚ÄôM IN‚Äù event, ‚ÄúUnleashing Potential: Transformational Leadership and Neuro Resilience‚Äù @ECTRIMS. Featuring Nobel Peace Prize Laureate @TawakkolKarman and #MultipleSclerosis specialists Dr. L√©orah Freeman and Dr. Augusto Miravalle #HCPsOnly #ECTRIMS2023 https://t.co/86TX8bVbzc",twitter,DEU,MerckHealthcare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","üìÖ join us today at our ‚Äúi‚Äôm in‚Äù event, ‚Äúunleashing potential: transformational leadership and neuro resilience‚Äù @ectrims. featuring nobel peace prize laureate @tawakkolkarman and #multiplesclerosis specialists dr. l√©orah freeman and dr. augusto miravalle #hcpsonly #ectrims2023 https://t.co/86tx8bvbzc",unknown,"#multiplesclerosis, #hcpsonly, #ectrims2023",,,6000000000,857893749959086080,,7566,623,14,,,4,28,4078,false,"join us today at our im in event, unleashing potential: transformational leadership and neuro resilience . featuring nobel peace prize laureate and multiple sclerosis specialists dr. lorah freeman and dr. augusto miravalle #hcpsonly ec trims"
261,2023-10-11 09:14:04.0,"#mentalhealth in people with #MS @#MSMilan2023 #ECTRIMS 

Adjustment to diagnosis &/or fnx change can feel like being hit by a tornado.

Prev rates #mentalhealth conditions in #MultipleSclerosis r 3-4x higher than the general population 

MS steals so much, don‚Äôt let it steal Joy https://t.co/uL5ew0c0rT",twitter,ITA,DrAmyBSullivan,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","#mentalhealth in people with #ms @#msmilan2023 #ectrims adjustment to diagnosis &/or fnx change can feel like being hit by a tornado. prev rates #mentalhealth conditions in #multiplesclerosis r 3-4x higher than the general population ms steals so much, don‚Äôt let it steal joy https://t.co/ul5ew0c0rt",female,"#mentalhealth, #ms, #msmilan2023, #ectrims, #mentalhealth, #multiplesclerosis",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,861179188430204928,,1967,1297,0,,,1,7,5644,false,"#mentalhealth in people with ms ms milan ec trims adjustment to diagnosis &/or fnx change can feel like being hit by a tornado. prev rates #mentalhealth conditions in multiple sclerosis r 3-4x higher than the general population ms steals so much, dont let it steal joy"
262,2023-10-11 09:00:31.0,"Pathology continually sparks curiosity,answering questions while raising new ones
@LucchinettiMD's captivating talk at @ECTRIMS highlighted distinctive pathology in MS,MOGAD,and AQP4+NMOSD
Unique meningeal lymphoid follicles in MS underscore CNS compartmentalization? #MSMilan2023 https://t.co/VFKK2Grx5p",twitter,ESP,andreuvilaseca7,"{id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","pathology continually sparks curiosity,answering questions while raising new ones @lucchinettimd's captivating talk at @ectrims highlighted distinctive pathology in ms,mogad,and aqp4+nmosd unique meningeal lymphoid follicles in ms underscore cns compartmentalization? #msmilan2023 https://t.co/vfkk2grx5p",male,#msmilan2023,,,6000000000,226254369,,504,791,0,,,0,2,2190,false,"pathology continually sparks curiosity,answering questions while raising new ones 's captivating talk at highlighted distinctive pathology in ms,mogad,and aqp4+nmosd unique meningeal lymphoid follicles in ms underscore cns compartmentalization? ms milan"
263,2023-10-11 08:56:03.0,"@J_SastreGarriga @ECTRIMS @cemcat_em @MAGNIMS @rocca_mara @DrWBRO @XMontalban @MarTintore @MSIntFederation @ACTRIMS @eumsplatform @FundacioEM @esclerosiseme @mssociety @MSJ_Research @EMdeMallorca Congratulations Pr Sastre-Garriga !! 25th Ectrims !!
Thank you for your career and your work for us !!
Thank you so much...
Nicolas, a French guy impacted by Multiple Sclerosis",twitter,FRA,D53Nicolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@j_sastregarriga @ectrims @cemcat_em @magnims @rocca_mara @drwbro @xmontalban @martintore @msintfederation @actrims @eumsplatform @fundacioem @esclerosiseme @mssociety @msj_research @emdemallorca congratulations pr sastre-garriga !! 25th ectrims !! thank you for your career and your work for us !! thank you so much... nicolas, a french guy impacted by multiple sclerosis",unknown,,Sports,,6000000000,1269759847035293700,,257,527,0,http://twitter.com/J_SastreGarriga/statuses/1711974035934826871,,0,7,24296,false,"congratulations pr sastre-garriga !! 25th ectrims !! thank you for your career and your work for us !! thank you so much... nicolas, a french guy impacted by multiple sclerosis"
264,2023-10-11 08:54:26.0,"üß†For #MentalHealthAwarenessDay I am fortunate to be in Milan @#MSMilan2023 #ECTRIMS presenting: Minding the Gap: #mentalhealth in #MS üß† üíö

So grateful for this opportunity üôåüôèüèΩ https://t.co/64piWDZYcp",twitter,USA,DrAmyBSullivan,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",üß†for #mentalhealthawarenessday i am fortunate to be in milan @#msmilan2023 #ectrims presenting: minding the gap: #mentalhealth in #ms üß† üíö so grateful for this opportunity üôåüôèüèΩ https://t.co/64piwdzycp,female,"#mentalhealthawarenessday, #msmilan2023, #ectrims, #mentalhealth, #ms",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Associate Professor}",6000000000,861179188430204928,,1967,1297,0,,,1,12,5643,false,for #mentalhealthawarenessday i am fortunate to be in milan ms milan ec trims presenting: minding the gap: #mentalhealth in ms so grateful for this opportunity
265,2023-10-11 08:44:00.0,"Ultimate goal for #nurses is to ‚Äúprovide a better standard of care for people with #MultipleSclerosis using #research, #evidencebased practice to ensure #qualityimprovement in MS services #role #value @iamIOMSN #UKMSSNA @ECTRIMS @amyharbour7 @MSTrustCEO @TheNeuroAcademy https://t.co/cxhELRJBxG",twitter,ITA,ruthstross,"{id=20711858, name=Important Trials: CD20, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ultimate goal for #nurses is to ‚Äúprovide a better standard of care for people with #multiplesclerosis using #research, #evidencebased practice to ensure #qualityimprovement in ms services #role #value @iamiomsn #ukmssna @ectrims @amyharbour7 @mstrustceo @theneuroacademy https://t.co/cxhelrjbxg",female,"#nurses, #multiplesclerosis, #research, #evidencebased, #qualityimprovement, #role, #value, #ukmssna","Travel, Family & Parenting","{profession=Health practitioner, jobTitle=Nurse}",6000000000,264140472,,154,597,0,,,0,10,323,false,"ultimate goal for #nurses is to provide a better standard of care for people with multiple sclerosis using #research, #evidencebased practice to ensure #qualityimprovement in ms services #role #value #ukmssna"
266,2023-10-11 08:40:12.0,"If at first you don‚Äôt succeed, use more tape. Lessons learned at #ECTRIMS 2023‚Ä¶

Stop by poster 203 this afternoon for a look at MS topography and our new Lesion Parenchymal Fraction concept! 
@ECTRIMS @icometrix https://t.co/aIHhKWMYXY",twitter,USA,SKriegerMD,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","if at first you don‚Äôt succeed, use more tape. lessons learned at #ectrims 2023‚Ä¶ stop by poster 203 this afternoon for a look at ms topography and our new lesion parenchymal fraction concept! @ectrims @icometrix https://t.co/aihhkwmyxy",male,#ectrims,Family & Parenting,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,3028542540,,3103,493,0,,,3,26,757,false,"if at first you dont succeed, use more tape. lessons learned at ec trims 2023 stop by poster 203 this afternoon for a look at ms topography and our new lesion parenchymal fraction concept!"
267,2023-10-11 08:38:06.0,Dr. Deborah Pareto @idi_cat @VHIR_ @cemcat_em is now presenting in #MSMilan2023 a @MAGNIMS multicentre study exploring Inter- and Intrahemispheric connectivity and their clinical impact in #multiplesclerosis - Many thanks to all centres involved! https://t.co/gOSEue1pWj,twitter,ESP,J_SastreGarriga,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",dr. deborah pareto @idi_cat @vhir_ @cemcat_em is now presenting in #msmilan2023 a @magnims multicentre study exploring inter- and intrahemispheric connectivity and their clinical impact in #multiplesclerosis - many thanks to all centres involved! https://t.co/goseue1pwj,male,"#msmilan2023, #multiplesclerosis",,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,829744742,,3211,866,1,,,9,25,6868,false,dr. deborah pareto is now presenting in ms milan a multicentre study exploring inter- and intrahemispheric connectivity and their clinical impact in multiple sclerosis - many thanks to all centres involved!
268,2023-10-11 08:31:35.0,"@DrHArmstrong @ECTRIMS Thank you for your work in MS and for your work for us, Dr Armstrong !!
Nicolas, a French guy impacted by Multiple Sclerosis",twitter,FRA,D53Nicolas,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}","@drharmstrong @ectrims thank you for your work in ms and for your work for us, dr armstrong !! nicolas, a french guy impacted by multiple sclerosis",unknown,,Sports,,6000000000,1269759847035293700,,257,526,0,http://twitter.com/DrHArmstrong/statuses/1711998683359629787,,0,1,24290,false,"thank you for your work in ms and for your work for us, dr armstrong !! nicolas, a french guy impacted by multiple sclerosis"
269,2023-10-11 08:25:44.0,"üì¢ Dr Paolo Preziosa
‚úÖ lesions/atrophy linked to worsened outcomes accumulative disability (EDSS) 
‚úÖ No single biomarker likely
‚úÖ Relapse onset MS vs PPMS
üîëIn early disease conventional MRI
üéØchronic inflammation + GM/spinal cord involvement in dx MS
#ECTRIMS2023 #MSMILAN2023 https://t.co/SfMtLN26c4",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15947099, name=Treatment, displayName=null, parentId=15944091, parentName=AML emotional journey}",üì¢ dr paolo preziosa ‚úÖ lesions/atrophy linked to worsened outcomes accumulative disability (edss) ‚úÖ no single biomarker likely ‚úÖ relapse onset ms vs ppms üîëin early disease conventional mri üéØchronic inflammation + gm/spinal cord involvement in dx ms #ectrims2023 #msmilan2023 https://t.co/sfmtln26c4,female,"#ectrims2023, #msmilan2023",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1795,1033,0,,,0,4,2212,false,dr paolo preziosa lesions/atrophy linked to worsened outcomes accumulative disability (edss) no single biomarker likely relapse onset ms vs ppms in early disease conventional mri chronic inflammation + gm/spinal cord involvement in dx ms ec trims ms milan
270,2023-10-11 08:24:39.0,"@mcomabellalopez @ECTRIMS @XMontalban @GeoArrambide @MarTintore @SuOteroRomero talks on individualized vaccination strategy  as standard care in #MS.

Happening now at #MSMilan2023! https://t.co/hG8pDk5FN4",twitter,ESP,cemcat_em,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@mcomabellalopez @ectrims @xmontalban @geoarrambide @martintore @suoteroromero talks on individualized vaccination strategy as standard care in #ms. happening now at #msmilan2023! https://t.co/hg8pdk5fn4,unknown,"#ms, #msmilan2023",,,6000000000,1197805298,,3142,486,1,http://twitter.com/cemcat_em/statuses/1712017025340526638,,4,13,2888,false,talks on individualized vaccination strategy as standard care in ms. happening now at ms milan!
271,2023-10-11 08:16:35.0,"üì¢ Dr Federica Esposito
‚úÖEpigenetic factors, DNA methylation, and environment risk in MS (smoking/obesity)
‚úÖMS display epigenetic age acceleration with immune links
#ECTRIMS2023 #MSMILAN2023 #MS https://t.co/1ABRg7Pxjl",twitter,CAN,DrHArmstrong,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üì¢ dr federica esposito ‚úÖepigenetic factors, dna methylation, and environment risk in ms (smoking/obesity) ‚úÖms display epigenetic age acceleration with immune links #ectrims2023 #msmilan2023 #ms https://t.co/1abrg7pxjl",female,"#ectrims2023, #msmilan2023, #ms",Beauty/Health & Fitness,"{profession=Teacher & Lecturer, jobTitle=Prof}",6000000000,2340290918,,1795,1033,0,,,0,0,2211,false,"dr federica esposito epigenetic factors, dna methylation, and environment risk in ms (smoking/obesity) ms display epigenetic age acceleration with immune links ec trims ms milan ms"
272,2023-10-11 08:16:02.0,Defining #multiplesclerosis #nursing @ECTRIMS the crucial role #nurses play within ALL parts of MS services from beginning onwards @alisonleary1 @amyharbour7 #UKMSSNA @Sue_NHiS @MSTrustCEO https://t.co/pcIHs0ePNh,twitter,ITA,ruthstross,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",defining #multiplesclerosis #nursing @ectrims the crucial role #nurses play within all parts of ms services from beginning onwards @alisonleary1 @amyharbour7 #ukmssna @sue_nhis @mstrustceo https://t.co/pcihs0epnh,female,"#multiplesclerosis, #nursing, #nurses, #ukmssna","Travel, Family & Parenting","{profession=Health practitioner, jobTitle=Nurse}",6000000000,264140472,,154,597,1,,,0,10,322,false,defining multiple sclerosis #nursing the crucial role #nurses play within all parts of ms services from beginning onwards #ukmssna
273,2023-10-11 08:09:34.0,Let's go üòç #MSmilan2023 #ms #multiplesclerosis #ectrims https://t.co/1cLzyDefGJ,twitter,,MSguncel,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",let's go üòç #msmilan2023 #ms #multiplesclerosis #ectrims https://t.co/1clzydefgj,female,"#msmilan2023, #ms, #multiplesclerosis, #ectrims",,,6000000000,1338606356346048512,,1448,61,0,,,1,21,819,false,let's go ms milan ms multiple sclerosis ec trims
274,2023-10-11 08:00:14.0,"Have you booked your Braindate at #MSMilan2023? Topic meetings are filling up. Connect & network with your colleagues via this customised service, available onsite and online
‚û°Ô∏è https://t.co/CjiX1Vj4Qo 

@e180 https://t.co/JWTpHUEpek",twitter,CHE,ECTRIMS,,"have you booked your braindate at #msmilan2023? topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online ‚û°Ô∏è https://t.co/cjix1vj4qo @e180 https://t.co/jwtphuepek",,#msmilan2023,,,6000000000,714464982,,7941,65,0,,,2,5,7099,false,"have you booked your braindate at ms milan? topic meetings are filling up. connect & network with your colleagues via this customised service, available onsite and online"
275,2023-10-11 07:58:35.0,Arrived at @ECTRIMS #MSMilan2023 ready to learn and share the latest research news on multiple sclerosis #MS! Goal is to improve the lives of those living with MS and hopefully preventing the disease! I‚Äôll be live tweeting as usual. https://t.co/jHsKUxYFAl,twitter,USA,drbarrysinger,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",arrived at @ectrims #msmilan2023 ready to learn and share the latest research news on multiple sclerosis #ms! goal is to improve the lives of those living with ms and hopefully preventing the disease! i‚Äôll be live tweeting as usual. https://t.co/jhskuxyfal,male,"#msmilan2023, #ms",Science,,6000000000,1430793013,,7200,393,6,,,5,116,3149,false,arrived at ms milan ready to learn and share the latest research news on multiple sclerosis ms! goal is to improve the lives of those living with ms and hopefully preventing the disease! ill be live tweeting as usual.
276,2023-10-11 07:48:48.0,"üöÄAnd so #MSMilan2023 has begun! 
üé•Before the start, we asked our President @HerbertTemmes why this event is important, why we participate and what is our contribution? 
Watch the video üëáto find out the answers. 
@ECTRIMS @ACTRIMS #MultipleSclerosis https://t.co/yryZ51IZza",twitter,BEL,eumsplatform,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üöÄand so #msmilan2023 has begun! üé•before the start, we asked our president @herberttemmes why this event is important, why we participate and what is our contribution? watch the video üëáto find out the answers. @ectrims @actrims #multiplesclerosis https://t.co/yryz51izza",female,"#msmilan2023, #multiplesclerosis",,,6000000000,600110872,,4862,891,0,,,7,20,5917,false,"and so ms milan has begun! before the start, we asked our president why this event is important, why we participate and what is our contribution? watch the video to find out the answers. multiple sclerosis"
277,2023-10-11 07:45:22.0,"Martina Absinta unveiled diverse mechanisms propelling the edge in chronic active MS lesions. Does this result from T lymphocytes or self-perpetuate via astrocytes nearby? A crucial query in understanding MS progression. #MultipleSclerosis 
#MSMilan2023 @ECTRIMS https://t.co/SR1CvheSYt",twitter,ESP,andreuvilaseca7,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",martina absinta unveiled diverse mechanisms propelling the edge in chronic active ms lesions. does this result from t lymphocytes or self-perpetuate via astrocytes nearby? a crucial query in understanding ms progression. #multiplesclerosis #msmilan2023 @ectrims https://t.co/sr1cvhesyt,male,"#multiplesclerosis, #msmilan2023",,,6000000000,226254369,,504,790,0,,,1,10,2189,false,martina absinta unveiled diverse mechanisms propelling the edge in chronic active ms lesions. does this result from t lymphocytes or self-perpetuate via astrocytes nearby? a crucial query in understanding ms progression. multiple sclerosis ms milan
278,2023-10-11 07:05:07.0,Aging in MS #ectrims2023 https://t.co/0Qi394kzST,twitter,,napolineuro,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",aging in ms #ectrims2023 https://t.co/0qi394kzst,male,#ectrims2023,,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,0,0,1787,false,aging in ms ec trims
279,2023-10-11 06:59:24.0,Who has it right? Smouldering vs smoldering MS #MSmilan2023 @Merck @sanofi  Excited to be at my first in-person @ECTRIMS conference https://t.co/wBlUMZpfi6,twitter,GBR,cawalton,"{id=16441708, name=Merck, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",who has it right? smouldering vs smoldering ms #msmilan2023 @merck @sanofi excited to be at my first in-person @ectrims conference https://t.co/wblumzpfi6,female,#msmilan2023,"Beauty/Health & Fitness, Sports, Animals & Pets",,6000000000,22329895,,1791,2178,1,,,1,14,3079,false,who has it right? smouldering vs smoldering ms ms milan excited to be at my first in-person conference
280,2023-10-11 06:53:59.0,"The NCNE Multiple Sclerosis Team is in Milan Italy for the largest gathering of MS specialists , researchers and industry leaders. We are here to learn of the newest updates in MS care! #patientsfirst#ectrims2023 https://t.co/YwrhqKH01M",twitter,,napolineuro,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","the ncne multiple sclerosis team is in milan italy for the largest gathering of ms specialists , researchers and industry leaders. we are here to learn of the newest updates in ms care! #patientsfirst#ectrims2023 https://t.co/ywrhqkh01m",male,"#patientsfirst, #ectrims2023",,"{profession=Scientist & Researcher, jobTitle=Neurologist}, {profession=Health practitioner, jobTitle=Medical Director}",6000000000,624617921,,467,2043,0,,,0,0,1786,false,"the ncne multiple sclerosis team is in milan italy for the largest gathering of ms specialists , researchers and industry leaders. we are here to learn of the newest updates in ms care! #patientsfirstec trims"
282,2023-10-11 06:10:45.0,"(Brain) Networks matter!
Honoured to be taking the stage at #MSMilan2023! Looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. See you all in Milan! üëã
#MAGNIMS #ECTRIMS https://t.co/OnrkQUdWG0",twitter,,VinzFleischer,"{id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}",(brain) networks matter! honoured to be taking the stage at #msmilan2023! looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. see you all in milan! üëã #magnims #ectrims https://t.co/onrkqudwg0,male,"#msmilan2023, #magnims, #ectrims",,,6000000000,735756919588065280,,57,111,0,,,1,18,22,false,(brain) networks matter! honoured to be taking the stage at ms milan! looking forward to to share our research findings and exchange knowledge with colleagues from all over the world. see you all in milan! #magnims ec trims
283,2023-10-11 05:01:01.0,"Shared decision-making can be an important factor in an MS patient‚Äôs journey. Join our discussion with an MS nurse and a person living with MS about empowering patients and finding solutions together for MS management from diagnosis to care #MSMilan23

https://t.co/k8l8mONEc4 https://t.co/J0W5ataNYr",twitter,,NovartisMedical,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",shared decision-making can be an important factor in an ms patient‚Äôs journey. join our discussion with an ms nurse and a person living with ms about empowering patients and finding solutions together for ms management from diagnosis to care #msmilan23 https://t.co/k8l8monec4 https://t.co/j0w5atanyr,,#msmilan23,Beauty/Health & Fitness,,6000000000,1529472917397970946,,7797,4,0,,,0,0,110,true,shared decision-making can be an important factor in an ms patients journey. join our discussion with an ms nurse and a person living with ms about empowering patients and finding solutions together for ms management from diagnosis to care msmilan23
284,2023-10-10 21:32:25.0,"#ECTRIMS2023 MS Patient Community Day on Saturday, Oct 14th. 3-5 pm CEST. Meet with the scientific community Learn about advancements in MS care.
Attend for FREE in-person or online. 

USA 6 am PDT, 7 am MDT, 8 am CDT, 9 am EST.
https://t.co/pYba8KNcKz",twitter,,SolvingMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ectrims2023 ms patient community day on saturday, oct 14th. 3-5 pm cest. meet with the scientific community learn about advancements in ms care. attend for free in-person or online. usa 6 am pdt, 7 am mdt, 8 am cdt, 9 am est. https://t.co/pyba8knckz",female,#ectrims2023,,,6000000000,1633532750434119680,,742,2300,2,,,3,6,718,false,"ec trims ms patient community day on saturday, oct 14th. 3-5 pm cest. meet with the scientific community learn about advancements in ms care. attend for free in-person or online. usa 6 am pdt, 7 am mdt, 8 am cdt, 9 am est."
285,2023-10-10 20:12:08.0,"Check out P344/1717 (Switching Between Disease Modifying Treatment for Relapsing Remitting Multiple Sclerosis, a Retrospective Review of Practice at a Regional Multiple Sclerosis Centre in England) by Dr Brex and colleagues #ECTRIMS2023",twitter,,KingsMScentre,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","check out p344/1717 (switching between disease modifying treatment for relapsing remitting multiple sclerosis, a retrospective review of practice at a regional multiple sclerosis centre in england) by dr brex and colleagues #ectrims2023",female,#ectrims2023,,,6000000000,1531038944766345217,,100,168,0,,,0,2,31,false,"check out p344/1717 (switching between disease modifying treatment for relapsing remitting multiple sclerosis, a retrospective review of practice at a regional multiple sclerosis centre in england) by dr brex and colleagues ec trims"
286,2023-10-10 20:10:59.0,Delighted to see colleagues from all over the world dedicated to accelerating research in MS and can‚Äôt wait to attend #MSmilan2023 @ECTRIMS tomorrow! https://t.co/OS0DPswE9c,twitter,CAN,PamelaKanellis,"{id=20279310, name=Ofev, displayName=null, parentId=20279181, parentName=ERS 2023 categories}, {id=15147375, name=Ofev, displayName=null, parentId=15147295, parentName=ESR 2022 Conference categories}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",delighted to see colleagues from all over the world dedicated to accelerating research in ms and can‚Äôt wait to attend #msmilan2023 @ectrims tomorrow! https://t.co/os0dpswe9c,female,#msmilan2023,,,6000000000,256679634,,1171,1912,0,,,2,14,6555,false,delighted to see colleagues from all over the world dedicated to accelerating research in ms and cant wait to attend ms milan tomorrow!
287,2023-10-10 20:10:09.0,Check out poster P064/1261 (Increasing medication exposure in MS pregnancies: results from the UK MS Pregnancy Register) by Dr Brex and colleagues #ECTRIMS2023,twitter,,KingsMScentre,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",check out poster p064/1261 (increasing medication exposure in ms pregnancies: results from the uk ms pregnancy register) by dr brex and colleagues #ectrims2023,female,#ectrims2023,,,6000000000,1531038944766345217,,100,168,0,,,1,2,30,false,check out poster p064/1261 (increasing medication exposure in ms pregnancies: results from the uk ms pregnancy register) by dr brex and colleagues ec trims
288,2023-10-10 18:31:22.0,"Congrats @MarTintore and team for #MSMilan2023, I will follow virtually the exciting conferences and speakers, for a #world without #MS @ECTRIMS @ACTRIMS @mssociety @XMontalban @Pluchinolab @tim_coetzee @BeboBruce the countdown to end #progressive #MS is on. https://t.co/qpjdaPZeho",twitter,USA,DrJim4MS,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","congrats @martintore and team for #msmilan2023, i will follow virtually the exciting conferences and speakers, for a #world without #ms @ectrims @actrims @mssociety @xmontalban @pluchinolab @tim_coetzee @bebobruce the countdown to end #progressive #ms is on. https://t.co/qpjdapzeho",male,"#msmilan2023, #world, #ms, #progressive, #ms",,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,294295726,,1769,619,0,,,3,7,7964,false,"congrats and team for ms milan, i will follow virtually the exciting conferences and speakers, for a #world without ms the countdown to end #progressive ms is on."
289,2023-10-10 16:55:09.0,"This week we're headed to #MSMilan2023 - the world's largest #MultipleSclerosis research event! üáÆüáπüîç Join this global community of #MS professionals and connect with our team of Simoa¬Æ experts at the event by reserving time here: https://t.co/dBmA5S0B46
@ECTRIMS üß™ https://t.co/S8rEvFdFjg",twitter,USA,QuanterixSimoa,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",this week we're headed to #msmilan2023 - the world's largest #multiplesclerosis research event! üáÆüáπüîç join this global community of #ms professionals and connect with our team of simoa¬Æ experts at the event by reserving time here: https://t.co/dbma5s0b46 @ectrims üß™ https://t.co/s8revfdfjg,unknown,"#msmilan2023, #multiplesclerosis, #ms",,,6000000000,979206722,,1299,626,0,,,0,0,3651,false,this week we're headed to ms milan - the world's largest multiple sclerosis research event! join this global community of ms professionals and connect with our team of simoa experts at the event by reserving time here:
290,2023-10-10 14:00:02.0,"üì¢ #News: @ECTRIMS is almost here, and we‚Äôre presenting key data from our treatment portfolio for people living with relapsing #MultipleSclerosis. Read more: https://t.co/3HavEgf1tZ 

#ECTRIMS2023 #MS #Neurology #HCPsOnly https://t.co/kwbkBvpE5R",twitter,USA,EMDSerono,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üì¢ #news: @ectrims is almost here, and we‚Äôre presenting key data from our treatment portfolio for people living with relapsing #multiplesclerosis. read more: https://t.co/3havegf1tz #ectrims2023 #ms #neurology #hcpsonly https://t.co/kwbkbvpe5r",unknown,"#news, #multiplesclerosis, #ectrims2023, #ms, #neurology, #hcpsonly",Business,,6000000000,574524931,,9118,781,0,,,0,1,4467,false,"#news: is almost here, and were presenting key data from our treatment portfolio for people living with relapsing multiple sclerosis. read more: ec trims ms #neurology #hcpsonly"
291,2023-10-10 13:23:19.0,"This has become my life. 
The higher cancer lesion risk seen in MS patients on high-efficacy DMTs may be due to immunosuppression and exposure to HPV, scientists say. https://t.co/7VdNiQzpmi",twitter,GBR,JustMsChelseaM,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this has become my life. the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say. https://t.co/7vdniqzpmi",female,,"Animals & Pets, Family & Parenting",,6000000000,613604052,,4715,2005,0,,,0,0,34629,false,"this has become my life. the higher cancer lesion risk seen in ms patients on high-efficacy dmts may be due to immunosuppression and exposure to hpv, scientists say."
292,2023-10-10 13:15:44.0,"Proposed #diagnostic criteria may not accurately distinguish #MOGAD from #MS, contributing to diagnostic inconsistencies across centers. MOG-IgG testing & consideration of MOGAD diagnosis are recommended only in absence of better alternative causes, such as MS. #ECTRIMS2023",twitter,,IJMSCtweets,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","proposed #diagnostic criteria may not accurately distinguish #mogad from #ms, contributing to diagnostic inconsistencies across centers. mog-igg testing & consideration of mogad diagnosis are recommended only in absence of better alternative causes, such as ms. #ectrims2023",,"#diagnostic, #mogad, #ms, #ectrims2023",,,6000000000,1054320667,,893,620,0,,,0,1,4135,false,"proposed #diagnostic criteria may not accurately distinguish #mogad from ms, contributing to diagnostic inconsistencies across centers. mog-igg testing & consideration of mogad diagnosis are recommended only in absence of better alternative causes, such as ms. ec trims"
293,2023-10-10 11:13:25.0,@samjcohn @ECTRIMS @ACTRIMS Safe travels! I hope for a cure for MS!,twitter,USA,GregoryAlexan10,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",@samjcohn @ectrims @actrims safe travels! i hope for a cure for ms!,male,,"Politics, Family & Parenting, Sports, Travel","{profession=Teacher & Lecturer, jobTitle=Educator}",6000000000,420587078,,292,640,0,http://twitter.com/samjcohn/statuses/1711618047193014488,,0,0,10339,false,safe travels! i hope for a cure for ms!
294,2023-10-10 09:00:41.0,"The #MS Special this week: ‚åõ Counting down the days to #MSMilan2023! Can‚Äôt wait to dive into the latest research and connect with experts in the field of #multiplesclerosis üî¨üí°ü§ùüèΩ. 
See you all there! 
#MS #msresearch https://t.co/M34joUyhLQ",twitter,,DSL_Deutschland,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",the #ms special this week: ‚åõ counting down the days to #msmilan2023! can‚Äôt wait to dive into the latest research and connect with experts in the field of #multiplesclerosis üî¨üí°ü§ùüèΩ. see you all there! #ms #msresearch https://t.co/m34jouyhlq,unknown,"#ms, #msmilan2023, #multiplesclerosis, #ms, #msresearch",,,6000000000,1587452051168034816,,177,348,0,,,0,0,593,false,the ms special this week: counting down the days to ms milan! cant wait to dive into the latest research and connect with experts in the field of multiple sclerosis . see you all there! ms msresearch
295,2023-10-10 08:55:01.0,Hans Lassmann telling us how important brain resident CD8+ T-cells are in the MS brain #ECTRIMS2023 #ECF https://t.co/NSO0dSGJUY,twitter,GBR,GavinGiovannoni,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",hans lassmann telling us how important brain resident cd8+ t-cells are in the ms brain #ectrims2023 #ecf https://t.co/nso0dsgjuy,male,"#ectrims2023, #ecf",,,6000000000,55284565,,14268,11,1,,,4,39,19595,true,hans lassmann telling us how important brain resident cd8+ t-cells are in the ms brain ec trims #ecf
296,2023-10-10 08:28:08.0,On my way to Milan to go to @ECTRIMS to learn more about #ms and meet a lot of people. Follow #MSmilan2023 https://t.co/U2NU0vyI5x,twitter,DEU,Birgitpower,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",on my way to milan to go to @ectrims to learn more about #ms and meet a lot of people. follow #msmilan2023 https://t.co/u2nu0vyi5x,female,"#ms, #msmilan2023",,,6000000000,22899395,,3334,1990,1,,,0,10,31834,false,on my way to milan to go to to learn more about ms and meet a lot of people. follow ms milan
297,2023-10-10 08:18:39.0,"@jefflan58459713 Totally, agree. I've done 5 clinical trials on remyelination at my #MS center but still need a breakthrough for people living with multiple sclerosis.  Check out the latest research this week at ECTRIMS meeting in #MSMilan2023. I'll  be live posting.",twitter,USA,drbarrysinger,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@jefflan58459713 totally, agree. i've done 5 clinical trials on remyelination at my #ms center but still need a breakthrough for people living with multiple sclerosis. check out the latest research this week at ectrims meeting in #msmilan2023. i'll be live posting.",male,"#ms, #msmilan2023",Science,,6000000000,1430793013,,7199,393,0,http://twitter.com/jefflan58459713/statuses/1711503561937322295,,0,0,3147,false,"totally, agree. i've done 5 clinical trials on remyelination at my ms center but still need a breakthrough for people living with multiple sclerosis. check out the latest research this week at ectrims meeting in ms milan. i'll be live posting."
298,2023-10-10 07:35:07.0,Biogen is gearing up for the #ECTRIMS2023 Congress in Milan this October!  Join us at booth A05 to explore the latest in #MultipleSclerosis and chat with our team about important topics in the field #MSMilan,twitter,USA,biogen,"{id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",biogen is gearing up for the #ectrims2023 congress in milan this october! join us at booth a05 to explore the latest in #multiplesclerosis and chat with our team about important topics in the field #msmilan,,"#ectrims2023, #multiplesclerosis, #msmilan","Beauty/Health & Fitness, Science",,6000000000,155650832,,45715,254,0,,,1,2,5857,false,biogen is gearing up for the ec trims congress in milan this october! join us at booth a05 to explore the latest in multiple sclerosis and chat with our team about important topics in the field msmilan
299,2023-10-10 06:24:26.0,"üì¢ #News: We‚Äôre presenting key data on the efficacy of our portfolio for relapsing #MultipleSclerosis  treatments at #ECTRIMS2023, which is starting soon. Find out more here: https://t.co/AUcVLyW1hy

#MS #Neurology #HCPsOnly https://t.co/whJiyD7Elk",twitter,DEU,MerckHealthcare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üì¢ #news: we‚Äôre presenting key data on the efficacy of our portfolio for relapsing #multiplesclerosis treatments at #ectrims2023, which is starting soon. find out more here: https://t.co/aucvlyw1hy #ms #neurology #hcpsonly https://t.co/whjiyd7elk",unknown,"#news, #multiplesclerosis, #ectrims2023, #ms, #neurology, #hcpsonly",,,6000000000,857893749959086080,,7566,623,0,,,2,6,4074,false,"#news: were presenting key data on the efficacy of our portfolio for relapsing multiple sclerosis treatments at ec trims, which is starting soon. find out more here: ms #neurology #hcpsonly"
300,2023-10-10 05:41:57.0,Heading to Milan for #MSMilan2023! Looking forward to connecting with colleagues and learning about the latest in Multiple Sclerosis research and treatment! @ECTRIMS @ACTRIMS https://t.co/8YmArxV39U,twitter,NLD,samjcohn,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",heading to milan for #msmilan2023! looking forward to connecting with colleagues and learning about the latest in multiple sclerosis research and treatment! @ectrims @actrims https://t.co/8ymarxv39u,male,#msmilan2023,Games,"{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,8294442,,13257,3175,3,,,2,65,13002,false,heading to milan for ms milan! looking forward to connecting with colleagues and learning about the latest in multiple sclerosis research and treatment!
301,2023-10-10 04:00:00.0,Our commitment to bridging science and clinical practice to drive better health outcomes for all continues. Thank you to the investigators who pave the way for advances in #multiplesclerosis research. Join us at #MSMilan2023 as we share 24 MS abstracts! #NeuroTwitter #ECTRIMS https://t.co/KgAHpU4l48,twitter,USA,GenentechMed,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",our commitment to bridging science and clinical practice to drive better health outcomes for all continues. thank you to the investigators who pave the way for advances in #multiplesclerosis research. join us at #msmilan2023 as we share 24 ms abstracts! #neurotwitter #ectrims https://t.co/kgahpu4l48,,"#multiplesclerosis, #msmilan2023, #neurotwitter, #ectrims",Beauty/Health & Fitness,,6000000000,1405237666677891073,,149,0,0,,,0,1,51,false,our commitment to bridging science and clinical practice to drive better health outcomes for all continues. thank you to the investigators who pave the way for advances in multiple sclerosis research. join us at ms milan as we share 24 ms abstracts! #neurotwitter ec trims
302,2023-10-10 02:40:19.0,"Have you ever experienced Medical gaslighting?
@GavinGiovannoni  is presenting his #MS patient survey at the biggest #MultipleSclerosis conference of the year! #ECTRIMS2023",twitter,,SolvingMS,"{id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",have you ever experienced medical gaslighting? @gavingiovannoni is presenting his #ms patient survey at the biggest #multiplesclerosis conference of the year! #ectrims2023,female,"#ms, #multiplesclerosis, #ectrims2023",,,6000000000,1633532750434119680,,743,2300,2,,,3,6,717,false,have you ever experienced medical gaslighting? is presenting his ms patient survey at the biggest multiple sclerosis conference of the year! ec trims
303,2023-10-10 02:20:29.0,"@GavinGiovannoni Dec 2021 my neuro refused to test for EBV.
""No chance you have EBV in your brain"". Gaslight!
Jan 2022 Harvard published proof #EBVcausesMS
Got EBV tests from GP.  Where do I go from here?
#ECTRIMS 2023 Hot Topic 1: MS and EBV > answers? https://t.co/JQHgb2vDFT",twitter,USA,SammyJoLDN,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","@gavingiovannoni dec 2021 my neuro refused to test for ebv. ""no chance you have ebv in your brain"". gaslight! jan 2022 harvard published proof #ebvcausesms got ebv tests from gp. where do i go from here? #ectrims 2023 hot topic 1: ms and ebv > answers? https://t.co/jqhgb2vdft",unknown,"#ebvcausesms, #ectrims","Beauty/Health & Fitness, Books","{profession=Artist, jobTitle=Co-author}",6000000000,29497803,,1221,2114,1,http://twitter.com/GavinGiovannoni/statuses/1711286408571191336,,0,3,5583,false,"dec 2021 my neuro refused to test for ebv. ""no chance you have ebv in your brain"". gaslight! jan 2022 harvard published proof #ebvcausesms got ebv tests from gp. where do i go from here? ec trims 2023 hot topic 1: ms and ebv > answers?"
304,2023-10-09 21:36:38.0,"Headed to Milan, Italy for MS conference. #MSMilan2023 #ECTRIMS https://t.co/Og21VCF4P6",twitter,USA,OdagoDr,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","headed to milan, italy for ms conference. #msmilan2023 #ectrims https://t.co/og21vcf4p6",male,"#msmilan2023, #ectrims","Beauty/Health & Fitness, Sports, Family & Parenting","{profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,1449379917750284289,,410,648,1,,,0,8,367,false,"headed to milan, italy for ms conference. ms milan ec trims"
305,2023-10-09 20:14:45.0,Great pleasure to finally meet Sumaira flower! Together we will contribute to make @ECTRIMS as the umbrella for #MS but also #nmosd #MOGAD,twitter,ESP,MarTintore,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711857, name=Disease: MOGAD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",great pleasure to finally meet sumaira flower! together we will contribute to make @ectrims as the umbrella for #ms but also #nmosd #mogad,unknown,"#ms, #nmosd, #mogad",,,6000000000,486940610,,2278,416,2,,,4,33,4780,false,great pleasure to finally meet sumaira flower! together we will contribute to make as the umbrella for ms but also #nmosd #mogad
306,2023-10-09 16:40:07.0,"üß†üöÄ Braindates are in high demand at #MSMilan2023! Don't wait - seize the chance to connect with fellow attendees. Ready to lead a discussion? 

Jump on the platform and share your topic üëâ https://t.co/gr5X58BSBi
Let's make every conversation count!

#networking #collaboration https://t.co/jltnAOvCM6",twitter,CHE,ECTRIMS,,üß†üöÄ braindates are in high demand at #msmilan2023! don't wait - seize the chance to connect with fellow attendees. ready to lead a discussion? jump on the platform and share your topic üëâ https://t.co/gr5x58bsbi let's make every conversation count! #networking #collaboration https://t.co/jltnaovcm6,,"#msmilan2023, #networking, #collaboration",,,6000000000,714464982,,7921,65,0,,,1,1,7087,false,braindates are in high demand at ms milan! don't wait - seize the chance to connect with fellow attendees. ready to lead a discussion? jump on the platform and share your topic let's make every conversation count! #networking #collaboration
307,2023-10-09 15:18:08.0,"We are eager to join with the MS community at @ECTRIMS #MSMilan2023.

We look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with #MS.

https://t.co/kEX5sZ1y2G https://t.co/dsdczfNpUc",twitter,,AbataTx,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","we are eager to join with the ms community at @ectrims #msmilan2023. we look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with #ms. https://t.co/kex5sz1y2g https://t.co/dsdczfnpuc",unknown,"#msmilan2023, #ms",Science,,6000000000,1367149082700087297,,209,78,0,,,0,0,136,false,"we are eager to join with the ms community at ms milan. we look forward to coming together with researchers, physicians, & advocates, who share in our dedication to improving quality of life for people living with ms."
308,2023-10-09 14:15:58.0,"üéóÔ∏èThe $IMUX team is looking forward to the #MSMilan2023 congress, taking place this week! It's going to be an exciting gathering of #MS researchers, healthcare professionals & industry leaders from all around the world.

#MultipleSclerosis #MSresearch #Immunic @ECTRIMS #ACTRIMS https://t.co/bqxebEbg8n",twitter,USA,ImmunicInc,"{id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üéóÔ∏èthe $imux team is looking forward to the #msmilan2023 congress, taking place this week! it's going to be an exciting gathering of #ms researchers, healthcare professionals & industry leaders from all around the world. #multiplesclerosis #msresearch #immunic @ectrims #actrims https://t.co/bqxebebg8n",,"#msmilan2023, #ms, #multiplesclerosis, #msresearch, #immunic, #actrims","Beauty/Health & Fitness, Business",,6000000000,951787758242226177,,590,756,0,,,2,5,1103,false,"the $imux team is looking forward to the ms milan congress, taking place this week! it's going to be an exciting gathering of ms researchers, healthcare professionals & industry leaders from all around the world. multiple sclerosis msresearch #immunic #actrims"
309,2023-10-09 11:37:48.0,"Ever had ur MS symptoms waved away or told they were in ur head?
Was ur MS diagnosis delayed because u weren't believed?
So thrilled this poster raising the issue of medical gaslighting in MS - written with @GavinGiovannoni, @NerdyNeuroMD & S√ºleyman G√ºler - debuts at @ECTRIMS.",twitter,GBR,RachelHorne19,"{id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","ever had ur ms symptoms waved away or told they were in ur head? was ur ms diagnosis delayed because u weren't believed? so thrilled this poster raising the issue of medical gaslighting in ms - written with @gavingiovannoni, @nerdyneuromd & s√ºleyman g√ºler - debuts at @ectrims.",female,,,"{profession=Journalist, jobTitle=Journalist}, {profession=Scientist & Researcher, jobTitle=Research Fellow}",6000000000,1284849469704540160,,6186,3465,21,,,22,96,5513,false,"ever had ur ms symptoms waved away or told they were in ur head? was ur ms diagnosis delayed because u weren't believed? so thrilled this poster raising the issue of medical gaslighting in ms - written with , & sleyman gler - debuts at ."
310,2023-10-09 08:00:57.0,We‚Äôre presenting new data at #MSMilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #NMOSD and improve the treatment experience for everyone living with this disease. Learn more: https://t.co/YLc9LIPVcD,twitter,IND,maheshpansare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",we‚Äôre presenting new data at #msmilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more: https://t.co/ylc9lipvcd,male,"#msmilan2023, #multiplesclerosis, #nmosd",,,6000000000,150924846,,446,2886,1,,,0,0,52537,false,were presenting new data at ms milan reflecting our long-standing commitment to advance the science in multiple sclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more:
312,2023-10-09 01:29:07.0,#immunology #neuroimmunology #publichealth #microbiome #ECTRIMS2023 #MS #multiple #sclerosis #COVID19 #SarsCov2 #T1DM #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #Tregs #health https://t.co/Q2XIq3Wpdi,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#immunology #neuroimmunology #publichealth #microbiome #ectrims2023 #ms #multiple #sclerosis #covid19 #sarscov2 #t1dm #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #tregs #health https://t.co/q2xiq3wpdi,unknown,"#immunology, #neuroimmunology, #publichealth, #microbiome, #ectrims2023, #ms, #multiple, #sclerosis, #covid19, #sarscov2, #t1dm, #womenshealth, #primarycare, #prevention, #autoimmune, #autoimmunity, #butyrate, #heartfailure, #microglia, #neurology, #cardiology, #obstetrics, #cytokines, #tregs, #health",,,6000000000,569107992,,4658,5105,0,,,0,0,52391,false,#immunology #neuroimmunology #publichealth #microbiome ec trims ms #multiple #sclerosis #covid19 #sarscov2 #t1dm #womenshealth #primarycare #prevention #autoimmune #autoimmunity #butyrate #heartfailure #microglia #neurology #cardiology #obstetrics #cytokines #tregs #health
313,2023-10-09 01:01:25.0,#MS #multiple #sclerosis #ECTRIMS2023 #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #OneHealth #AI #health #autoimmunity https://t.co/NiJej9eMD6,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#ms #multiple #sclerosis #ectrims2023 #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #onehealth #ai #health #autoimmunity https://t.co/nijej9emd6,unknown,"#ms, #multiple, #sclerosis, #ectrims2023, #autoimmune, #neuroimmunology, #womenshealth, #primarycare, #ankylosing, #spondylitis, #autoantibodies, #exposome, #environmental, #health, #rheumatoid, #arthritis, #psoriasis, #microbiome, #dietetics, #onehealth, #ai, #health, #autoimmunity",,,6000000000,569107992,,4658,5105,0,,,0,0,52390,false,ms #multiple #sclerosis ec trims #autoimmune #neuroimmunology #womenshealth #primarycare #ankylosing cancer under 50 #spondylitis #autoantibodies #exposome #environmental #health #rheumatoid #arthritis #psoriasis #microbiome #dietetics #onehealth #ai #health #autoimmunity
314,2023-10-09 00:28:51.0,"#MS #multiple #sclerosis #ECTRIMS2023 #womenshealth #exposome 

Multi-generational exposure to pollution
and insufficient sunlight prescriptions
during preconception, prenatal development and throughout life
adversely affect
microbiome health, brain health and immune function. https://t.co/4CBLBbmHNT",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ms #multiple #sclerosis #ectrims2023 #womenshealth #exposome multi-generational exposure to pollution and insufficient sunlight prescriptions during preconception, prenatal development and throughout life adversely affect microbiome health, brain health and immune function. https://t.co/4cblbbmhnt",unknown,"#ms, #multiple, #sclerosis, #ectrims2023, #womenshealth, #exposome",,,6000000000,569107992,,4658,5105,0,,,0,0,52389,false,"ms #multiple #sclerosis ec trims #womenshealth #exposome multi-generational exposure to pollution and insufficient sunlight prescriptions during preconception, prenatal development and throughout life adversely affect microbiome health, brain health and immune function."
315,2023-10-09 00:25:07.0,"#ECTRIMS2023 #womenshealth #MS #multiple #sclerosis #ClimateActionNow #publichealth #exposome #OneHealth

Multi-generational exposure to environmental pollutants
and insufficient sunlight prescriptions
increases the risk of
autoimmune disorders,
neurological disorders
and cancer. https://t.co/5JQJWwo7w7",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#ectrims2023 #womenshealth #ms #multiple #sclerosis #climateactionnow #publichealth #exposome #onehealth multi-generational exposure to environmental pollutants and insufficient sunlight prescriptions increases the risk of autoimmune disorders, neurological disorders and cancer. https://t.co/5jqjwwo7w7",unknown,"#ectrims2023, #womenshealth, #ms, #multiple, #sclerosis, #climateactionnow, #publichealth, #exposome, #onehealth",,,6000000000,569107992,,4658,5105,0,,,0,0,52395,false,"ec trims #womenshealth ms #multiple #sclerosis #climateactionnow #publichealth #exposome #onehealth multi-generational exposure to environmental pollutants and insufficient sunlight prescriptions increases the risk of autoimmune disorders, neurological disorders and cancer."
316,2023-10-09 00:16:42.0,#neuroimmunology #digital #health #virtual #health #ehealth #AI #health #prevention #primarycare AI in healthcare #ECTRIMS2023 #MS #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain https://t.co/ofbD7jgVaT,twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#neuroimmunology #digital #health #virtual #health #ehealth #ai #health #prevention #primarycare ai in healthcare #ectrims2023 #ms #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain https://t.co/ofbd7jgvat,unknown,"#neuroimmunology, #digital, #health, #virtual, #health, #ehealth, #ai, #health, #prevention, #primarycare, #ectrims2023, #ms, #multiple, #sclerosis, #aging, #longevity, #healthspan, #agedcare, #demenz, #microglia, #microbiome, #endometriosis, #rheumatoid, #arthritis, #chronic, #pain",,,6000000000,569107992,,4658,5105,1,,,0,0,52386,false,#neuroimmunology #digital #health #virtual #health #ehealth #ai #health #prevention #primarycare ai in healthcare ec trims ms #multiple #sclerosis #aging #longevity #healthspan #agedcare #demenz #microglia #microbiome #endometriosis #rheumatoid #arthritis #chronic #pain
317,2023-10-09 00:08:05.0,"#womenshealth #rheumatoid #arthritis #ECTRIMS2023 #MS #multiple #sclerosis #exposome 

Sunlight prescriptions (infrared, UVA, UVB)
need to be adequate for each genotype.

(nitro-)PAHs,
black carbon,
diesel compounds,
benzene metabolites
arsenic
and fluoride
need to be measured. https://t.co/OTxuaIlh9k",twitter,AUS,SilkeLeFay,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#womenshealth #rheumatoid #arthritis #ectrims2023 #ms #multiple #sclerosis #exposome sunlight prescriptions (infrared, uva, uvb) need to be adequate for each genotype. (nitro-)pahs, black carbon, diesel compounds, benzene metabolites arsenic and fluoride need to be measured. https://t.co/otxuailh9k",unknown,"#womenshealth, #rheumatoid, #arthritis, #ectrims2023, #ms, #multiple, #sclerosis, #exposome",,,6000000000,569107992,,4658,5105,0,,,0,0,52384,false,"#womenshealth #rheumatoid #arthritis ec trims ms #multiple #sclerosis #exposome sunlight prescriptions (infrared, uva, uvb) need to be adequate for each genotype. (nitro-)pahs, black carbon, diesel compounds, benzene metabolites arsenic and fluoride need to be measured."
318,2023-10-07 14:48:52.0,"Just one week till #MSMilan2023 Patient Community Day! ‚è∞ Don't miss this opportunity to connect with experts in the MS field and learn more about the latest #MSResearch. Will you be joining online? üëâ https://t.co/aUfYTUsO5a 
#ECTRIMS4me @ECTRIMS @ACTRIMS @aism_nazionale https://t.co/ZL9N6HXPKr",twitter,,MSIntFederation,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",just one week till #msmilan2023 patient community day! ‚è∞ don't miss this opportunity to connect with experts in the ms field and learn more about the latest #msresearch. will you be joining online? üëâ https://t.co/aufytuso5a #ectrims4me @ectrims @actrims @aism_nazionale https://t.co/zl9n6hxpkr,female,"#msmilan2023, #msresearch, #ectrims4me",,,6000000000,390672087,,6652,380,1,,,3,13,3451,false,just one week till ms milan patient community day! don't miss this opportunity to connect with experts in the ms field and learn more about the latest msresearch. will you be joining online? ec trims4me
320,2023-10-07 09:00:13.0,"Just 1Ô∏è‚É£ week till #MSMilan2023 Patient Community Day! 
Don't miss this opportunity to connect with experts in the #MS field and learn more about the latest #MSResearch. 
Will you be joining online? üëâ https://t.co/pHsSSRMhIq
#ECTRIMS4me @ECTRIMS @ACTRIMS @aism_nazionale https://t.co/aIdZh7fwND",twitter,BEL,eumsplatform,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",just 1Ô∏è‚É£ week till #msmilan2023 patient community day! don't miss this opportunity to connect with experts in the #ms field and learn more about the latest #msresearch. will you be joining online? üëâ https://t.co/phsssrmhiq #ectrims4me @ectrims @actrims @aism_nazionale https://t.co/aidzh7fwnd,female,"#msmilan2023, #ms, #msresearch, #ectrims4me",,,6000000000,600110872,,4857,890,0,,,0,6,5914,false,just 1 week till ms milan patient community day! don't miss this opportunity to connect with experts in the ms field and learn more about the latest msresearch. will you be joining online? ec trims4me
321,2023-10-06 13:14:04.0,"üì¢ We‚Äôre heading to Milan for #ECTRIMS2023 where we'll be sharing our latest data and research on #MS. 

üëã See you soon @ECTRIMS #HCPsOnly https://t.co/qqIfiG1za6 https://t.co/RWCEiK5eRj",twitter,USA,EMDSerono,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",üì¢ we‚Äôre heading to milan for #ectrims2023 where we'll be sharing our latest data and research on #ms. üëã see you soon @ectrims #hcpsonly https://t.co/qqifig1za6 https://t.co/rwceik5erj,unknown,"#ectrims2023, #ms, #hcpsonly",Business,,6000000000,574524931,,9120,781,0,,,0,6,4473,false,were heading to milan for ec trims where we'll be sharing our latest data and research on ms. see you soon #hcpsonly
322,2023-10-06 13:00:37.0,"I am excited to remotely attend #ECTRIMS - the world‚Äôs largest research meeting for Multiple Sclerosis. The MS Patient Comminty day is Saturday, October 14! Will anyone else be there?

#MultipleSclerosis #ECTRIMS4me #MSresearch #MSCommunity #innovation https://t.co/W66kk9L3aH",twitter,USA,JessicaBraggin,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","i am excited to remotely attend #ectrims - the world‚Äôs largest research meeting for multiple sclerosis. the ms patient comminty day is saturday, october 14! will anyone else be there? #multiplesclerosis #ectrims4me #msresearch #mscommunity #innovation https://t.co/w66kk9l3ah",female,"#ectrims, #multiplesclerosis, #ectrims4me, #msresearch, #mscommunity, #innovation",Beauty/Health & Fitness,,6000000000,709974061,,163,909,0,,,0,0,428,false,"i am excited to remotely attend ec trims - the worlds largest research meeting for multiple sclerosis. the ms patient comminty day is saturday, october 14! will anyone else be there? multiple sclerosis ec trims4me msresearch mscommunity #innovation"
323,2023-10-06 08:47:09.0,"Join me in #Milan2023 #ECTRIMS for a #Braindate, we will discuss MS treatments for the less fortunate. The acceess of MS patients to new expensive treaments still poses a problem in developing countries. We need alternatives, off-label options, trials. https://t.co/0hwmkyLPTJ",twitter,EGY,MHegazyMD,"{id=15960147, name=Zynteglo/ Pricing, displayName=null, parentId=15960144, parentName=Hemgenix SML}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","join me in #milan2023 #ectrims for a #braindate, we will discuss ms treatments for the less fortunate. the acceess of ms patients to new expensive treaments still poses a problem in developing countries. we need alternatives, off-label options, trials. https://t.co/0hwmkylptj",male,"#milan2023, #ectrims, #braindate",Business,"{profession=Teacher & Lecturer, jobTitle=Professor}",6000000000,1455259296,,120,236,0,,,0,3,75,false,"join me in milan2023 ec trims for a #braindate, we will discuss ms treatments for the less fortunate. the acceess of ms patients to new expensive treaments still poses a problem in developing countries. we need alternatives, off-label options, trials."
324,2023-10-05 18:59:00.0,"üì¢Ferran Prados, researcher at the @ADaSLab from #eHealthUOC, will be taking the role of chair in the session on ""Artificial Intelligence in MS: from diagnosis to prediction and treatment monitoring"" at @ECTRIMS in Milan. ü§ñüß†#ECTRIMS #MultipleSclerosis https://t.co/LVQ1d9337c https://t.co/V6jrnIhbV2",twitter,ESP,eHealthUOC,"{id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15944093, name=Diagnosis, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üì¢ferran prados, researcher at the @adaslab from #ehealthuoc, will be taking the role of chair in the session on ""artificial intelligence in ms: from diagnosis to prediction and treatment monitoring"" at @ectrims in milan. ü§ñüß†#ectrims #multiplesclerosis https://t.co/lvq1d9337c https://t.co/v6jrnihbv2",unknown,"#ehealthuoc, #ectrims, #multiplesclerosis",Beauty/Health & Fitness,,6000000000,843855847914704897,,2843,1259,0,,,0,2,8975,false,"ferran prados, researcher at the from #ehealthuoc, will be taking the role of chair in the session on ""artificial intelligence in ms: from diagnosis to prediction and treatment monitoring"" at in milan. ec trims multiple sclerosis"
325,2023-10-05 14:44:23.0,"ViewMind Inc.¬†will be exhibiting at¬†#msmilan2023 and presenting posters based on studies supported by Biogen and Hospital Ramos Mej√≠a. (Booth D30)
#MS #multiplesclerosis¬†#healthcare¬†#MSresearch ECTRIMS Congress ACTRIMS ¬Æ",twitter,USA,ViewMind_,"{id=16441714, name=Biogen, displayName=null, parentId=16441705, parentName=CI Updates'22}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",viewmind inc. will be exhibiting at #msmilan2023 and presenting posters based on studies supported by biogen and hospital ramos mej√≠a. (booth d30) #ms #multiplesclerosis #healthcare #msresearch ectrims congress actrims ¬Æ,unknown,"#msmilan2023, #ms, #multiplesclerosis, #healthcare, #msresearch",Beauty/Health & Fitness,,6000000000,986583802154799104,,213,778,0,,,0,1,389,false,viewmind inc. will be exhibiting at ms milan and presenting posters based on studies supported by biogen and hospital ramos meja. (booth d30) ms multiple sclerosis #healthcare msresearch ectrims congress actrims
326,2023-10-05 14:22:21.0,"üß† Join us at #MSMilan2023 for discussions on key topics like #biomarkers, future therapies, new #MS technologies, and more. Don't miss our poster presentations exploring digital health tools and in-depth MS research insights! #BrainAI #MultipleSclerosis #ECTRIMS https://t.co/dptK91Ko7C",twitter,BEL,icometrix,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üß† join us at #msmilan2023 for discussions on key topics like #biomarkers, future therapies, new #ms technologies, and more. don't miss our poster presentations exploring digital health tools and in-depth ms research insights! #brainai #multiplesclerosis #ectrims https://t.co/dptk91ko7c",unknown,"#msmilan2023, #biomarkers, #ms, #brainai, #multiplesclerosis, #ectrims",Beauty/Health & Fitness,,6000000000,434832427,,3318,2785,0,,,0,3,1335,false,"join us at ms milan for discussions on key topics like #biomarkers, future therapies, new ms technologies, and more. don't miss our poster presentations exploring digital health tools and in-depth ms research insights! #brainai multiple sclerosis ec trims"
327,2023-10-05 14:05:09.0,"üìÖ We're looking forward to #ECTRIMS2023 in Milan, Oct 11-13. 
üì¢ Our team will be sharing the latest data and research that have the potential to improve outcomes for people living with #MS.
üîó Read our blog about our activities at @ECTRIMS: https://t.co/RQMzvIMtBW #HCPsOnly https://t.co/bOCsPZfUKk",twitter,DEU,MerckHealthcare,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","üìÖ we're looking forward to #ectrims2023 in milan, oct 11-13. üì¢ our team will be sharing the latest data and research that have the potential to improve outcomes for people living with #ms. üîó read our blog about our activities at @ectrims: https://t.co/rqmzvimtbw #hcpsonly https://t.co/bocspzfukk",unknown,"#ectrims2023, #ms, #hcpsonly",,,6000000000,857893749959086080,,7549,622,0,,,2,39,4064,false,"we're looking forward to ec trims in milan, oct 11-13. our team will be sharing the latest data and research that have the potential to improve outcomes for people living with ms. read our blog about our activities at : #hcpsonly"
328,2023-10-05 09:04:28.0,"This time next week we will be at #MSMilan2023 üáÆüáπ We can't wait to connect with researchers, clinicians, and industry professionals. 

Join us at our booth for networking opportunities and to explore potential collaborations ü§ùüèΩüì∑

#MS #MultiplsSclerosis #MSResearch https://t.co/AzNfOuaMO6",twitter,GBR,UKMSRegister,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","this time next week we will be at #msmilan2023 üáÆüáπ we can't wait to connect with researchers, clinicians, and industry professionals. join us at our booth for networking opportunities and to explore potential collaborations ü§ùüèΩüì∑ #ms #multiplssclerosis #msresearch https://t.co/aznfouamo6",,"#msmilan2023, #ms, #multiplssclerosis, #msresearch",,,6000000000,325527212,,2283,1814,0,,,4,10,1815,false,"this time next week we will be at ms milan we can't wait to connect with researchers, clinicians, and industry professionals. join us at our booth for networking opportunities and to explore potential collaborations ms #multiplssclerosis msresearch"
330,2023-10-03 20:03:07.0,"Roche - Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD - Oct 02 2023

https://t.co/2S9cC9edkn",twitter,IND,lswonline,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",roche - roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd - oct 02 2023 https://t.co/2s9cc9edkn,,,,,6000000000,1032901399,,83,160,0,,,0,0,1503,false,roche - roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd - oct 02 2023
331,2023-10-03 15:20:11.0,"ForuMS: Highlights in MS Care. 

A 75-minute online video that reviews important information presented at the CMSC meeting and other meetings, such as ECTRIMS, as well as key updates in MS care that happened in 2022.

@CatMedEd

https://t.co/X2URcWkpmu https://t.co/DtF3YTU5TQ",twitter,USA,mscare,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","forums: highlights in ms care. a 75-minute online video that reviews important information presented at the cmsc meeting and other meetings, such as ectrims, as well as key updates in ms care that happened in 2022. @catmeded https://t.co/x2urcwkpmu https://t.co/dtf3ytu5tq",unknown,,Beauty/Health & Fitness,,6000000000,47616454,,2614,370,0,,,0,0,2397,false,"forums: highlights in ms care. a 75-minute online video that reviews important information presented at the cmsc meeting and other meetings, such as ectrims, as well as key updates in ms care that happened in 2022."
332,2023-10-03 13:56:53.0,"Only a week to go ... So get ready to rub shoulders with esteemed figures in the field of MS!

Register nowüì≤ https://t.co/h1uXXxEaFX #PreECTRIMS2023 #ECTRIMS #MSMILAN2023 #MedExLearning #EuropeanCharcotFoundation #ECF #fondazioneprada #MS #CME #MedicalEducation https://t.co/GEHxsItdqK",twitter,ITA,Medexlearning_,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",only a week to go ... so get ready to rub shoulders with esteemed figures in the field of ms! register nowüì≤ https://t.co/h1uxxxeafx #preectrims2023 #ectrims #msmilan2023 #medexlearning #europeancharcotfoundation #ecf #fondazioneprada #ms #cme #medicaleducation https://t.co/gehxsitdqk,unknown,"#preectrims2023, #ectrims, #msmilan2023, #medexlearning, #europeancharcotfoundation, #ecf, #fondazioneprada, #ms, #cme, #medicaleducation",,,6000000000,199276285,,1302,819,0,,,0,0,2893,false,only a week to go ... so get ready to rub shoulders with esteemed figures in the field of ms! register now #preectrims2023 ec trims ms milan #medexlearning #europeancharcotfoundation #ecf #fondazioneprada ms #cme #medicaleducation
333,2023-10-03 02:36:26.0,Whoooo! I‚Äôm outta here next week! I‚Äôll be at @ECTRIMS  in #Milan to keep fighting MS. https://t.co/pWARBkqYqr,twitter,USA,PruePlummer,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",whoooo! i‚Äôm outta here next week! i‚Äôll be at @ectrims in #milan to keep fighting ms. https://t.co/pwarbkqyqr,unknown,#milan,"Science, Animals & Pets, Fashion","{profession=Scientist & Researcher, jobTitle=Scientist}, {profession=Health practitioner, jobTitle=Clinician}",6000000000,72426830,,484,849,1,,,0,4,2468,false,whoooo! im outta here next week! ill be at in milan to keep fighting ms.
334,2023-10-02 20:30:33.0,"Pharma/Biotech Highlights:

$TRVN: Trevena presents respiratory monitoring study results.
$HZNP: Horizon presents UPLIZNA data at ECTRIMS.
$TGTX: TG Therapeutics highlights BRIUMVIG at European conference.
$SAVA: Cassava completes Alzheimer's trial enrollment successfully. https://t.co/eQRyd2oDRW",twitter,USA,OzmosiHealth,"{id=15947100, name=Follow up and monitoring, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",pharma/biotech highlights: $trvn: trevena presents respiratory monitoring study results. $hznp: horizon presents uplizna data at ectrims. $tgtx: tg therapeutics highlights briumvig at european conference. $sava: cassava completes alzheimer's trial enrollment successfully. https://t.co/eqryd2odrw,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1359,792,6,,,0,0,7046,true,pharma/biotech highlights: $trvn: trevena presents respiratory monitoring study results. $hznp: horizon presents uplizna data at ectrims. $tgtx: tg therapeutics highlights briumvig at european conference. $sava: cassava completes alzheimer's trial enrollment successfully.
335,2023-10-02 18:42:25.0,"$HZNP
Horizon Therapeutics plc Announces New UPLIZNA¬Æ (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 - https://t.co/hKnV1UhJuc",twitter,,MarcJacksonLA,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$hznp horizon therapeutics plc announces new uplizna¬Æ (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 - https://t.co/hknv1uhjuc,unknown,,Technology,,6000000000,4058194633,,3645,386,1,,,0,0,91493,false,$hznp horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 -
336,2023-10-02 18:41:05.0,Can anti-CD20 monoclonal antibodies be passed to breastmilk in postpartum women with #MS? A recent study found that the treatment is well-tolerated for mother and child. Read more MS research new in the #ECTRIMSBulletin: https://t.co/aDZJaOk7tj https://t.co/0nGsjDdZVG,twitter,CHE,ECTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",can anti-cd20 monoclonal antibodies be passed to breastmilk in postpartum women with #ms? a recent study found that the treatment is well-tolerated for mother and child. read more ms research new in the #ectrimsbulletin: https://t.co/adzjaok7tj https://t.co/0ngsjddzvg,,"#ms, #ectrimsbulletin",,,6000000000,714464982,,7886,65,0,,,2,3,7077,false,can anti-cd20 monoclonal antibodies be passed to breastmilk in postpartum women with ms? a recent study found that the treatment is well-tolerated for mother and child. read more ms research new in the ec trimsbulletin:
337,2023-10-02 14:37:31.0,"$RHHBY
Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD  https://t.co/X1ECgg0AV9",twitter,,MarcJacksonLA,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/x1ecgg0av9,unknown,,Technology,,6000000000,4058194633,,3644,386,1,,,0,0,91437,false,$rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
338,2023-10-02 13:15:41.0,"$HZNP Horizon Therapeutics reveals updated UPLIZNA¬Æ (inebilizumab-cdon) findings on Neuromyelitis Optica Spectrum Disorder (NMOSD) at ECTRIMS 2023.

More Info: https://t.co/uypS7Sflo0 $XBI $IBB $XPH $PPH https://t.co/t6qPKEsFrS",twitter,USA,OzmosiHealth,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$hznp horizon therapeutics reveals updated uplizna¬Æ (inebilizumab-cdon) findings on neuromyelitis optica spectrum disorder (nmosd) at ectrims 2023. more info: https://t.co/uyps7sflo0 $xbi $ibb $xph $pph https://t.co/t6qpkesfrs,unknown,,"Beauty/Health & Fitness, Business, Technology",,6000000000,1055982930,,1358,791,0,,,0,0,7010,true,$hznp horizon therapeutics reveals updated uplizna (inebilizumab-cdon) findings on neuromyelitis optica spectrum disorder (nmosd) at ectrims 2023. more info: $xbi $ibb $xph $pph
339,2023-10-02 12:08:45.0,Horizon Therapeutics plc Announces New UPLIZNA¬Æ (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 https://t.co/6Vb38SNfij https://t.co/gbxxpJF2Jo,twitter,,NewsFromBW,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",horizon therapeutics plc announces new uplizna¬Æ (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 https://t.co/6vb38snfij https://t.co/gbxxpjf2jo,,,Business,,6000000000,976297820532518914,,3110,25,0,,,0,0,581486,false,horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023
340,2023-10-02 12:06:30.0,NEWS: Today we announced that new data for our neuromyelitis optica spectrum disorder (#NMOSD) medicine will be presented at the 39th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (@ECTRIMS). Learn more: https://t.co/oFd6oi0REP. #MSMilan2023 https://t.co/2JhfikXveH,twitter,IRL,HorizonNews,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",news: today we announced that new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 39th congress of the european committee for treatment and research in multiple sclerosis (@ectrims). learn more: https://t.co/ofd6oi0rep. #msmilan2023 https://t.co/2jhfikxveh,unknown,"#nmosd, #msmilan2023",Science,,6000000000,2880366354,,4657,1594,0,,,2,6,4942,false,news: today we announced that new data for our neuromyelitis optica spectrum disorder (#nmosd) medicine will be presented at the 39th congress of the european committee for treatment and research in multiple sclerosis (). learn more: . ms milan
342,2023-10-02 12:03:02.0,Horizon Therapeutics plc Announces New UPLIZNA¬Æ (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023 $HZNP https://t.co/bHMtVx2aSZ,twitter,USA,health_stocks,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20712220, name=NMOSD drugs, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20740633, name=Uplizna / inebilizumab, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",horizon therapeutics plc announces new uplizna¬Æ (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 $hznp https://t.co/bhmtvx2asz,unknown,,"Business, Science",,6000000000,1090012514820280324,,649,155,0,,,0,0,14294,true,horizon therapeutics plc announces new uplizna (inebilizumab-cdon) data in neuromyelitis optica spectrum disorder (nmosd) to be presented at ectrims 2023 $hznp
343,2023-10-02 11:55:15.0,"Excited to share groundbreaking #MS #GWAS findings on Time of Conversion to SPMS and Age at MS Progression at #ECTRIMS2023/#ACTRIMS2023! üß¨ Join me at Poster Session [2], Poster number P520 to explore the first ever study done on this MS severity!",twitter,,SoumeenJin,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","excited to share groundbreaking #ms #gwas findings on time of conversion to spms and age at ms progression at #ectrims2023/#actrims2023! üß¨ join me at poster session [2], poster number p520 to explore the first ever study done on this ms severity!",unknown,"#ms, #gwas, #ectrims2023, #actrims2023","Beauty/Health & Fitness, Science","{profession=Student, jobTitle=Student}",6000000000,1609553391180546048,,5,16,0,,,0,0,2,false,"excited to share groundbreaking ms #gwas findings on time of conversion to spms and age at ms progression at ec trims/#actrims2023! join me at poster session [2], poster number p520 to explore the first ever study done on this ms severity!"
344,2023-10-02 08:18:07.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD #BusinessWire  https://t.co/LgzPz3QYXY,twitter,,Stock_Market_Pr,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd #businesswire https://t.co/lgzpz3qyxy,,#businesswire,Business,,6000000000,1089978712685273090,,30284,61,0,,,0,0,393467,false,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd businesswire
345,2023-10-02 05:26:06.0,"$RO.SW | $ROG.SW | $RHHBY
üá®üá≠
Roche 

To present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD 

https://t.co/VQnibja2gq https://t.co/06IySOjP7R",twitter,FIN,BullBearBres,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",$ro.sw | $rog.sw | $rhhby üá®üá≠ roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/vqnibja2gq https://t.co/06iysojp7r,unknown,,,,6000000000,1384738758587817986,,289,1,0,,,1,4,3846,false,$ro.sw | $rog.sw | $rhhby roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
346,2023-10-02 05:08:44.0,"$RHHBY [15s. delayed]: Issued Press Release on October 02, 01:00:00: Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD https://t.co/pxZCYpv0tH",twitter,USA,FlashAlert_me,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/pxzcypv0th",,,,,6000000000,1069693680066420736,,4641,0,0,,,0,0,1410768,false,"$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd"
347,2023-10-02 05:06:03.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD $RHHBY https://t.co/KF6sAmi1OI,twitter,USA,health_stocks,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd $rhhby https://t.co/kf6sami1oi,unknown,,"Business, Science",,6000000000,1090012514820280324,,648,155,0,,,0,0,14265,true,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd $rhhby
348,2023-10-02 05:03:23.0,"$RHHBY [15s. delayed]: Issued Press Release on October 02, 01:00:00: Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD https://t.co/lUr5jsTxpx",twitter,USA,FlashAlert_me,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/lur5jstxpx",,,,,6000000000,1069693680066420736,,4641,0,0,,,0,0,1410764,false,"$rhhby [15s. delayed]: issued press release on october 02, 01:00:00: roche to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd"
349,2023-10-02 05:02:35.0,Genentech to Present New Key Clinical and Real-world Data at ECTRIMS-ACTRIMS 2023 Showcasing Strength of Long-term Outcomes in MS and NMOSD https://t.co/feiwDux815 https://t.co/MBBQQJOPgL,twitter,,NewsFromBW,"{id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd https://t.co/feiwdux815 https://t.co/mbbqqjopgl,,,Business,,6000000000,976297820532518914,,3109,25,0,,,0,0,581322,false,genentech to present new key clinical and real-world data at ectrims-actrims 2023 showcasing strength of long-term outcomes in ms and nmosd
350,2023-10-02 05:01:54.0,#Breaking: We‚Äôre presenting new data at #MSMilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #NMOSD and improve the treatment experience for everyone living with this disease. Learn more: https://t.co/tvJ7mvfLNX,twitter,USA,genentech,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711856, name=Disease: NMOSD, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",#breaking: we‚Äôre presenting new data at #msmilan2023 reflecting our long-standing commitment to advance the science in #multiplesclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more: https://t.co/tvj7mvflnx,,"#breaking, #msmilan2023, #multiplesclerosis, #nmosd",,,6000000000,16150688,,128328,237,0,,,2,9,7658,false,#breaking: were presenting new data at ms milan reflecting our long-standing commitment to advance the science in multiple sclerosis and #nmosd and improve the treatment experience for everyone living with this disease. learn more:
351,2023-10-01 08:25:14.0,"T-minus 10 days until #MSMilan2023 ‚è∞

Milan is set to be the epicenter of MS breakthroughs and discussions.! While we connect virtually, our commitment to bringing you the latest is unwavering. Stay tuned to ‚ú®https://t.co/FB5htuqt0q‚ú®

@ECTRIMS https://t.co/edadj8uxa2",twitter,,VJNeurology,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","t-minus 10 days until #msmilan2023 ‚è∞ milan is set to be the epicenter of ms breakthroughs and discussions.! while we connect virtually, our commitment to bringing you the latest is unwavering. stay tuned to ‚ú®https://t.co/fb5htuqt0q‚ú® @ectrims https://t.co/edadj8uxa2",,#msmilan2023,Photo & Video,,6000000000,751336894068355072,,22530,582,0,,,0,0,3270,true,"t-minus 10 days until ms milan milan is set to be the epicenter of ms breakthroughs and discussions.! while we connect virtually, our commitment to bringing you the latest is unwavering. stay tuned to"
352,2023-10-01 06:24:14.0,/ @OxMEDiscovery  I noticed in NP today that in Milan there's going to be a meeting for European Committee for Treatment and Research in MS (ECTRIMS). Will you be presenting your Raman Spectroscopy and AI there- that it can differentiate between ME/CFS /MS/ HC's would be helpful?,twitter,,MECFSNanoneedle,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",/ @oxmediscovery i noticed in np today that in milan there's going to be a meeting for european committee for treatment and research in ms (ectrims). will you be presenting your raman spectroscopy and ai there- that it can differentiate between me/cfs /ms/ hc's would be helpful?,unknown,,,,6000000000,1548186101403172866,,482,1946,1,,,0,4,3253,false,/ i noticed in np today that in milan there's going to be a meeting for european committee for treatment and research in ms (ectrims). will you be presenting your raman spectroscopy and ai there- that it can differentiate between me/cfs /ms/ hc's would be helpful?
353,2023-09-30 22:46:12.0,Prof Sokhi and colleagues published their data from Kenyans with MS (https://t.co/Kg5a5lVUeT) which has set the stage for other studies in the continent. We will be presenting our data from @MayoClinicNeuro on Somalis with MS living in Minnesota @ECTRIMS next month. (2/2),twitter,USA,neuronathoo,"{id=15944094, name=Staging and risk assessment, displayName=null, parentId=15944091, parentName=AML emotional journey}, {id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580996, name=Third person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}",prof sokhi and colleagues published their data from kenyans with ms (https://t.co/kg5a5lvuet) which has set the stage for other studies in the continent. we will be presenting our data from @mayoclinicneuro on somalis with ms living in minnesota @ectrims next month. (2/2),female,,,"{profession=Teacher & Lecturer, jobTitle=Assistant Professor}, {profession=Scientist & Researcher, jobTitle=Neurologist}",6000000000,231585347,,733,736,0,,,6,19,2251,false,prof sokhi and colleagues published their data from kenyans with ms () which has set the stage for other studies in the continent. we will be presenting our data from on somalis with ms living in minnesota next month. (2/2)
354,2023-10-12 18:39:45.0,"Rhonda Voskuhl, MD, neurologist, research scientist and clinician at the University of California (UCLA) is the first winner of the Rachel Horne Prize for Women‚Äôs Research in MS. Dr. Voskuhl serves on the ACTRIMS Program Committee. https://t.co/YeL8XhgIeZ 
#ACTRIMS #MSMilan23",twitter,USA,ACTRIMS,"{id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","rhonda voskuhl, md, neurologist, research scientist and clinician at the university of california (ucla) is the first winner of the rachel horne prize for women‚Äôs research in ms. dr. voskuhl serves on the actrims program committee. https://t.co/yel8xhgiez #actrims #msmilan23",,"#actrims, #msmilan23",,,6000000000,556155283,,4384,330,0,,,0,2,656,false,"rhonda voskuhl, md, neurologist, research scientist and clinician at the university of california (ucla) is the first winner of the rachel horne prize for womens research in ms. dr. voskuhl serves on the actrims program committee. #actrims msmilan23"
355,2023-10-03 15:11:14.0,"#ACTRIMSForum 2024 theme is ""Breaking Barriers in MS."" Register now and join us February 29 - March 2 in West Palm Beach, Florida. Visit our website for details. https://t.co/zYJOCLzIWS https://t.co/ISx6nkBUWh",twitter,USA,ACTRIMS,"{id=15389480, name=First person, displayName=null, parentId=15389474, parentName=MCED_Vizia Oct'22}, {id=14580995, name=First person, displayName=null, parentId=14580736, parentName=MCED_August refresh-2022}, {id=20711855, name=Disease: MS, displayName=null, parentId=20711852, parentName=ECTRIMS 2023}","#actrimsforum 2024 theme is ""breaking barriers in ms."" register now and join us february 29 - march 2 in west palm beach, florida. visit our website for details. https://t.co/zyjoclziws https://t.co/isx6nkbuwh",,#actrimsforum,,,6000000000,556155283,,4349,330,0,,,0,0,654,false,"act rims forum 2024 theme is ""breaking barriers in ms."" register now and join us february 29 - march 2 in west palm beach, florida. visit our website for details."
